BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, Lane DP. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA. 1990;87:7555-7559. [PMID: 1699228 DOI: 10.1073/pnas.87.19.7555] [Cited by in Crossref: 603] [Cited by in F6Publishing: 646] [Article Influence: 18.8] [Reference Citation Analysis]
Number Citing Articles
1 Narayan S, Raza A, Mahmud I, Koo N, Garrett TJ, Law ME, Law BK, Sharma AK. Sensitization of FOLFOX-resistant colorectal cancer cells via the modulation of a novel pathway involving protein phosphatase 2A. iScience 2022;25:104518. [PMID: 35754740 DOI: 10.1016/j.isci.2022.104518] [Reference Citation Analysis]
2 Ogiri M, Seishima R, Nakamura K, Aimono E, Matsui S, Shigeta K, Chiyoda T, Tanishima S, Okabayashi K, Nishihara H, Kitagawa Y. Real-world application of next-generation sequencing-based test for surgically resectable colorectal cancer in clinical practice. Future Oncol 2022. [PMID: 35818975 DOI: 10.2217/fon-2022-0122] [Reference Citation Analysis]
3 Hálková T, Ptáčková R, Semyakina A, Suchánek Š, Traboulsi E, Ngo O, Hejcmanová K, Májek O, Bureš J, Zavoral M, Minárik M, Benešová L. Somatic Mutations in Exon 7 of the TP53 Gene in Index Colorectal Lesions Are Associated with the Early Occurrence of Metachronous Adenoma. Cancers (Basel) 2022;14:2823. [PMID: 35740488 DOI: 10.3390/cancers14122823] [Reference Citation Analysis]
4 Wang Y, Zhang L, Shi G, Liu M, Zhao W, Zhang Y, Wang Y, Zhang N. Effects of Inflammatory Response Genes on the Immune Microenvironment in Colorectal Cancer. Front Genet 2022;13:886949. [DOI: 10.3389/fgene.2022.886949] [Reference Citation Analysis]
5 Smith JC, Sheltzer JM. Genome-wide identification and analysis of prognostic features in human cancers. Cell Rep 2022;38:110569. [PMID: 35354049 DOI: 10.1016/j.celrep.2022.110569] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
6 Jayathilake AG, Kadife E, Kuol N, Luwor RB, Nurgali K, Su XQ. Krill oil supplementation reduces the growth of CT-26 orthotopic tumours in Balb/c mice. BMC Complement Med Ther 2022;22:34. [PMID: 35120511 DOI: 10.1186/s12906-022-03521-4] [Reference Citation Analysis]
7 Fukusada S, Shimura T, Iwasaki H, Okuda Y, Katano T, Ozeki T, Kitagawa M, Nishie H, Tanaka M, Ozeki K, Kubota E, Tanida S, Kataoka H. Relationship between gene mutations and clinicopathological features in nonampullary duodenal epithelial tumors. Dig Liver Dis 2021:S1590-8658(21)00892-6. [PMID: 34961702 DOI: 10.1016/j.dld.2021.12.004] [Reference Citation Analysis]
8 Rusu S, Verocq C, Trepant AL, Maris C, De Nève N, Blanchard O, Van Campenhout C, De Clercq S, Rorive S, Cotoi OS, Decaestecker C, Salmon I, D'Haene N. Immunohistochemistry as an accurate tool for the assessment of BRAF V600E and TP53 mutations in primary and metastatic melanoma. Mol Clin Oncol 2021;15:270. [PMID: 34790354 DOI: 10.3892/mco.2021.2432] [Reference Citation Analysis]
9 Nikodijević DD, Jovankić JV, Cvetković DM, Anđelković MZ, Nikezić AG, Milutinović MG. L-amino acid oxidase from snake venom: Biotransformation and induction of apoptosis in human colon cancer cells. Eur J Pharmacol 2021;910:174466. [PMID: 34481879 DOI: 10.1016/j.ejphar.2021.174466] [Reference Citation Analysis]
10 Spencer PS, Kisby GE. Role of Hydrazine-Related Chemicals in Cancer and Neurodegenerative Disease. Chem Res Toxicol 2021. [PMID: 34379394 DOI: 10.1021/acs.chemrestox.1c00150] [Reference Citation Analysis]
11 Doubleday PF, Fornelli L, Ntai I, Kelleher NL. Oncogenic KRAS creates an aspartate metabolism signature in colorectal cancer cells. FEBS J 2021. [PMID: 34227245 DOI: 10.1111/febs.16111] [Reference Citation Analysis]
12 Jiso A, Demuth P, Bachowsky M, Haas M, Seiwert N, Heylmann D, Rasenberger B, Christmann M, Dietrich L, Brunner T, Riyanti, Schäberle TF, Plubrukarn A, Fahrer J. Natural Merosesquiterpenes Activate the DNA Damage Response via DNA Strand Break Formation and Trigger Apoptotic Cell Death in p53-Wild-type and Mutant Colorectal Cancer. Cancers (Basel) 2021;13:3282. [PMID: 34209047 DOI: 10.3390/cancers13133282] [Reference Citation Analysis]
13 Ho CT, Wu MH, Chen MJ, Lin SP, Yen YT, Hung SC. Combination of Mesenchymal Stem Cell-Delivered Oncolytic Virus with Prodrug Activation Increases Efficacy and Safety of Colorectal Cancer Therapy. Biomedicines 2021;9:548. [PMID: 34068264 DOI: 10.3390/biomedicines9050548] [Reference Citation Analysis]
14 Ho K, Luo H, Zhu W, Tang Y. Critical role of SMG7 in activation of the ATR-CHK1 axis in response to genotoxic stress. Sci Rep 2021;11:7502. [PMID: 33820915 DOI: 10.1038/s41598-021-86957-x] [Reference Citation Analysis]
15 Li H, Wang J, Huang K, Zhang T, Gao L, Yang S, Yi W, Niu Y, Liu H, Wang Z, Wang G, Tao K, Wang L, Cai K. Nkx2.5 Functions as a Conditional Tumor Suppressor Gene in Colorectal Cancer Cells via Acting as a Transcriptional Coactivator in p53-Mediated p21 Expression. Front Oncol 2021;11:648045. [PMID: 33869046 DOI: 10.3389/fonc.2021.648045] [Reference Citation Analysis]
16 Dionellis VS, Norkin M, Karamichali A, Rossetti GG, Huelsken J, Ordonez-Moran P, Halazonetis TD. Genomic Instability Profiles at the Single Cell Level in Mouse Colorectal Cancers of Defined Genotypes. Cancers (Basel) 2021;13:1267. [PMID: 33809306 DOI: 10.3390/cancers13061267] [Reference Citation Analysis]
17 He W, Azzi-Martin L, Velasco V, Lehours P, Dubus P, Djavaheri-Mergny M, Ménard A. The CDT of Helicobacter hepaticus induces pro-survival autophagy and nucleoplasmic reticulum formation concentrating the RNA binding proteins UNR/CSDE1 and P62/SQSTM1. PLoS Pathog 2021;17:e1009320. [PMID: 33662035 DOI: 10.1371/journal.ppat.1009320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Pham TH, Park HM, Kim J, Hong JT, Yoon DY. STAT3 and p53: Dual Target for Cancer Therapy. Biomedicines 2020;8:E637. [PMID: 33371351 DOI: 10.3390/biomedicines8120637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Grimes DR, Jansen M, Macauley RJ, Scott JG, Basanta D. Evidence for hypoxia increasing the tempo of evolution in glioblastoma. Br J Cancer 2020;123:1562-9. [PMID: 32848201 DOI: 10.1038/s41416-020-1021-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Mohammed AA, Arif SH, Pity IS. P53 expression and micro-vessel density in relation with 5-year survival in patients with colorectal cancer. Ann Med Surg (Lond) 2020;57:311-4. [PMID: 32874562 DOI: 10.1016/j.amsu.2020.08.006] [Reference Citation Analysis]
21 Reischmann N, Andrieux G, Griffin R, Reinheckel T, Boerries M, Brummer T. BRAFV600E drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation. Oncogene 2020;39:6053-70. [PMID: 32792685 DOI: 10.1038/s41388-020-01414-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
22 Denu RA, Burkard ME. Analysis of the "centrosome-ome" identifies MCPH1 deletion as a cause of centrosome amplification in human cancer. Sci Rep 2020;10:11921. [PMID: 32681070 DOI: 10.1038/s41598-020-68629-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Chaudhry GE, Akim A, Zafar MN, Abdullah MA, Sung YY, Muhammad TST. Induction of apoptosis and role of paclitaxel-loaded hyaluronic acid-crosslinked nanoparticles in the regulation of AKT and RhoA. J Adv Pharm Technol Res 2020;11:101-6. [PMID: 33102192 DOI: 10.4103/japtr.JAPTR_26_20] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
24 Saito T, Chambers JK, Nakashima K, Nibe K, Ohno K, Tsujimoto H, Uchida K, Nakayama H. Immunohistochemical analysis of beta-catenin, E-cadherin and p53 in canine gastrointestinal epithelial tumors. J Vet Med Sci 2020;82:1277-86. [PMID: 32655099 DOI: 10.1292/jvms.20-0297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Hsu YC, Luo CW, Huang WL, Wu CC, Chou CL, Chen CI, Chang SJ, Chai CY, Wang HC, Chen TY, Li CF, Pan MR. BMI1-KLF4 axis deficiency improves responses to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer. Radiother Oncol 2020;149:249-58. [PMID: 32592893 DOI: 10.1016/j.radonc.2020.06.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 Sumsuzzman DM, Jin Y, Choi J, Yu J, Lee TH, Hong Y. Pathophysiological role of endogenous irisin against tumorigenesis and metastasis: Is it a potential biomarker and therapeutic? Tumour Biol 2019;41:101042831989279. [DOI: 10.1177/1010428319892790] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Huang Y, Liu N, Liu J, Liu Y, Zhang C, Long S, Luo G, Zhang L, Zhang Y. Mutant p53 drives cancer chemotherapy resistance due to loss of function on activating transcription of PUMA. Cell Cycle 2019;18:3442-55. [PMID: 31726940 DOI: 10.1080/15384101.2019.1688951] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
28 Ray D, Ray P, Ferrer-Torres D, Wang Z, Nancarrow D, Yoon HW, San Martinho M, Hinton T, Owens S, Thomas D, Jiang H, Lawrence TS, Lin J, Lagisetty K, Chang AC, Beer DG. Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells. Gastroenterology 2020;158:583-597.e1. [PMID: 31715145 DOI: 10.1053/j.gastro.2019.10.040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
29 Stastna M, Janeckova L, Hrckulak D, Kriz V, Korinek V. Human Colorectal Cancer from the Perspective of Mouse Models. Genes (Basel) 2019;10:E788. [PMID: 31614493 DOI: 10.3390/genes10100788] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
30 Miller JJ, Blanchet A, Orvain C, Nouchikian L, Reviriot Y, Clarke RM, Martelino D, Wilson D, Gaiddon C, Storr T. Bifunctional ligand design for modulating mutant p53 aggregation in cancer. Chem Sci 2019;10:10802-14. [PMID: 32055386 DOI: 10.1039/c9sc04151f] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
31 Kumar K, Kumar Dhara A, Kumar Chaudhary V, Sandip N, Roy P, Verma P, Ghosh K. The influence of the tertiary butyl group in the ligand frame on the catalytic activities, DNA cleavage ability and cytotoxicity of dinuclear nickel(II) complexes. Inorganica Chimica Acta 2019;495:118993. [DOI: 10.1016/j.ica.2019.118993] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
32 Williams DS, Mouradov D, Browne C, Palmieri M, Elliott MJ, Nightingale R, Fang CG, Li R, Mariadason JM, Faragher I, Jones IT, Churilov L, Tebbutt NC, Gibbs P, Sieber OM. Overexpression of TP53 protein is associated with the lack of adjuvant chemotherapy benefit in patients with stage III colorectal cancer. Mod Pathol 2020;33:483-95. [DOI: 10.1038/s41379-019-0353-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
33 Xue Y, San Luis B, Lane DP. Intratumour heterogeneity of p53 expression; causes and consequences. J Pathol 2019;249:274-85. [PMID: 31322742 DOI: 10.1002/path.5328] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
34 Neitzel C, Seiwert N, Göder A, Diehl E, Weber C, Nagel G, Stroh S, Rasenberger B, Christmann M, Fahrer J. Lipoic Acid Synergizes with Antineoplastic Drugs in Colorectal Cancer by Targeting p53 for Proteasomal Degradation. Cells 2019;8:E794. [PMID: 31366086 DOI: 10.3390/cells8080794] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
35 Chung SS, Dutta P, Chard N, Wu Y, Chen QH, Chen G, Vadgama J. A novel curcumin analog inhibits canonical and non-canonical functions of telomerase through STAT3 and NF-κB inactivation in colorectal cancer cells. Oncotarget 2019;10:4516-31. [PMID: 31360301 DOI: 10.18632/oncotarget.27000] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
36 Nam TW, Park SY, Lee JH, Roh JI, Lee HW. Effect of EI24 expression on the tumorigenesis of ApcMin/+ colorectal cancer mouse model. Biochem Biophys Res Commun 2019;514:1087-92. [PMID: 31097220 DOI: 10.1016/j.bbrc.2019.04.186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
37 Zhang X, Zhang H, Shen B, Sun XF. Chromogranin-A Expression as a Novel Biomarker for Early Diagnosis of Colon Cancer Patients. Int J Mol Sci 2019;20:E2919. [PMID: 31207989 DOI: 10.3390/ijms20122919] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
38 Li J, Wang Q, Wang Z, Cui N, Yang B, Niu W, Kuang H. Tetrandrine inhibits colon carcinoma HT-29 cells growth via the Bcl-2/Caspase 3/PARP pathway and G1/S phase. Biosci Rep 2019;39:BSR20182109. [PMID: 31040202 DOI: 10.1042/BSR20182109] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
39 Ma Q, Lu Y, Gu Y. ENKUR Is Involved in the Regulation of Cellular Biology in Colorectal Cancer Cells via PI3K/Akt Signaling Pathway. Technol Cancer Res Treat 2019;18:1533033819841433. [PMID: 30947633 DOI: 10.1177/1533033819841433] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Zhang L, Hu DL, Tang B, Cheng Y, Jiao C, Cheng L, Tan ZR, Zhou HH. NFE2L3 Inhibition Induces Cell Cycle Arrest at the G0/G1 Phase in Colorectal Cancer Cells through Downregulating CCND1 and pRb1-ser807/811. Dis Markers 2019;2019:2829798. [PMID: 31191746 DOI: 10.1155/2019/2829798] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
41 Milczarek M, Rossowska J, Klopotowska D, Stachowicz M, Kutner A, Wietrzyk J. Tacalcitol increases the sensitivity of colorectal cancer cells to 5-fluorouracil by downregulating the thymidylate synthase. J Steroid Biochem Mol Biol 2019;190:139-51. [PMID: 30923017 DOI: 10.1016/j.jsbmb.2019.03.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
42 Fernández-Aroca DM, Roche O, Sabater S, Pascual-Serra R, Ortega-Muelas M, Sánchez Pérez I, Belandia B, Ruiz-Hidalgo MJ, Sánchez-Prieto R. P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy. Cancer Lett 2019;451:23-33. [PMID: 30872077 DOI: 10.1016/j.canlet.2019.02.049] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
43 Paul P, Deka H, Malakar AK, Halder B, Chakraborty S. Nasopharyngeal carcinoma: understanding its molecular biology at a fine scale. Eur J Cancer Prev 2018;27:33-41. [PMID: 27748661 DOI: 10.1097/CEJ.0000000000000314] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
44 Campra P, Aznar-Garcia MJ, Ramos-Bueno RP, Gonzalez-Fernandez MJ, Khaldi H, Garrido-Cardenas JA. A whole-food approach to the in vitro assessment of the antitumor activity of gazpacho. Food Res Int 2019;121:441-52. [PMID: 31108768 DOI: 10.1016/j.foodres.2018.11.058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
45 Afrin S, Giampieri F, Gasparrini M, Forbes-Hernández TY, Cianciosi D, Reboredo-Rodriguez P, Zhang J, Manna PP, Daglia M, Atanasov AG, Battino M. Dietary phytochemicals in colorectal cancer prevention and treatment: A focus on the molecular mechanisms involved. Biotechnol Adv 2020;38:107322. [PMID: 30476540 DOI: 10.1016/j.biotechadv.2018.11.011] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 16.0] [Reference Citation Analysis]
46 Hosseini F, Sam MR, Jabbari N, Mozdarani H. Modulating Survivin as a Radioresistant Factor, Caspase-3, and Apoptosis by Omega-3 Docosahexaenoic Acid Sensitizes Mutant- p53 Colorectal Cancer Cells to γ-Irradiation. Cancer Biotherapy and Radiopharmaceuticals 2018;33:387-95. [DOI: 10.1089/cbr.2018.2445] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
47 Chung SS, Dutta P, Austin D, Wang P, Awad A, Vadgama JV. Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells. Oncotarget 2018;9:32943-57. [PMID: 30250641 DOI: 10.18632/oncotarget.25993] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
48 Paredes J, Ji P, Lacomb JF, Shroyer KR, Martello LA, Williams JL. Establishment of three novel cell lines derived from African American patients with colorectal carcinoma: A unique tool for assessing racial health disparity. Int J Oncol 2018;53:1516-28. [PMID: 30066857 DOI: 10.3892/ijo.2018.4510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Zhao Y, Zhang L, Wu Y, Dai Q, Zhou Y, Li Z, Yang L, Guo Q, Lu N. Selective anti-tumor activity of wogonin targeting the Warburg effect through stablizing p53. Pharmacol Res 2018;135:49-59. [PMID: 30031170 DOI: 10.1016/j.phrs.2018.07.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
50 Ansari H, Shahrisa A, Birgani YT, Birgani MT, Hajjari M, Asl JM. Long Noncoding RNAs in Colorectal Adenocarcinoma; an in silico Analysis. Pathol Oncol Res 2019;25:1387-94. [PMID: 29948619 DOI: 10.1007/s12253-018-0428-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
51 Dubey NK, Peng BY, Lin CM, Wang PD, Wang JR, Chan CH, Wei HJ, Deng WP. NSC 95397 Suppresses Proliferation and Induces Apoptosis in Colon Cancer Cells through MKP-1 and the ERK1/2 Pathway. Int J Mol Sci 2018;19:E1625. [PMID: 29857489 DOI: 10.3390/ijms19061625] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
52 Patra T, Ghosh P, Alam N, Murmu N. Supra-physiological concentration of glyoxylate inhibits proliferation of human colon cancer cells through oxidative stress. Life Sci 2018;207:80-9. [PMID: 29852189 DOI: 10.1016/j.lfs.2018.05.047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
53 Zargar P, Ghani E, Mashayekhi FJ, Ramezani A, Eftekhar E. Acriflavine enhances the antitumor activity of the chemotherapeutic drug 5-fluorouracil in colorectal cancer cells. Oncol Lett 2018;15:10084-90. [PMID: 29928378 DOI: 10.3892/ol.2018.8569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
54 Wu X, Shen Y. PMN inhibits colorectal cancer cells through inducing mitotic arrest and p53-dependent apoptosis via the inhibition of tubulin polymerization. Biochem Biophys Res Commun 2018;499:927-33. [PMID: 29626471 DOI: 10.1016/j.bbrc.2018.04.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
55 Lima S, Takabe K, Newton J, Saurabh K, Young MM, Leopoldino AM, Hait NC, Roberts JL, Wang HG, Dent P, Milstien S, Booth L, Spiegel S. TP53 is required for BECN1- and ATG5-dependent cell death induced by sphingosine kinase 1 inhibition. Autophagy 2018;14:942-57. [PMID: 29368980 DOI: 10.1080/15548627.2018.1429875] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
56 Yang H, Tian T, Wu D, Guo D, Lu J. Prevention and treatment effects of edible berries for three deadly diseases: Cardiovascular disease, cancer and diabetes. Critical Reviews in Food Science and Nutrition 2018;59:1903-12. [DOI: 10.1080/10408398.2018.1432562] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
57 Hosain SB, Khiste SK, Uddin MB, Vorubindi V, Ingram C, Zhang S, Hill RA, Gu X, Liu YY. Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells. Oncotarget 2016;7:60575-92. [PMID: 27517620 DOI: 10.18632/oncotarget.11169] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
58 Lim Y, Yu S, Yun JA, Do IG, Cho L, Kim YH, Kim HC. The prognostic significance of protein arginine methyltransferase 6 expression in colon cancer. Oncotarget 2018;9:9010-20. [PMID: 29507670 DOI: 10.18632/oncotarget.23809] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
59 Jung CH, Ho JN, Park JK, Kim EM, Hwang SG, Um HD. Involvement of SULF2 in y-irradiation-induced invasion and resistance of cancer cells by inducing IL-6 expression. Oncotarget 2016;7:16090-103. [PMID: 26895473 DOI: 10.18632/oncotarget.7449] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
60 Cristobal A, van den Toorn HWP, van de Wetering M, Clevers H, Heck AJR, Mohammed S. Personalized Proteome Profiles of Healthy and Tumor Human Colon Organoids Reveal Both Individual Diversity and Basic Features of Colorectal Cancer. Cell Rep 2017;18:263-74. [PMID: 28052255 DOI: 10.1016/j.celrep.2016.12.016] [Cited by in Crossref: 80] [Cited by in F6Publishing: 75] [Article Influence: 16.0] [Reference Citation Analysis]
61 Ma Y, Silveri L, LaCava J, Dokudovskaya S. Tumor suppressor NPRL2 induces ROS production and DNA damage response. Sci Rep 2017;7:15311. [PMID: 29127423 DOI: 10.1038/s41598-017-15497-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
62 Chen Y, Rao X, Huang K, Jiang X, Wang H, Teng L. FH535 Inhibits Proliferation and Motility of Colon Cancer Cells by Targeting Wnt/β-catenin Signaling Pathway. J Cancer 2017;8:3142-53. [PMID: 29158786 DOI: 10.7150/jca.19273] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
63 Shahab U, Ahmad MK, Mahdi AA, Waseem M, Arif B, Moinuddin, Ahmad S. The receptor for advanced glycation end products: A fuel to pancreatic cancer. Semin Cancer Biol 2018;49:37-43. [PMID: 28811077 DOI: 10.1016/j.semcancer.2017.07.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
64 Raja SB, Rajendiran V, Kasinathan NK, P A, Venkatabalasubramanian S, Murali MR, Devaraj H, Devaraj SN. Differential cytotoxic activity of Quercetin on colonic cancer cells depends on ROS generation through COX-2 expression. Food and Chemical Toxicology 2017;106:92-106. [DOI: 10.1016/j.fct.2017.05.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
65 Seidel DV, Azcárate-Peril MA, Chapkin RS, Turner ND. Shaping functional gut microbiota using dietary bioactives to reduce colon cancer risk. Semin Cancer Biol 2017;46:191-204. [PMID: 28676459 DOI: 10.1016/j.semcancer.2017.06.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 6.6] [Reference Citation Analysis]
66 Lasry A, Aran D, Butte AJ, Ben-Neriah Y. Cancer Cell-Autonomous Parainflammation Mimics Immune Cell Infiltration. Cancer Res 2017;77:3740-4. [PMID: 28667073 DOI: 10.1158/0008-5472.CAN-16-3383] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
67 Péré-Védrenne C, Prochazkova-Carlotti M, Rousseau B, He W, Chambonnier L, Sifré E, Buissonnière A, Dubus P, Mégraud F, Varon C, Ménard A. The Cytolethal Distending Toxin Subunit CdtB of Helicobacter hepaticus Promotes Senescence and Endoreplication in Xenograft Mouse Models of Hepatic and Intestinal Cell Lines. Front Cell Infect Microbiol 2017;7:268. [PMID: 28713773 DOI: 10.3389/fcimb.2017.00268] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
68 Squiban B, Ahmed ST, Frazer JK. Creation of a human T-ALL cell line online database. Leuk Lymphoma 2017;58:2728-30. [PMID: 28609209 DOI: 10.1080/10428194.2017.1300896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
69 Cabrita MA, Bose R, Vanzyl EJ, Pastic A, Marcellus KA, Pan E, Hamill JD, Mckay BC. The p53 protein induces stable miRNAs that have the potential to modify subsequent p53 responses. Gene 2017;608:86-94. [DOI: 10.1016/j.gene.2017.01.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
70 Toba T, Inoshita N, Kaise M, Nomura K, Kuribayashi Y, Tanaka M, Yamashita S, Furuhata T, Kikuchi D, Matsui A, Mitani T, Iizuka T, Hoteya S. Clinicopathological features of superficial non-ampurally duodenal epithelial tumor; gastric phenotype of histology correlates to higher malignant potency. J Gastroenterol 2018;53:64-70. [PMID: 28321513 DOI: 10.1007/s00535-017-1327-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
71 Ren NSX, Ji M, Tokar EJ, Busch EL, Xu X, Lewis D, Li X, Jin A, Zhang Y, Wu WKK, Huang W, Li L, Fargo DC, Keku TO, Sandler RS, Li X. Haploinsufficiency of SIRT1 Enhances Glutamine Metabolism and Promotes Cancer Development. Curr Biol 2017;27:483-94. [PMID: 28162896 DOI: 10.1016/j.cub.2016.12.047] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 5.6] [Reference Citation Analysis]
72 Cvetković DM, Živanović MN, Milutinović MG, Djukić TR, Radović MD, Cvetković AM, Filipović ND, Zdravković ND. Real-time monitoring of cytotoxic effects of electroporation on breast and colon cancer cell lines. Bioelectrochemistry 2017;113:85-94. [DOI: 10.1016/j.bioelechem.2016.10.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
73 Dominguez-Brauer C, Khatun R, Elia AJ, Thu KL, Ramachandran P, Baniasadi SP, Hao Z, Jones LD, Haight J, Sheng Y, Mak TW. E3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signaling. Proc Natl Acad Sci U S A 2017;114:E1148-57. [PMID: 28137882 DOI: 10.1073/pnas.1621355114] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
74 Xie J, Wang C, Gore JC. High Throughput Screening for Colorectal Cancer Specific Compounds. Comb Chem High Throughput Screen 2016;19:180-8. [PMID: 26830359 DOI: 10.2174/1386207319666160202120928] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
75 Ahn EH, Schroeder JJ. Sphingoid Bases and Ceramide Induce Apoptosis in HT-29 and HCT-116 Human Colon Cancer Cells. Exp Biol Med (Maywood) 2002;227:345-53. [DOI: 10.1177/153537020222700507] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 10.3] [Reference Citation Analysis]
76 Cho SH, Park SM, Lee HS, Lee HY, Cho KH. Attractor landscape analysis of colorectal tumorigenesis and its reversion. BMC Syst Biol 2016;10:96. [PMID: 27765040 DOI: 10.1186/s12918-016-0341-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
77 Lin ST, Tu SH, Yang PS, Hsu SP, Lee WH, Ho CT, Wu CH, Lai YH, Chen MY, Chen LC. Apple Polyphenol Phloretin Inhibits Colorectal Cancer Cell Growth via Inhibition of the Type 2 Glucose Transporter and Activation of p53-Mediated Signaling. J Agric Food Chem. 2016;64:6826-6837. [PMID: 27538679 DOI: 10.1021/acs.jafc.6b02861] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
78 Dlugosz A, Barakat AM, Björkström NK, Öst Å, Bergquist A. Diagnostic yield of endomicroscopy for dysplasia in primary sclerosing cholangitis associated inflammatory bowel disease: a feasibility study. Endosc Int Open 2016;4:E901-11. [PMID: 27540581 DOI: 10.1055/s-0042-111203] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
79 Naka T, Iwamoto Y, Shinohara N, Chuman H, Tsuneyoshi M. p53 Accumulation in Malignant Bone Tumors: An Immunohistochemical Analysis of 217 Cases. Int J Surg Pathol 1997;5:1-9. [DOI: 10.1177/106689699700500101] [Reference Citation Analysis]
80 Goldblum JR, Frank TS, Poy EL, Weiss SW. p53 Mutations and Tumor Progression in Well-differentiated Liposarcoma and Dermatofibrosarcoma Protuberans. Int J Surg Pathol 1995;3:35-41. [DOI: 10.1177/106689699500300106] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
81 Lasry A, Zinger A, Ben-Neriah Y. Inflammatory networks underlying colorectal cancer. Nat Immunol. 2016;17:230-240. [PMID: 26882261 DOI: 10.1038/ni.3384] [Cited by in Crossref: 245] [Cited by in F6Publishing: 229] [Article Influence: 40.8] [Reference Citation Analysis]
82 Shu J, Dolman GE, Duan J, Qiu G, Ilyas M. Statistical colour models: an automated digital image analysis method for quantification of histological biomarkers. Biomed Eng Online 2016;15:46. [PMID: 27121383 DOI: 10.1186/s12938-016-0161-6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 7.2] [Reference Citation Analysis]
83 Wang X, Ji P, Zhang Y, LaComb JF, Tian X, Li E, Williams JL. Aberrant DNA Methylation: Implications in Racial Health Disparity. PLoS One 2016;11:e0153125. [PMID: 27111221 DOI: 10.1371/journal.pone.0153125] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
84 Krattinger R, Boström A, Schiöth HB, Thasler WE, Mwinyi J, Kullak-Ublick GA. microRNA-192 suppresses the expression of the farnesoid X receptor. Am J Physiol Gastrointest Liver Physiol 2016;310:G1044-51. [PMID: 27079614 DOI: 10.1152/ajpgi.00297.2015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
85 Miller M, Braitbard O, Hochman J, Tshuva EY. Insights into molecular mechanism of action of salan titanium(IV) complex with in vitro and in vivo anticancer activity. J Inorg Biochem 2016;163:250-7. [PMID: 27090292 DOI: 10.1016/j.jinorgbio.2016.04.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
86 Thamkachy R, Kumar R, Rajasekharan KN, Sengupta S. ERK mediated upregulation of death receptor 5 overcomes the lack of p53 functionality in the diaminothiazole DAT1 induced apoptosis in colon cancer models: efficiency of DAT1 in Ras-Raf mutated cells. Mol Cancer 2016;15:22. [PMID: 26956619 DOI: 10.1186/s12943-016-0505-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
87 Moncsek A, Gruner M, Meyer H, Lehmann A, Kloetzel PM, Stohwasser R. Evidence for anti-apoptotic roles of proteasome activator 28γ via inhibiting caspase activity. Apoptosis 2015;20:1211-28. [PMID: 26201457 DOI: 10.1007/s10495-015-1149-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
88 Cabrita MA, Vanzyl EJ, Hamill JD, Pan E, Marcellus KA, Tolls VJ, Alonzi RC, Pastic A, Rambo TM, Sayed H, McKay BC. A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing. PLoS One 2016;11:e0148529. [PMID: 26840126 DOI: 10.1371/journal.pone.0148529] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
89 Afrin S, Giampieri F, Gasparrini M, Forbes-Hernandez TY, Varela-López A, Quiles JL, Mezzetti B, Battino M. Chemopreventive and Therapeutic Effects of Edible Berries: A Focus on Colon Cancer Prevention and Treatment. Molecules 2016;21:169. [PMID: 26840292 DOI: 10.3390/molecules21020169] [Cited by in Crossref: 85] [Cited by in F6Publishing: 68] [Article Influence: 14.2] [Reference Citation Analysis]
90 Cacan E, Spring AM, Kumari A, Greer SF, Garnett-Benson C. Combination Treatment with Sublethal Ionizing Radiation and the Proteasome Inhibitor, Bortezomib, Enhances Death-Receptor Mediated Apoptosis and Anti-Tumor Immune Attack. Int J Mol Sci 2015;16:30405-21. [PMID: 26703577 DOI: 10.3390/ijms161226238] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
91 He X, Liao J, Liu F, Yan J, Yan J, Shang H, Dou Q, Chang Y, Lin J, Song Y. Functional repair of p53 mutation in colorectal cancer cells using trans-splicing. Oncotarget 2015;6:2034-45. [PMID: 25576916 DOI: 10.18632/oncotarget.2988] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
92 Ganai AA, Farooqi H. Bioactivity of genistein: A review of in vitro and in vivo studies. Biomedicine & Pharmacotherapy 2015;76:30-8. [DOI: 10.1016/j.biopha.2015.10.026] [Cited by in Crossref: 110] [Cited by in F6Publishing: 94] [Article Influence: 15.7] [Reference Citation Analysis]
93 Nowacki L, Vigneron P, Rotellini L, Cazzola H, Merlier F, Prost E, Ralanairina R, Gadonna JP, Rossi C, Vayssade M. Betanin-Enriched Red Beetroot (Beta vulgaris L.) Extract Induces Apoptosis and Autophagic Cell Death in MCF-7 Cells. Phytother Res 2015;29:1964-73. [PMID: 26463240 DOI: 10.1002/ptr.5491] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 6.9] [Reference Citation Analysis]
94 Ferguson PJ, Sykelyk A, Figueredo R, Koropatnick J. Synergistic cytotoxicity against human tumor cell lines by oncolytic adenovirus dl1520 (ONYX-015) and melphalan. Tumori 2016;102:31-9. [PMID: 26429639 DOI: 10.5301/tj.5000438] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
95 Hehlgans S, Oppermann J, Reichert S, Fulda S, Rödel C, Rödel F. The SMAC mimetic BV6 sensitizes colorectal cancer cells to ionizing radiation by interfering with DNA repair processes and enhancing apoptosis. Radiat Oncol 2015;10:198. [PMID: 26383618 DOI: 10.1186/s13014-015-0507-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
96 Elliott K, Mcquaid S, Salto-tellez M, Maxwell P. Immunohistochemistry should undergo robust validation equivalent to that of molecular diagnostics. J Clin Pathol 2015;68:766-70. [DOI: 10.1136/jclinpath-2015-203178] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
97 Han J, Shi X, Zhang Y, Xu Y, Jiang Y, Zhang C, Feng L, Yang H, Shang D, Sun Z, Su F, Li C, Li X. ESEA: Discovering the Dysregulated Pathways based on Edge Set Enrichment Analysis. Sci Rep 2015;5:13044. [PMID: 26267116 DOI: 10.1038/srep13044] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
98 Puerta-García E, Cañadas-Garre M, Calleja-Hernández MÁ. Molecular biomarkers in colorectal carcinoma. Pharmacogenomics 2015;16:1189-222. [PMID: 26237292 DOI: 10.2217/PGS.15.63] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
99 Gazzard L, Williams K, Chen H, Axford L, Blackwood E, Burton B, Chapman K, Crackett P, Drobnick J, Ellwood C, Epler J, Flagella M, Gancia E, Gill M, Goodacre S, Halladay J, Hewitt J, Hunt H, Kintz S, Lyssikatos J, Macleod C, Major S, Médard G, Narukulla R, Ramiscal J, Schmidt S, Seward E, Wiesmann C, Wu P, Yee S, Yen I, Malek S. Mitigation of Acetylcholine Esterase Activity in the 1,7-Diazacarbazole Series of Inhibitors of Checkpoint Kinase 1. J Med Chem 2015;58:5053-74. [PMID: 25988399 DOI: 10.1021/acs.jmedchem.5b00464] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
100 Setyawati MI, Tay CY, Leong DT. Mechanistic Investigation of the Biological Effects of SiO 2 , TiO 2 , and ZnO Nanoparticles on Intestinal Cells. Small 2015;11:3458-68. [DOI: 10.1002/smll.201403232] [Cited by in Crossref: 92] [Cited by in F6Publishing: 79] [Article Influence: 13.1] [Reference Citation Analysis]
101 Miyazaki M, Uoto K, Sugimoto Y, Naito H, Yoshida K, Okayama T, Kawato H, Miyazaki M, Kitagawa M, Seki T, Fukutake S, Aonuma M, Soga T. Discovery of DS-5272 as a promising candidate: A potent and orally active p53-MDM2 interaction inhibitor. Bioorg Med Chem 2015;23:2360-7. [PMID: 25882531 DOI: 10.1016/j.bmc.2015.03.069] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
102 He X, Kong X, Yan J, Yan J, Zhang Y, Wu Q, Chang Y, Shang H, Dou Q, Song Y, Liu F. CP-31398 prevents the growth of p53-mutated colorectal cancer cells in vitro and in vivo. Tumour Biol 2015;36:1437-44. [PMID: 25663456 DOI: 10.1007/s13277-014-2389-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
103 Selbo PK, Bostad M, Olsen CE, Edwards VT, Høgset A, Weyergang A, Berg K. Photochemical internalisation, a minimally invasive strategy for light-controlled endosomal escape of cancer stem cell-targeting therapeutics. Photochem Photobiol Sci 2015;14:1433-50. [DOI: 10.1039/c5pp00027k] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
104 Tyagi N, Chakraborty A, Singh UP, Roy P, Ghosh K. Mononuclear iron( iii ) complexes of tridentate ligands with efficient nuclease activity and studies of their cytotoxicity. Org Biomol Chem 2015;13:11445-58. [DOI: 10.1039/c5ob01623a] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 2.1] [Reference Citation Analysis]
105 Dörsam B, Göder A, Seiwert N, Kaina B, Fahrer J. Lipoic acid induces p53-independent cell death in colorectal cancer cells and potentiates the cytotoxicity of 5-fluorouracil. Arch Toxicol 2015;89:1829-46. [PMID: 25526924 DOI: 10.1007/s00204-014-1434-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
106 Sánchez Y, Segura V, Marín-Béjar O, Athie A, Marchese FP, González J, Bujanda L, Guo S, Matheu A, Huarte M. Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature. Nat Commun 2014;5:5812. [PMID: 25524025 DOI: 10.1038/ncomms6812] [Cited by in Crossref: 120] [Cited by in F6Publishing: 121] [Article Influence: 15.0] [Reference Citation Analysis]
107 Wan LZ, Ma B, Zhang YQ. Preparation of morusin from Ramulus mori and its effects on mice with transplanted H22 hepatocarcinoma. Biofactors 2014;40:636-45. [PMID: 25422054 DOI: 10.1002/biof.1191] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
108 Abe N, Hou DX, Munemasa S, Murata Y, Nakamura Y. Nuclear factor-kappaB sensitizes to benzyl isothiocyanate-induced antiproliferation in p53-deficient colorectal cancer cells. Cell Death Dis 2014;5:e1534. [PMID: 25412312 DOI: 10.1038/cddis.2014.495] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
109 Kang H, Kiess A, Chung CH. Emerging biomarkers in head and neck cancer in the era of genomics. Nat Rev Clin Oncol. 2015;12:11-26. [PMID: 25403939 DOI: 10.1038/nrclinonc.2014.192] [Cited by in Crossref: 165] [Cited by in F6Publishing: 166] [Article Influence: 20.6] [Reference Citation Analysis]
110 Ando K, Oki E, Saeki H, Yan Z, Tsuda Y, Hidaka G, Kasagi Y, Otsu H, Kawano H, Kitao H, Morita M, Maehara Y. Discrimination of p53 immunohistochemistry-positive tumors by its staining pattern in gastric cancer. Cancer Med. 2015;4:75-83. [PMID: 25354498 DOI: 10.1002/cam4.346] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
111 Oka S, Leon J, Tsuchimoto D, Sakumi K, Nakabeppu Y. MUTYH, an adenine DNA glycosylase, mediates p53 tumor suppression via PARP-dependent cell death. Oncogenesis. 2014;3:e121. [PMID: 25310643 DOI: 10.1038/oncsis.2014.35] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
112 Hedbrant A, Erlandsson A, Delbro D, Wijkander J. Conditioned media from human macrophages of M1 phenotype attenuate the cytotoxic effect of 5‑fluorouracil on the HT‑29 colon cancer cell line. Int J Oncol 2015;46:37-46. [PMID: 25310018 DOI: 10.3892/ijo.2014.2696] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
113 Isoda T, Nakatsu Y, Yamauchi K, Piao J, Yao T, Honda H, Nakabeppu Y, Tsuzuki T. Abnormality in Wnt signaling is causatively associated with oxidative stress-induced intestinal tumorigenesis in MUTYH-null mice. Int J Biol Sci 2014;10:940-7. [PMID: 25170306 DOI: 10.7150/ijbs.9241] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
114 Yong FL, Wang CW, Roslani AC, Law CW. The involvement of miR-23a/APAF1 regulation axis in colorectal cancer. Int J Mol Sci. 2014;15:11713-11729. [PMID: 24992592 DOI: 10.3390/ijms 150711713] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
115 Yong FL, Wang CW, Roslani AC, Law CW. The involvement of miR-23a/APAF1 regulation axis in colorectal cancer. Int J Mol Sci 2014;15:11713-29. [PMID: 24992592 DOI: 10.3390/ijms150711713] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
116 Zdravkovic ND, Jovanovic IP, Radosavljevic GD, Arsenijevic AN, Zdravkovic ND, Mitrovic SLj, Arsenijevic NN. Potential dual immunomodulatory role of VEGF in ulcerative colitis and colorectal carcinoma. Int J Med Sci 2014;11:936-47. [PMID: 25076849 DOI: 10.7150/ijms.8277] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
117 Krell J, Frampton AE, Mirnezami R, Harding V, De Giorgio A, Roca Alonso L, Cohen P, Ottaviani S, Colombo T, Jacob J, Pellegrino L, Buchanan G, Stebbing J, Castellano L. Growth arrest-specific transcript 5 associated snoRNA levels are related to p53 expression and DNA damage in colorectal cancer. PLoS One. 2014;9:e98561. [PMID: 24926850 DOI: 10.1371/journal.pone.0098561] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 5.6] [Reference Citation Analysis]
118 Huang YT, Lin CI, Chien PH, Tang TT, Lin J, Chao JI. The depletion of securin enhances butein-induced apoptosis and tumor inhibition in human colorectal cancer. Chem Biol Interact 2014;220:41-50. [PMID: 24931875 DOI: 10.1016/j.cbi.2014.06.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
119 Leroy B, Girard L, Hollestelle A, Minna JD, Gazdar AF, Soussi T. Analysis of TP53 mutation status in human cancer cell lines: a reassessment. Hum Mutat. 2014;35:756-765. [PMID: 24700732 DOI: 10.1002/humu.22556] [Cited by in Crossref: 99] [Cited by in F6Publishing: 93] [Article Influence: 12.4] [Reference Citation Analysis]
120 Ines C, Donia O, Rahma B, Ben Ammar A, Sameh A, Khalfallah T, Abdelmajid BH, Sabeh M, Saadia B. Implication of K-ras and p53 in colorectal cancer carcinogenesis in Tunisian population cohort. Tumour Biol 2014;35:7163-75. [PMID: 24763823 DOI: 10.1007/s13277-014-1874-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
121 Tsikitis VL, White I, Mori M, Potter A, Bhattcharyya A, Hamilton SR, Buckmeier J, Lance P, Thompson P. Differential expression of microRNA-320a, -145, and -192 along the continuum of normal mucosa to high-grade dysplastic adenomas of the colorectum. Am J Surg. 2014;207:717-722; discussion 722. [PMID: 24791633 DOI: 10.1016/j.amjsurg.2013.12.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
122 Suzuki M, Nishiumi S, Matsubara A, Azuma T, Yoshida M. Metabolome analysis for discovering biomarkers of gastroenterological cancer. J Chromatogr B Analyt Technol Biomed Life Sci 2014;966:59-69. [PMID: 24636738 DOI: 10.1016/j.jchromb.2014.02.042] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
123 Bell GP, Thompson BJ. Colorectal cancer progression: lessons from Drosophila? Semin Cell Dev Biol 2014;28:70-7. [PMID: 24583474 DOI: 10.1016/j.semcdb.2014.02.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
124 Mikawa T, Maruyama T, Okamoto K, Nakagama H, Lleonart ME, Tsusaka T, Hori K, Murakami I, Izumi T, Takaori-Kondo A, Yokode M, Peters G, Beach D, Kondoh H. Senescence-inducing stress promotes proteolysis of phosphoglycerate mutase via ubiquitin ligase Mdm2. J Cell Biol 2014;204:729-45. [PMID: 24567357 DOI: 10.1083/jcb.201306149] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
125 Sun Y, Myers CJ, Dicker AP, Lu B. A novel radiation-induced p53 mutation is not implicated in radiation resistance via a dominant-negative effect. PLoS One 2014;9:e87492. [PMID: 24558369 DOI: 10.1371/journal.pone.0087492] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
126 Sagaert X. Prognostic biomarkers in colorectal cancer: where do we stand? Virchows Arch. 2014;464:379-391. [PMID: 24487787 DOI: 10.1007/s00428-013-1532-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
127 Ye S, Wu Y, Zhang W, Li N, Tang B. A sensitive SERS assay for detecting proteins and nucleic acids using a triple-helix molecular switch for cascade signal amplification. Chem Commun 2014;50:9409-12. [DOI: 10.1039/c4cc03988b] [Cited by in Crossref: 29] [Cited by in F6Publishing: 2] [Article Influence: 3.6] [Reference Citation Analysis]
128 Setyawati MI, Tay CY, Leong DT. Effect of zinc oxide nanomaterials-induced oxidative stress on the p53 pathway. Biomaterials 2013;34:10133-42. [DOI: 10.1016/j.biomaterials.2013.09.024] [Cited by in Crossref: 114] [Cited by in F6Publishing: 103] [Article Influence: 12.7] [Reference Citation Analysis]
129 Cruz-Bravo RK, Guevara-González RG, Ramos-Gómez M, Oomah BD, Wiersma P, Campos-Vega R, Loarca-Piña G. The fermented non-digestible fraction of common bean (Phaseolus vulgaris L.) triggers cell cycle arrest and apoptosis in human colon adenocarcinoma cells. Genes Nutr 2014;9:359. [PMID: 24293398 DOI: 10.1007/s12263-013-0359-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
130 Zhou Y, Zhao C, Gery S, Braunstein GD, Okamoto R, Alvarez R, Miles SA, Doan NB, Said JW, Gu J, Phillip Koeffler H. Off-target effects of c-MET inhibitors on thyroid cancer cells. Mol Cancer Ther 2014;13:134-43. [PMID: 24170771 DOI: 10.1158/1535-7163.MCT-13-0187] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
131 Guerriero E, Capone F, Rusolo F, Colonna G, Castello G, Costantini S. Dissimilar cytokine patterns in different human liver and colon cancer cell lines. Cytokine 2013;64:584-9. [PMID: 24064000 DOI: 10.1016/j.cyto.2013.09.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
132 Coelho TR, Gaspar R, Figueiredo P, Mendonça C, Lazo PA, Almeida L. Human JC polyomavirus in normal colorectal mucosa, hyperplastic polyps, sporadic adenomas, and adenocarcinomas in Portugal: JCV Presence in Normal or Abnormal Colorectal Mucosa. J Med Virol 2013;85:2119-27. [DOI: 10.1002/jmv.23705] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
133 Reyes-Zurita FJ, Rufino-Palomares EE, Medina PP, Leticia García-Salguero E, Peragón J, Cascante M, Lupiáñez JA. Antitumour activity on extrinsic apoptotic targets of the triterpenoid maslinic acid in p53-deficient Caco-2 adenocarcinoma cells. Biochimie 2013;95:2157-67. [PMID: 23973282 DOI: 10.1016/j.biochi.2013.08.017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
134 Park SY, Jung CH, Song B, Park OJ, Kim YM. Pro-apoptotic and migration-suppressing potential of EGCG, and the involvement of AMPK in the p53-mediated modulation of VEGF and MMP-9 expression. Oncol Lett 2013;6:1346-50. [PMID: 24179522 DOI: 10.3892/ol.2013.1533] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
135 Qiu L, Qiu L, Wu Z, Shen G, Yu R. Cooperative Amplification-Based Electrochemical Sensor for the Zeptomole Detection of Nucleic Acids. Anal Chem 2013;85:8225-31. [DOI: 10.1021/ac401300a] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
136 Lee SJ, No YR, Dang DT, Dang LH, Yang VW, Shim H, Yun CC. Regulation of hypoxia-inducible factor 1α (HIF-1α) by lysophosphatidic acid is dependent on interplay between p53 and Krüppel-like factor 5. J Biol Chem 2013;288:25244-53. [PMID: 23880760 DOI: 10.1074/jbc.M113.489708] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
137 Piotrowska H, Kucinska M, Murias M. Expression of CYP1A1, CYP1B1 and MnSOD in a panel of human cancer cell lines. Mol Cell Biochem 2013;383:95-102. [PMID: 23873331 DOI: 10.1007/s11010-013-1758-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
138 Ando K, Oki E, Zhao Y, Ikawa-Yoshida A, Kitao H, Saeki H, Kimura Y, Ida S, Morita M, Kusumoto T, Maehara Y. Mortalin is a prognostic factor of gastric cancer with normal p53 function. Gastric Cancer 2014;17:255-62. [PMID: 23828548 DOI: 10.1007/s10120-013-0279-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
139 Chen Z, Li Y, Zhang C, Yi H, Wu C, Wang J, Liu Y, Tan J, Wen J. Downregulation of Beclin 1 and impairment of autophagy in a small population of colorectal cancer. Dig Dis Sci. 2013;58:2887-2894. [PMID: 23812859 DOI: 10.1007/s10620-013-2732-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
140 Jung KA, Kwak MK. Enhanced 4-hydroxynonenal resistance in KEAP1 silenced human colon cancer cells. Oxid Med Cell Longev 2013;2013:423965. [PMID: 23766854 DOI: 10.1155/2013/423965] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
141 Roy N, Bommi PV, Bhat UG, Bhattacharjee S, Elangovan I, Li J, Patra KC, Kopanja D, Blunier A, Benya R. DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer. Cancer Res. 2013;73:3771-3782. [PMID: 23610444 DOI: 10.1158/0008-5472.can-12-4069] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
142 Nissim S, Idos GE, Wu B. Genetic markers of malignant transformation in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis. Pancreas. 2012;41:1195-1205. [PMID: 22750975 DOI: 10.1097/mpa.0b013e3182580fb4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
143 Shchors K, Persson AI, Rostker F, Tihan T, Lyubynska N, Li N, Swigart LB, Berger MS, Hanahan D, Weiss WA, Evan GI. Using a preclinical mouse model of high-grade astrocytoma to optimize p53 restoration therapy. Proc Natl Acad Sci U S A 2013;110:E1480-9. [PMID: 23542378 DOI: 10.1073/pnas.1219142110] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
144 Malhotra P, Anwar M, Nanda N, Kochhar R, Wig JD, Vaiphei K, Mahmood S. Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians. Tumour Biol. 2013;34:1901-1911. [PMID: 23526092 DOI: 10.1007/s13277-013-0734-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
145 Loriaux PM, Hoffmann A. A protein turnover signaling motif controls the stimulus-sensitivity of stress response pathways. PLoS Comput Biol 2013;9:e1002932. [PMID: 23468615 DOI: 10.1371/journal.pcbi.1002932] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
146 Laranjo M, Serra AC, Abrantes M, Piñeiro M, Gonçalves AC, Casalta-lopes J, Carvalho L, Sarmento-ribeiro AB, Rocha-gonsalves A, Botelho F. 2-Bromo-5-hydroxyphenylporphyrins for photodynamic therapy: Photosensitization efficiency, subcellular localization and in vivo studies. Photodiagnosis and Photodynamic Therapy 2013;10:51-61. [DOI: 10.1016/j.pdpdt.2012.05.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
147 Peerless Y, Simon E, Sabo E, Ben-Izhak O, Hershkovitz D. Normal colon tissue and colon carcinoma show no difference in heparanase promoter methylation. Exp Mol Pathol 2013;94:309-13. [PMID: 23313782 DOI: 10.1016/j.yexmp.2013.01.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
148 Shin YJ, Kim MS, Kim MS, Lee J, Kang M, Jeong JH. High-mobility group box 2 (HMGB2) modulates radioresponse and is downregulated by p53 in colorectal cancer cell. Cancer Biol Ther 2013;14:213-21. [PMID: 23255232 DOI: 10.4161/cbt.23292] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
149 Pradhan MP, Nagulapalli K, Palakal MJ. Cliques for the identification of gene signatures for colorectal cancer across population. BMC Syst Biol 2012;6 Suppl 3:S17. [PMID: 23282040 DOI: 10.1186/1752-0509-6-S3-S17] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
150 Campos-vega R, García-gasca T, Guevara-gonzalez R, Ramos-gomez M, Oomah BD, Loarca-piña G. Human Gut Flora-Fermented Nondigestible Fraction from Cooked Bean (Phaseolus vulgaris L.) Modifies Protein Expression Associated with Apoptosis, Cell Cycle Arrest, and Proliferation in Human Adenocarcinoma Colon Cancer Cells. J Agric Food Chem 2012;60:12443-50. [DOI: 10.1021/jf303940r] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
151 Lefort ÉC, Blay J. Apigenin and its impact on gastrointestinal cancers. Mol Nutr Food Res 2013;57:126-44. [PMID: 23197449 DOI: 10.1002/mnfr.201200424] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 6.7] [Reference Citation Analysis]
152 Schumacher U, Nehmann N, Adam E, Mukthar D, Slotki IN, Horny HP, Flens MJ, Schlegelberger B, Steinemann D. MDR-1-overexpression in HT 29 colon cancer cells grown in SCID mice. Acta Histochem 2012;114:594-602. [PMID: 22154301 DOI: 10.1016/j.acthis.2011.11.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
153 Im E, Jung J, Rhee SH. Toll-like receptor 5 engagement induces interleukin-17C expression in intestinal epithelial cells. J Interferon Cytokine Res 2012;32:583-91. [PMID: 22994872 DOI: 10.1089/jir.2012.0053] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
154 Tsui MMK, Tai WCS, Wong WY, Hsiao WLW. Selective G2/M arrest in a p53Val135-transformed cell line induced by lithium is mediated through an intricate network of MAPK and β-catenin signaling pathways. Life Sciences 2012;91:312-21. [DOI: 10.1016/j.lfs.2012.07.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
155 Zhu Y, Soroka DN, Sang S. Synthesis and Inhibitory Activities against Colon Cancer Cell Growth and Proteasome of Alkylresorcinols. J Agric Food Chem 2012;60:8624-31. [DOI: 10.1021/jf302872a] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
156 Chen HJ, Hsu LS, Shia YT, Lin MW, Lin CM. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway. Biochem Pharmacol. 2012;84:1143-1153. [PMID: 22935447 DOI: 10.1016/j.bcp.2012.08.011] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 7.2] [Reference Citation Analysis]
157 Solier S, Zhang YW, Ballestrero A, Pommier Y, Zoppoli G. DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment. Curr Cancer Drug Targets 2012;12:356-71. [PMID: 22385513 DOI: 10.2174/156800912800190901] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
158 Pradhan MP, Prasad NK, Palakal MJ. A systems biology approach to the global analysis of transcription factors in colorectal cancer. BMC Cancer 2012;12:331. [PMID: 22852817 DOI: 10.1186/1471-2407-12-331] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
159 Hoskins JM, Ong PS, Keku TO, Galanko JA, Martin CF, Coleman CA, Wolfe M, Sandler RS, McLeod HL. Association of eleven common, low-penetrance colorectal cancer susceptibility genetic variants at six risk loci with clinical outcome. PLoS One 2012;7:e41954. [PMID: 22848671 DOI: 10.1371/journal.pone.0041954] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
160 Kim J, Jayaprakasha GK, Vikram A, Patil BS. Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro. Toxicol In Vitro 2012;26:1216-23. [PMID: 22728232 DOI: 10.1016/j.tiv.2012.06.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
161 Nyiraneza C, Sempoux C, Detry R, Kartheuser A, Dahan K. Hypermethylation of the 5' CpG island of the p14ARF flanking exon 1β in human colorectal cancer displaying a restricted pattern of p53 overexpression concomitant with increased MDM2 expression. Clin Epigenetics 2012;4:9. [PMID: 22703554 DOI: 10.1186/1868-7083-4-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
162 Munck JM, Batey MA, Zhao Y, Jenkins H, Richardson CJ, Cano C, Tavecchio M, Barbeau J, Bardos J, Cornell L. Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K. Mol Cancer Ther. 2012;11:1789-1798. [PMID: 22576130 DOI: 10.1158/1535-7163.mct-11-0535] [Cited by in Crossref: 85] [Cited by in F6Publishing: 38] [Article Influence: 8.5] [Reference Citation Analysis]
163 Shen T, Huang S. . ACAMC 2012;12:631-9. [DOI: 10.2174/187152012800617678] [Cited by in Crossref: 87] [Cited by in F6Publishing: 84] [Article Influence: 8.7] [Reference Citation Analysis]
164 Thakral NK, Ray AR, Bar-Shalom D, Eriksson AH, Majumdar DK. Soluplus--solubilized citrated camptothecin--a potential drug delivery strategy in colon cancer. AAPS PharmSciTech 2012;13:59-66. [PMID: 22105472 DOI: 10.1208/s12249-011-9720-0] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
165 Lan YH, Chiang JH, Huang WW, Lu CC, Chung JG, Wu TS, Jhan JH, Lin KL, Pai SJ, Chiu YJ, Tsuzuki M, Yang JS. Activations of Both Extrinsic and Intrinsic Pathways in HCT 116 Human Colorectal Cancer Cells Contribute to Apoptosis through p53-Mediated ATM/Fas Signaling by Emilia sonchifolia Extract, a Folklore Medicinal Plant. Evid Based Complement Alternat Med 2012;2012:178178. [PMID: 22474491 DOI: 10.1155/2012/178178] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
166 López I, P Oliveira L, Tucci P, Alvarez-Valín F, A Coudry R, Marín M. Different mutation profiles associated to P53 accumulation in colorectal cancer. Gene. 2012;499:81-87. [PMID: 22373952 DOI: 10.1016/j.gene.2012.02.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
167 Livesey KM, Kang R, Vernon P, Buchser W, Loughran P, Watkins SC, Zhang L, Manfredi JJ, Zeh HJ, Li L. p53/HMGB1 complexes regulate autophagy and apoptosis. Cancer Res. 2012;72:1996-2005. [PMID: 22345153 DOI: 10.1158/0008-5472.can-11-2291] [Cited by in Crossref: 160] [Cited by in F6Publishing: 106] [Article Influence: 16.0] [Reference Citation Analysis]
168 Lindgren T, Stigbrand T, Riklund K, Johansson L, Eriksson D. Gene expression profiling in MOLT-4 cells during gamma-radiation-induced apoptosis. Tumor Biol 2012;33:689-700. [DOI: 10.1007/s13277-012-0329-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
169 Belt EJ, Brosens RP, Delis-van Diemen PM, Bril H, Tijssen M, van Essen DF, Heymans MW, Beliën JA, Stockmann HB, Meijer S, Meijer GA. Cell cycle proteins predict recurrence in stage II and III colon cancer. Ann Surg Oncol 2012;19 Suppl 3:S682-92. [PMID: 22311118 DOI: 10.1245/s10434-012-2216-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
170 Han X, Xu B, Beevers CS, Odaka Y, Chen L, Liu L, Luo Y, Zhou H, Chen W, Shen T, Huang S. Curcumin inhibits protein phosphatases 2A and 5, leading to activation of mitogen-activated protein kinases and death in tumor cells. Carcinogenesis 2012;33:868-75. [PMID: 22298641 DOI: 10.1093/carcin/bgs029] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 5.6] [Reference Citation Analysis]
171 Xia Z, Correa RG, Das JK, Farhana L, Castro DJ, Yu J, Oshima RG, Fontana JA, Reed JC, Dawson MI. Analogues of Orphan Nuclear Receptor Small Heterodimer Partner Ligand and Apoptosis Inducer ( E )-4-[3-(1-Adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic Acid. 2. Impact of 3-Chloro Group Replacement on Inhibition of Proliferation and Induction of Apoptosis of Leukemia and Cancer Cell Lines. J Med Chem 2012;55:233-49. [DOI: 10.1021/jm2011436] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
172 Nyiraneza C, Jouret-mourin A, Kartheuser A, Camby P, Plomteux O, Detry R, Dahan K, Sempoux C. Distinctive patterns of p53 protein expression and microsatellite instability in human colorectal cancer. Human Pathology 2011;42:1897-910. [DOI: 10.1016/j.humpath.2010.06.021] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
173 Sivagami G, Vinothkumar R, Bernini R, Preethy CP, Riyasdeen A, Akbarsha MA, Menon VP, Nalini N. Role of hesperetin (a natural flavonoid) and its analogue on apoptosis in HT-29 human colon adenocarcinoma cell line--a comparative study. Food Chem Toxicol 2012;50:660-71. [PMID: 22142698 DOI: 10.1016/j.fct.2011.11.038] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
174 Poehlmann A, Habold C, Walluscheck D, Reissig K, Bajbouj K, Ullrich O, Hartig R, Gali-Muhtasib H, Diestel A, Roessner A, Schneider-Stock R. Cutting edge: Chk1 directs senescence and mitotic catastrophe in recovery from G₂ checkpoint arrest. J Cell Mol Med 2011;15:1528-41. [PMID: 20716119 DOI: 10.1111/j.1582-4934.2010.01143.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
175 Melanson BD, Bose R, Hamill JD, Marcellus KA, Pan EF, McKay BC. The role of mRNA decay in p53-induced gene expression. RNA 2011;17:2222-34. [PMID: 22020975 DOI: 10.1261/rna.030122.111] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
176 Kendziorra E, Ahlborn K, Spitzner M, Rave-Fränk M, Emons G, Gaedcke J, Kramer F, Wolff HA, Becker H, Beissbarth T, Ebner R, Ghadimi BM, Pukrop T, Ried T, Grade M. Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy. Carcinogenesis 2011;32:1824-31. [PMID: 21983179 DOI: 10.1093/carcin/bgr222] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 6.3] [Reference Citation Analysis]
177 Wong RS. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 2011;30:87. [PMID: 21943236 DOI: 10.1186/1756-9966-30-87] [Cited by in Crossref: 1026] [Cited by in F6Publishing: 1014] [Article Influence: 93.3] [Reference Citation Analysis]
178 Ruiz-Magaña MJ, Rodríguez-Vargas JM, Morales JC, Saldivia MA, Schulze-Osthoff K, Ruiz-Ruiz C. The DNA methyltransferase inhibitors zebularine and decitabine induce mitochondria-mediated apoptosis and DNA damage in p53 mutant leukemic T cells. Int J Cancer 2012;130:1195-207. [PMID: 21455989 DOI: 10.1002/ijc.26107] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
179 Zachar Z, Marecek J, Maturo C, Gupta S, Stuart SD, Howell K, Schauble A, Lem J, Piramzadian A, Karnik S. Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo. J Mol Med (Berl). 2011;89:1137-1148. [PMID: 21769686 DOI: 10.1007/s00109-011-0785-8] [Cited by in Crossref: 100] [Cited by in F6Publishing: 91] [Article Influence: 9.1] [Reference Citation Analysis]
180 Beggs AD, Hodgson SV. The genomics of colorectal cancer: state of the art. Curr Genomics 2008;9:1-10. [PMID: 19424478 DOI: 10.2174/138920208783884865] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
181 Liang D, Qin Y, Zhao W, Zhai X, Guo Z, Wang R, Tong L, Lin L, Chen H, Wong YC, Zhong Z. S-allylmercaptocysteine effectively inhibits the proliferation of colorectal cancer cells under in vitro and in vivo conditions. Cancer Lett 2011;310:69-76. [PMID: 21794975 DOI: 10.1016/j.canlet.2011.06.019] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
182 Qi W, Weber CR, Wasland K, Savkovic SD. Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity. BMC Cancer 2011;11:219. [PMID: 21639915 DOI: 10.1186/1471-2407-11-219] [Cited by in Crossref: 71] [Cited by in F6Publishing: 56] [Article Influence: 6.5] [Reference Citation Analysis]
183 Subramaniya BR, Srinivasan G, Sadullah SS, Davis N, Subhadara LB, Halagowder D, Sivasitambaram ND. Apoptosis inducing effect of plumbagin on colonic cancer cells depends on expression of COX-2. PLoS One 2011;6:e18695. [PMID: 21559086 DOI: 10.1371/journal.pone.0018695] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
184 Williams JL, Ji P, Ouyang N, Kopelovich L, Rigas B. Protein nitration and nitrosylation by NO-donating aspirin in colon cancer cells: Relevance to its mechanism of action. Exp Cell Res 2011;317:1359-67. [PMID: 21406194 DOI: 10.1016/j.yexcr.2011.03.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
185 Maldonado ME, Bousserouel S, Gossé F, Lobstein A, Raul F. Implicación de NF-κB y p53 en la expresión de receptores de muerte-TRAIL y apoptosis por procianidinas en células metastásicas humanas SW620. biomedica 2011;30:577. [DOI: 10.7705/biomedica.v30i4.296] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
186 Lee ALZ, Dhillon SHK, Wang Y, Pervaiz S, Fan W, Yang YY. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles. Mol BioSyst 2011;7:1512. [DOI: 10.1039/c0mb00266f] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
187 Kellett A, O'connor M, Mccann M, Howe O, Casey A, Mccarron P, Kavanagh K, Mcnamara M, Kennedy S, May DD, Skell PS, O'shea D, Devereux M. Water-soluble bis(1,10-phenanthroline) octanedioate Cu2+ and Mn2+ complexes with unprecedented nano and picomolar in vitro cytotoxicity: promising leads for chemotherapeutic drug development. Med Chem Commun 2011;2:579. [DOI: 10.1039/c0md00266f] [Cited by in Crossref: 50] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
188 Mikeš J, Hýžďalová M, Kočí L, Jendželovský R, Kovaľ J, Vaculová A, Hofmanová J, Kozubík A, Fedoročko P. Lower sensitivity of FHC fetal colon epithelial cells to photodynamic therapy compared to HT-29 colon adenocarcinoma cells despite higher intracellular accumulation of hypericin. Photochem Photobiol Sci 2011;10:626. [DOI: 10.1039/c0pp00359j] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
189 Kellett A, O'connor M, Mccann M, Mcnamara M, Lynch P, Rosair G, Mckee V, Creaven B, Walsh M, Mcclean S, Foltyn A, O'shea D, Howe O, Devereux M. Bis-phenanthroline copper(ii) phthalate complexes are potent in vitro antitumour agents with ‘self-activating’ metallo-nuclease and DNA binding properties. Dalton Trans 2011;40:1024-7. [DOI: 10.1039/c0dt01607a] [Cited by in Crossref: 76] [Cited by in F6Publishing: 11] [Article Influence: 6.9] [Reference Citation Analysis]
190 Yu SH, Yang PM, Peng CW, Yu YC, Chiu SJ. Securin depletion sensitizes human colon cancer cells to fisetin-induced apoptosis. Cancer Lett 2011;300:96-104. [PMID: 20974518 DOI: 10.1016/j.canlet.2010.09.015] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
191 Tsukahara T, Hanazawa S, Kobayashi T, Iwamoto Y, Murakami-Murofushi K. Cyclic phosphatidic acid decreases proliferation and survival of colon cancer cells by inhibiting peroxisome proliferator-activated receptor γ. Prostaglandins Other Lipid Mediat. 2010;93:126-133. [PMID: 20932931 DOI: 10.1016/j.prostaglandins.2010.09.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
192 Jin Z, Wallace L, Harper SQ, Yang J. PP2A:B56{epsilon}, a substrate of caspase-3, regulates p53-dependent and p53-independent apoptosis during development. J Biol Chem 2010;285:34493-502. [PMID: 20807766 DOI: 10.1074/jbc.M110.169581] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
193 Berchuck A, Kohler MF, Boente MP, Rodriguez GC, Whitaker RS, Bast RC. Growth regulation and transformation of ovarian epithelium. Cancer 1993;71:545-51. [DOI: 10.1002/cncr.2820710209] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
194 Chen MF, Lee KD, Yeh CH, Chen WC, Huang WS, Chin CC, Lin PY, Wang JY. Role of peroxiredoxin I in rectal cancer and related to p53 status. Int J Radiat Oncol Biol Phys 2010;78:868-78. [PMID: 20732753 DOI: 10.1016/j.ijrobp.2010.05.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
195 Maslon MM, Hupp TR. Drug discovery and mutant p53. Trends Cell Biol. 2010;20:542-555. [PMID: 20656489 DOI: 10.1016/j.tcb.2010.06.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
196 Scott N, Martin I, Jack AS, Dixon MF, Quirke P. Genes mediating programmed cell death: an immunohistochemical study of bcl-2, c-myc and p53 expression in colorectal neoplasia. Clin Mol Pathol 1996;49:M151-8. [PMID: 16696064 DOI: 10.1136/mp.49.3.m151] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
197 Bennett MA, Kay EW, Mulcahy H, O'flaherty L, O'donoghue DP, Leader M, Croke DT. ras and p53 in the prediction of survival in Dukes' stage B colorectal carcinoma. Clin Mol Pathol 1995;48:M310-5. [PMID: 16696029 DOI: 10.1136/mp.48.6.m310] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
198 Ofner D, Maier H, Riedmann B, Holzberger P, Nogler M, Tötsch M, Bankfalvi A, Winde G, Böcker W, Schmid KW. Immunohistochemically detectable p53 and mdm-2 oncoprotein expression in colorectal carcinoma: prognostic significance. Clin Mol Pathol 1995;48:M12-6. [PMID: 16695968 DOI: 10.1136/mp.48.1.m12] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
199 Vanamala J, Reddivari L, Radhakrishnan S, Tarver C. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer. 2010;10:238. [PMID: 20504360 DOI: 10.1186/1471-2407-10-238] [Cited by in Crossref: 151] [Cited by in F6Publishing: 139] [Article Influence: 12.6] [Reference Citation Analysis]
200 Watson JL, Hill R, Yaffe PB, Greenshields A, Walsh M, Lee PW, Giacomantonio CA, Hoskin DW. Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells. Cancer Lett 2010;297:1-8. [PMID: 20472336 DOI: 10.1016/j.canlet.2010.04.018] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 6.8] [Reference Citation Analysis]
201 Walter A, Etienne-Selloum N, Brasse D, Khallouf H, Bronner C, Rio MC, Beretz A, Schini-Kerth VB. Intake of grape-derived polyphenols reduces C26 tumor growth by inhibiting angiogenesis and inducing apoptosis. FASEB J 2010;24:3360-9. [PMID: 20442318 DOI: 10.1096/fj.09-149419] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 4.0] [Reference Citation Analysis]
202 Campos-vega R, Guevara-gonzalez R, Guevara-olvera B, Dave Oomah B, Loarca-piña G. Bean (Phaseolus vulgaris L.) polysaccharides modulate gene expression in human colon cancer cells (HT-29). Food Research International 2010;43:1057-64. [DOI: 10.1016/j.foodres.2010.01.017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
203 Sun Z, Cheng Z, Taylor CA, McConkey BJ, Thompson JE. Apoptosis induction by eIF5A1 involves activation of the intrinsic mitochondrial pathway. J Cell Physiol 2010;223:798-809. [PMID: 20232312 DOI: 10.1002/jcp.22100] [Cited by in Crossref: 7] [Cited by in F6Publishing: 25] [Article Influence: 0.6] [Reference Citation Analysis]
204 Chang C, Chiou PP, Chen W, Li Y, Yiu J, Cheng Y, Chen S, Lin C, Lai Y. Assessment of the tumorigenesis and drug susceptibility of three new canine mammary tumor cell lines. Research in Veterinary Science 2010;88:285-93. [DOI: 10.1016/j.rvsc.2009.08.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
205 Réti A, Barna G, Pap E, Adleff V, L Komlósi V, Jeney A, Kralovánszky J, Budai B. Enhancement of 5-fluorouracil efficacy on high COX-2 expressing HCA-7 cells by low dose indomethacin and NS-398 but not on low COX-2 expressing HT-29 cells. Pathol Oncol Res 2009;15:335-44. [PMID: 19048402 DOI: 10.1007/s12253-008-9126-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
206 Roncoroni L, Elli L, Bardella MT, Dogliotti E, Grimoldi MG, Viaggi S, Erba E, Zunino A, Doneda L. Cytogenetic Characterization and Cell Cycle Analysis of Three Human Colon Adenocarcinoma Cell Lines: Comparison Between Two- and Three-Dimensional Cell Culture Systems. Cancer Investigation 2009;28:7-12. [DOI: 10.3109/07357900802653431] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
207 Daee DL, Mertz TM, Shcherbakova PV. A cancer-associated DNA polymerase delta variant modeled in yeast causes a catastrophic increase in genomic instability. Proc Natl Acad Sci U S A 2010;107:157-62. [PMID: 19966286 DOI: 10.1073/pnas.0907526106] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
208 Garrett WS, Punit S, Gallini CA, Michaud M, Zhang D, Sigrist KS, Lord GM, Glickman JN, Glimcher LH. Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells. Cancer Cell. 2009;16:208-219. [PMID: 19732721 DOI: 10.1016/j.ccr.2009.07.015] [Cited by in Crossref: 120] [Cited by in F6Publishing: 111] [Article Influence: 9.2] [Reference Citation Analysis]
209 Rao CV, Steele VE, Swamy MV, Patlolla JM, Guruswamy S, Kopelovich L. Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats. Cancer Res 2009;69:8175-82. [PMID: 19826045 DOI: 10.1158/0008-5472.CAN-09-1377] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
210 De Roock W, Biesmans B, De Schutter J, Tejpar S. Clinical biomarkers in oncology: focus on colorectal cancer. Mol Diagn Ther 2009;13:103-14. [PMID: 19537845 DOI: 10.1007/BF03256319] [Cited by in Crossref: 34] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
211 Willimott S, Barker J, Jones LA, Opara EI. An in vitro based investigation of the cytotoxic effect of water extracts of the Chinese herbal remedy LD on cancer cells. Chem Cent J 2009;3:12. [PMID: 19785738 DOI: 10.1186/1752-153X-3-12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
212 Plumb CL, Adamcic U, Shahrzad S, Minhas K, Adham SA, Coomber BL. Modulation of the tumor suppressor protein alpha-catenin by ischemic microenvironment. Am J Pathol 2009;175:1662-74. [PMID: 19745064 DOI: 10.2353/ajpath.2009.090007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
213 Shchepotin IB, Soldatenkov V, Wroblewski JT, Surin A, Shabahang M, Buras RR, Nauta RJ, Pulyaeva H, Evans SRT. Apoptosis induced by hyperthermia and verapamil in vitro in a human colon cancer cell line. International Journal of Hyperthermia 2009;13:547-57. [DOI: 10.3109/02656739709023553] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
214 Cardesa A, Nadal A, Jares P, Mallofré C, Fernández PL, Campo E, Traserra J. Hyperplastic lesions of the larynx. Experience of the Barcelona group. Acta Otolaryngol Suppl 1997;527:43-6. [PMID: 9197479 DOI: 10.3109/00016489709124032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
215 Nagai J, Kigasawa H, Koga N, Katoh A, Nishihira H, Nagao T. Clinical Significance of Detecting p53 Protein in Burkitt Lymphoma and B-cell Acute Lymphoblastic Leukemia Using Immunocytochemistry. Leukemia & Lymphoma 2009;28:591-7. [DOI: 10.3109/10428199809058368] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
216 Reimer R, Helmbold H, Szalay B, Hagel C, Hohenberg H, Deppert W, Bohn W. Nestin modulates glucocorticoid receptor function by cytoplasmic anchoring. PLoS One 2009;4:e6084. [PMID: 19562035 DOI: 10.1371/journal.pone.0006084] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
217 Lebovitz RM, Albrecht S. Molecular Biology in the Diagnosis and Prognosis of Solid and Lymphoid Tumors. Cancer Investigation 2009;10:399-416. [DOI: 10.3109/07357909209024798] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
218 Clairambault J. Modelling Physiological and Pharmacological Control on Cell Proliferation to Optimise Cancer Treatments. Math Model Nat Phenom 2009;4:12-67. [DOI: 10.1051/mmnp/20094302] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
219 Herbst A, Bommer GT, Kriegl L, Jung A, Behrens A, Csanadi E, Gerhard M, Bolz C, Riesenberg R, Zimmermann W, Dietmaier W, Wolf I, Brabletz T, Göke B, Kolligs FT. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition. Gastroenterology 2009;137:639-48, 648.e1-9. [PMID: 19394332 DOI: 10.1053/j.gastro.2009.04.049] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
220 Weyergang A, Berg K, Kaalhus O, Peng Q, Selbo PK. Photodynamic therapy targets the mTOR signaling network in vitro and in vivo. Mol Pharm 2009;6:255-64. [PMID: 19125612 DOI: 10.1021/mp800156e] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
221 Villegas I, Sánchez-Fidalgo S, Alarcón de la Lastra C. New mechanisms and therapeutic potential of curcumin for colorectal cancer. Mol Nutr Food Res 2008;52:1040-61. [PMID: 18655004 DOI: 10.1002/mnfr.200700280] [Cited by in Crossref: 94] [Cited by in F6Publishing: 78] [Article Influence: 7.2] [Reference Citation Analysis]
222 Kunnumakkara AB, Guha S, Aggarwal BB. Curcumin and colorectal cancer: Add spice to your life. Curr colorectal cancer rep 2009;5:5-14. [DOI: 10.1007/s11888-009-0002-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
223 Wang YD, Honores E, Wu B, Johnson S, Powell D, Miranda M, McGinnis JP, Discafani C, Rabindran SK, Cheng W, Krishnamurthy G. Synthesis, SAR study and biological evaluation of novel pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides as anti-proliferative agents. Bioorg Med Chem 2009;17:2091-100. [PMID: 19200741 DOI: 10.1016/j.bmc.2008.12.046] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
224 Lara E, Mai A, Calvanese V, Altucci L, Lopez-Nieva P, Martinez-Chantar ML, Varela-Rey M, Rotili D, Nebbioso A, Ropero S, Montoya G, Oyarzabal J, Velasco S, Serrano M, Witt M, Villar-Garea A, Imhof A, Mato JM, Esteller M, Fraga MF. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect. Oncogene 2009;28:781-91. [PMID: 19060927 DOI: 10.1038/onc.2008.436] [Cited by in Crossref: 180] [Cited by in F6Publishing: 179] [Article Influence: 12.9] [Reference Citation Analysis]
225 Suzuki S, Takeshita K, Asamoto M, Takahashi S, Kandori H, Tsujimura K, Saito F, Masuko K, Shirai T. High mobility group box associated with cell proliferation appears to play an important role in hepatocellular carcinogenesis in rats and humans. Toxicology 2009;255:160-70. [PMID: 19041683 DOI: 10.1016/j.tox.2008.10.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
226 Rao CV, Swamy MV, Patlolla JM, Kopelovich L. Suppression of familial adenomatous polyposis by CP-31398, a TP53 modulator, in APCmin/+ mice. Cancer Res 2008;68:7670-5. [PMID: 18794156 DOI: 10.1158/0008-5472.CAN-08-1610] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
227 Nelson E. Laboratory Probing of Oncogenes from Human Liquid and Solid Specimens as Markers of Exposure to Toxicants. Critical Reviews in Toxicology 2008;26:483-549. [DOI: 10.3109/10408449609037476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
228 Ohta M, Sugimoto T, Seto M, Mohri D, Asaoka Y, Tada M, Tanaka Y, Yamaji Y, Kanai F, Kawabe T, Omata M. Genetic alterations in colorectal cancers with demethylation of insulin-like growth factor II. Human Pathology 2008;39:1301-8. [DOI: 10.1016/j.humpath.2008.02.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
229 Liu HF, Hsiao PW, Chao JI. Celecoxib induces p53-PUMA pathway for apoptosis in human colorectal cancer cells. Chem Biol Interact 2008;176:48-57. [PMID: 18760266 DOI: 10.1016/j.cbi.2008.07.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
230 Gan Y, Gu J, Cai X, Hu J, Liu XY, Zhao X. Adenovirus-mediated HCCS1 overexpression elicits a potent antitumor efficacy on human colorectal cancer and hepatoma cells both in vitro and in vivo. Cancer Gene Ther 2008;15:808-16. [DOI: 10.1038/cgt.2008.52] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
231 Srivastava A, Pandey SN, Choudhuri G, Mittal B. CCR5 Delta32 polymorphism: associated with gallbladder cancer susceptibility. Scand J Immunol. 2008;67:516-522. [PMID: 18405329 DOI: 10.1111/j.1365-3083.2008.02097.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
232 Wu Y, Fang B, Yang XQ, Wang L, Chen D, Krasnykh V, Carter BZ, Morris JS, Shureiqi I. Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancer. Mol Ther 2008;16:886-92. [PMID: 18388920 DOI: 10.1038/mt.2008.44] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
233 Tejpar S. The multidisciplinary management of gastrointestinal cancer. The use of molecular markers in the diagnosis and treatment of colorectal cancer. Best Pract Res Clin Gastroenterol 2007;21:1071-87. [PMID: 18070704 DOI: 10.1016/j.bpg.2007.10.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
234 Tanaka T, Watanabe T, Kazama Y, Tanaka J, Kanazawa T, Kazama S, Nagawa H. Loss of Smad4 protein expression and 18qLOH as molecular markers indicating lymph node metastasis in colorectal cancer--a study matched for tumor depth and pathology. J Surg Oncol. 2008;97:69-73. [PMID: 17786972 DOI: 10.1002/jso.20896] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
235 Matkar SS, Wrischnik LA, Hellmann-Blumberg U. Sanguinarine causes DNA damage and p53-independent cell death in human colon cancer cell lines. Chem Biol Interact. 2008;172:63-71. [PMID: 18243168 DOI: 10.1016/j.cbi.2007.12.006] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 3.5] [Reference Citation Analysis]
236 Chiu S, Hsu T, Chao J. Expression of securin promotes colorectal cancer cell death via a p53-independent pathway after radiation. Chemico-Biological Interactions 2007;170:153-61. [DOI: 10.1016/j.cbi.2007.07.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
237 Koehler A, Kunz-Schughart LA, Hofstaedter F, Dietmaier W. Multiple molecular analyses from minimal cell quantities by sequential isolation and preamplification of DNA and RNA. Diagn Mol Pathol 2007;16:141-6. [PMID: 17721321 DOI: 10.1097/PDM.0b013e318050aace] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
238 Skwarska A, Augustin E, Konopa J. Sequential induction of mitotic catastrophe followed by apoptosis in human leukemia MOLT4 cells by imidazoacridinone C-1311. Apoptosis 2007;12:2245-57. [DOI: 10.1007/s10495-007-0144-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
239 Derouet M, Wu X, May L, Hoon Yoo B, Sasazuki T, Shirasawa S, Rak J, Rosen KV. Acquisition of anoikis resistance promotes the emergence of oncogenic K-ras mutations in colorectal cancer cells and stimulates their tumorigenicity in vivo. Neoplasia 2007;9:536-45. [PMID: 17710156 DOI: 10.1593/neo.07217] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
240 Zacal N, Rainbow AJ. Photodynamic therapy resistant human colon carcinoma HT29 cells show cross-resistance to UVA but not UVC light. Photochem Photobiol 2007;83:730-7. [PMID: 17576382 DOI: 10.1111/j.1751-1097.2007.00078.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
241 Kadaja-Saarepuu L, Laos S, Jääger K, Viil J, Balikova A, Lõoke M, Hansson GC, Maimets T. CD43 promotes cell growth and helps to evade FAS-mediated apoptosis in non-hematopoietic cancer cells lacking the tumor suppressors p53 or ARF. Oncogene 2008;27:1705-15. [PMID: 17891181 DOI: 10.1038/sj.onc.1210802] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
242 Tan XL, Nieters A, Hoffmeister M, Beckmann L, Brenner H, Chang-Claude J. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction? Pharmacogenet Genomics 2007;17:639-45. [PMID: 17622940 DOI: 10.1097/FPC.0b013e3280d5121c] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
243 Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci U S A. 2007;104:15472-15477. [PMID: 17875987 DOI: 10.1073/pnas.0707351104] [Cited by in Crossref: 658] [Cited by in F6Publishing: 650] [Article Influence: 43.9] [Reference Citation Analysis]
244 Saito K, Ogawa A, Ohki I. Immunohistochemical Study of Colorectal Polyps with Antibodies against CEA, CA19‐9, CA125, CA15‐3 (DF3), PCNA and p53. Digestive Endoscopy 2007;8:93-100. [DOI: 10.1111/j.1443-1661.1996.tb00422.x] [Reference Citation Analysis]
245 Stein U, Schlag PM. Clinical, biological, and molecular aspects of metastasis in colorectal cancer. Recent Results Cancer Res 2007;176:61-80. [PMID: 17607917 DOI: 10.1007/978-3-540-46091-6_7] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 4.1] [Reference Citation Analysis]
246 Shaham J, Fireman E, Korenstein-ilan A, Lerman Y. Detection of p53 Protein in Induced Sputum After Occupational Exposure to Crystalline Silica. Journal of Occupational & Environmental Medicine 2007;49:730-5. [DOI: 10.1097/jom.0b013e31805d0be4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
247 Shen XY, Zacal N, Singh G, Rainbow AJ. Alterations in Mitochondrial and Apoptosis-regulating Gene Expression in Photodynamic Therapy-resistant Variants of HT29 Colon Carcinoma Cells¶. Photochemistry and Photobiology 2005;81:306-13. [DOI: 10.1111/j.1751-1097.2005.tb00188.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
248 Shi R, Huang Q, Zhu X, Ong YB, Zhao B, Lu J, Ong CN, Shen HM. Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization. Mol Cancer Ther 2007;6:1338-47. [PMID: 17431112 DOI: 10.1158/1535-7163.MCT-06-0638] [Cited by in Crossref: 63] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
249 Clemons NJ, Anderson RL. TRAIL-induced apoptosis is enhanced by heat shock protein 70 expression. Cell Stress Chaperones 2006;11:343-55. [PMID: 17278883 DOI: 10.1379/csc-206.1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
250 Mikes J, Kleban J, Sacková V, Horváth V, Jamborová E, Vaculová A, Kozubík A, Hofmanová J, Fedorocko P. Necrosis predominates in the cell death of human colon adenocarcinoma HT-29 cells treated under variable conditions of photodynamic therapy with hypericin. Photochem Photobiol Sci. 2007;6:758-766. [PMID: 17609769 DOI: 10.1039/B700350A] [Cited by in Crossref: 36] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
251 Keller JW, Franklin JL, Graves-Deal R, Friedman DB, Whitwell CW, Coffey RJ. Oncogenic KRAS provides a uniquely powerful and variable oncogenic contribution among RAS family members in the colonic epithelium. J Cell Physiol 2007;210:740-9. [PMID: 17133351 DOI: 10.1002/jcp.20898] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
252 Fábián Z, Csatary CM, Szeberényi J, Csatary LK. p53-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell lines. J Virol 2007;81:2817-30. [PMID: 17215292 DOI: 10.1128/JVI.02490-06] [Cited by in Crossref: 51] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
253 Einspahr JG, Martinez ME, Jiang R, Hsu CH, Rashid A, Bhattacharrya AK, Ahnen DJ, Jacobs ET, Houlihan PS, Webb CR. Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics. Cancer Epidemiol Biomarkers Prev. 2006;15:1443-1450. [PMID: 16896030 DOI: 10.1158/1055-9965.epi-06-0144] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
254 Diehl HC, Stühler K, Klein-Scory S, Volmer MW, Schöneck A, Bieling C, Schmiegel W, Meyer HE, Schwarte-Waldhoff I. A catalogue of proteins released by colorectal cancer cells in vitro as an alternative source for biomarker discovery. Proteomics Clin Appl. 2007;1:47-61. [PMID: 21136611 DOI: 10.1002/prca.200600491] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
255 Chiu S, Hsu T, Chao J. Opposing securin and p53 protein expression in the oxaliplatin-induced cytotoxicity of human colorectal cancer cells. Toxicology Letters 2006;167:122-30. [DOI: 10.1016/j.toxlet.2006.08.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
256 Ricci-vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007;445:111-5. [DOI: 10.1038/nature05384] [Cited by in Crossref: 2810] [Cited by in F6Publishing: 2610] [Article Influence: 175.6] [Reference Citation Analysis]
257 Taylor CA, Sun Z, Cliche DO, Ming H, Eshaque B, Jin S, Hopkins MT, Thai B, Thompson JE. Eukaryotic translation initiation factor 5A induces apoptosis in colon cancer cells and associates with the nucleus in response to tumour necrosis factor alpha signalling. Exp Cell Res 2007;313:437-49. [PMID: 17187778 DOI: 10.1016/j.yexcr.2006.09.030] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 3.3] [Reference Citation Analysis]
258 Li W, Sanki A, Karim RZ, Thompson JF, Soon Lee C, Zhuang L, McCarthy SW, Scolyer RA. The role of cell cycle regulatory proteins in the pathogenesis of melanoma. Pathology. 2006;38:287-301. [PMID: 16916716 DOI: 10.1080/00313020600817951] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 5.8] [Reference Citation Analysis]
259 Popat S, Chen Z, Zhao D, Pan H, Hearle N, Chandler I, Shao Y, Aherne W, Houlston R. A prospective, blinded analysis of thymidylate synthase and p53 expression as prognostic markers in the adjuvant treatment of colorectal cancer. Ann Oncol. 2006;17:1810-1817. [PMID: 16971666 DOI: 10.1093/annonc/mdl301] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
260 Zauber NP, Sabbath-solitare M, Marotta S, Perera LP, Bishop DT. Adequacy of Colonoscopic Biopsy Specimens for Molecular Analysis: A Comparative Study With Colectomy Tissue: . Diagnostic Molecular Pathology 2006;15:162-8. [DOI: 10.1097/01.pdm.0000213457.68268.83] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
261 Neal C, Garcea G, Doucas H, Manson M, Sutton C, Dennison A, Berry D. Molecular prognostic markers in resectable colorectal liver metastases: A systematic review. European Journal of Cancer 2006;42:1728-43. [DOI: 10.1016/j.ejca.2006.01.056] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 2.9] [Reference Citation Analysis]
262 Campbell C, Quinn A, Angus B, Rees J. The relation between p53 mutation and p53 immunostaining in non-melanoma skin cancer. British Journal of Dermatology 1993;129:235-41. [DOI: 10.1111/j.1365-2133.1993.tb11840.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
263 Goodrow TL, Storer RD, Leander KR, Prahalada SR, van Zwieten MJ, Bradley MO. Murine p53 intron sequences 5-8 and their use in polymerase chain reaction/direct sequencing analysis of p53 mutations in CD-1 mouse liver and lung tumors: p53 IN MOUSE LUNG AND LIVER TUMORS. Mol Carcinog 1992;5:9-15. [DOI: 10.1002/mc.2940050105] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 2.9] [Reference Citation Analysis]
264 Tian Y, Song Y. Effects of inositol hexaphosphate on proliferation of HT-29 human colon carcinoma cell line. World J Gastroenterol 2006; 12(26): 4137-4142 [PMID: 16830361 DOI: 10.3748/wjg.v12.i26.4137] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
265 Popat S, Wort R, Houlston RS. Inter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: implications for chemoresistance. BMC Cancer 2006;6:150. [PMID: 16753067 DOI: 10.1186/1471-2407-6-150] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
266 Xu JL, He SX, Chen JH, Fu H, Zhao G, Wang YL, Ren MD. Effect of tanshinone II A on COX-2 expression in hepatocellular carcinoma cell line SMMC-7721. Shijie Huaren Xiaohua Zazhi 2006; 14(14): 1352-1356 [DOI: 10.11569/wcjd.v14.i14.1352] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
267 Funaioli C, Pinto C, Mutri V, Di Fabio F, Ceccarelli C, Angelo Martoni A. Does Biomolecular Characterization of Stage II/III Colorectal Cancer Have Any Prognostic Value? Clinical Colorectal Cancer 2006;6:38-45. [DOI: 10.3816/ccc.2006.n.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
268 Ko H, Jung HH, Seo KH, Kang Y, Kim H, Park SJ, Lee H, Im S. Platelet-activating factor-induced NF-κB activation enhances VEGF expression through a decrease in p53 activity. FEBS Letters 2006;580:3006-12. [DOI: 10.1016/j.febslet.2006.04.042] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
269 van Erk MJ, Krul CA, Caldenhoven E, Stierum RH, Peters WH, Woutersen RA, van Ommen B. Expression profiling of colon cancer cell lines and colon biopsies: towards a screening system for potential cancer-preventive compounds. Eur J Cancer Prev 2005;14:439-57. [PMID: 16175049 DOI: 10.1097/01.cej.0000174781.51883.21] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
270 Fingrut O, Reischer D, Rotem R, Goldin N, Altboum I, Zan-Bar I, Flescher E. Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells. Br J Pharmacol 2005;146:800-8. [PMID: 16170329 DOI: 10.1038/sj.bjp.0706394] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
271 Fujiwara Y, Kawada K, Takano D, Tanimura S, Ozaki K, Kohno M. Inhibition of the PI3 kinase/Akt pathway enhances doxorubicin-induced apoptotic cell death in tumor cells in a p53-dependent manner. Biochemical and Biophysical Research Communications 2006;340:560-6. [DOI: 10.1016/j.bbrc.2005.12.039] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
272 César ACG, Calmon MF, Cury PM, Caetano A, Borim AA, Silva AE. Genetic alterations in benign lesions: Chronic gastritis and gastric ulcer. World J Gastroenterol 2006; 12(4): 625-629 [PMID: 16489680 DOI: 10.3748/wjg.v12.i4.625] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
273 Yao K, Gietema JA, Shida S, Selvakumaran M, Fonrose X, Haas NB, Testa J, O'Dwyer PJ. In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo. Br J Cancer. 2005;93:1356-1363. [PMID: 16333244 DOI: 10.1038/sj.bjc.6602864] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
274 Myong NH. Tissue microarray analysis of Fas and FasL expressions in human non-small cell lung carcinomas; with reference to the p53 and bcl-2 overexpressions. J Korean Med Sci 2005;20:770-6. [PMID: 16224150 DOI: 10.3346/jkms.2005.20.5.770] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
275 Liu Y, Bodmer WF. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. Proc Natl Acad Sci USA. 2006;103:976-981. [PMID: 16418264 DOI: 10.1073/pnas.0510146103] [Cited by in Crossref: 146] [Cited by in F6Publishing: 136] [Article Influence: 9.1] [Reference Citation Analysis]
276 Frattini M, Perrone F, Suardi S, Balestra D, Caramuta S, Colombo F, Licitra L, Cantù G, Pierotti MA, Pilotti S. Phenotype–genotype correlation: Challenge of intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Head Neck 2006;28:909-15. [DOI: 10.1002/hed.20433] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
277 Matsumoto K, Akao Y, Ohguchi K, Ito T, Tanaka T, Iinuma M, Nozawa Y. Xanthones induce cell-cycle arrest and apoptosis in human colon cancer DLD-1 cells. Bioorg Med Chem. 2005;. [PMID: 16112579 DOI: 10.1016/j.bmc.2005.06.065] [Cited by in Crossref: 112] [Cited by in F6Publishing: 90] [Article Influence: 6.6] [Reference Citation Analysis]
278 Chao J, Hsu S, Tsou T. Depletion of Securin Increases Arsenite-Induced Chromosome Instability and Apoptosis via a p53-Independent Pathway. Toxicological Sciences 2006;90:73-86. [DOI: 10.1093/toxsci/kfj070] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
279 Kashiwagi H, Spigelman AD, Talbot IC, Phillip RKS. Overexpression of p53 in duodenal tumours in patients with familial adenomatous polyposis: p53 OVEREXPRESSION AND DUODENAL MALIGNANCY. Br J Surg 1996;83:225-8. [DOI: 10.1046/j.1365-2168.1996.02135.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
280 Song G, Mao Y, Cai Q, Yao L, Ouyang G, Bao S. Curcumin induces human HT-29 colon adenocarcinoma cell apoptosis by activating p53 and regulating apoptosis-related protein expression. Braz J Med Biol Res 2005;38:1791-8. [DOI: 10.1590/s0100-879x2005001200007] [Cited by in Crossref: 72] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
281 Kim I, Kang HC, Jang S, Kim K, Ahn S, Yoon H, Yoon SN, Park J. Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and K- ras mutations. Carcinogenesis 2006;27:392-404. [DOI: 10.1093/carcin/bgi237] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
282 Chao J, Liu H. The Blockage of Survivin and Securin Expression Increases the Cytochalasin B-Induced Cell Death and Growth Inhibition in Human Cancer Cells. Mol Pharmacol 2005;69:154-64. [DOI: 10.1124/mol.105.015503] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
283 Shen XY, Zacal N, Singh G, Rainbow AJ. Alterations in mitochondrial and apoptosis-regulating gene expression in photodynamic therapy-resistant variants of HT29 colon carcinoma cells. Photochem Photobiol. 2005;81:306-313. [PMID: 15560738 DOI: 10.1562/2004-07-22-RA-242.1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 1] [Article Influence: 1.6] [Reference Citation Analysis]
284 Rochette PJ, Bastien N, Lavoie J, Guérin SL, Drouin R. SW480, a p53 Double-mutant Cell Line Retains Proficiency for Some p53 Functions. Journal of Molecular Biology 2005;352:44-57. [DOI: 10.1016/j.jmb.2005.06.033] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 3.4] [Reference Citation Analysis]
285 Bode H, Lenzner L, Kraemer OH, Kroesen AJ, Bendfeldt K, Schulzke JD, Fromm M, Stoltenburg-didinger G, Zeitz M, Ullrich R. The HIV Protease Inhibitors Saquinavir, Ritonavir, and Nelfinavir Induce Apoptosis and Decrease Barrier Function in Human Intestinal Epithelial Cells. Antiviral Therapy 2005;10:645-55. [DOI: 10.1177/135965350501000506] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
286 Lee J, Kuo M, Cheng S, Chiang C, Jeng J, Chang H, Kuo Y, Lan W, Kok S. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2005;99:471-8. [DOI: 10.1016/j.tripleo.2004.10.018] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
287 Ragnarsson-Olding B, Platz A, Olding L, Ringborg U. p53 protein expression and TP53 mutations in malignant melanomas of sun-sheltered mucosal membranes versus chronically sun-exposed skin. Melanoma Res 2004;14:395-401. [PMID: 15457096 DOI: 10.1097/00008390-200410000-00010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
288 Hyzy M, Bozko P, Konopa J, Skladanowski A. Antitumour imidazoacridone C-1311 induces cell death by mitotic catastrophe in human colon carcinoma cells. Biochemical Pharmacology 2005;69:801-9. [DOI: 10.1016/j.bcp.2004.11.028] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
289 Bar-sela G, Arush MWB, Sabo E, Kuten A, Minkov I, Ben-izhak O. Pediatric nasopharyngeal carcinoma: Better prognosis and increased c-Kit expression as compared to adults. Pediatr Blood Cancer 2005;45:291-7. [DOI: 10.1002/pbc.20264] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
290 Takhar AS, Eremin O, Watson SA. The role of gastrin in colorectal carcinogenesis. Surgeon. 2004;2:251-257. [PMID: 15570843 DOI: 10.1016/s1479-666x(04)80093-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
291 Perletti G, Marras E, Dondi D, Osti D, Congiu T, Ferrarese R, de Eguileor M, Tashjian AH Jr. p21(Waf1/Cip1) and p53 are downstream effectors of protein kinase C delta in tumor suppression and differentiation in human colon cancer cells. Int J Cancer 2005;113:42-53. [PMID: 15386430 DOI: 10.1002/ijc.20535] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
292 Gomez-lazaro M, Fernandez-gomez FJ, Jordán J. p53: Twenty five years understanding the mechanism of genome protection. J Physiol Biochem 2004;60:287-307. [DOI: 10.1007/bf03167075] [Cited by in Crossref: 75] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
293 Juang SH, Wei SJ, Hung YM, Hsu CY, Yang DM, Liu KJ, Chen WS, Yang WK. IFN-beta induces caspase-mediated apoptosis by disrupting mitochondria in human advanced stage colon cancer cell lines. J Interferon Cytokine Res. 2004;24:231-243. [PMID: 15144569 DOI: 10.1089/107999004323034105] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
294 Soliman PT, Slomovitz BM, Wolf JK. Mechanisms of cervical cancer. Drug Discovery Today: Disease Mechanisms 2004;1:253-8. [DOI: 10.1016/j.ddmec.2004.09.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
295 Tang R, Wang JY, Fan CW, Tsao KC, Chen HH, Wu CM, Chen JS, Changchien CR, Hsieh LL. p53 is an independent pre-treatment markers for long-term survival in stage II and III colorectal cancers: an analysis of interaction between genetic markers and fluorouracil-based adjuvant therapy. Cancer Lett. 2004;210:101-109. [PMID: 15172127 DOI: 10.1016/j.canlet.2004.01.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
296 Wang T, Chen F, Chen Z, Wu YF, Xu XL, Zheng S, Hu X. Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World J Gastroenterol 2004; 10(15): 2205-2208 [PMID: 15259066 DOI: 10.3748/wjg.v10.i15.2205] [Cited by in CrossRef: 94] [Cited by in F6Publishing: 76] [Article Influence: 5.2] [Reference Citation Analysis]
297 Tou SI, Drye ER, Boulos PB, Hollingsworth SJ. Activity (transcription) of the genes for MLH1, MSH2 and p53 in sporadic colorectal tumours with micro-satellite instability. Br J Cancer 2004;90:2006-12. [PMID: 15138486 DOI: 10.1038/sj.bjc.6601823] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
298 Sharma C, Pradeep A, Wong L, Rana A, Rana B. Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway. J Biol Chem 2004;279:35583-94. [PMID: 15190077 DOI: 10.1074/jbc.M403143200] [Cited by in Crossref: 99] [Cited by in F6Publishing: 67] [Article Influence: 5.5] [Reference Citation Analysis]
299 Murphy PJ, Galigniana MD, Morishima Y, Harrell JM, Kwok RP, Ljungman M, Pratt WB. Pifithrin-alpha inhibits p53 signaling after interaction of the tumor suppressor protein with hsp90 and its nuclear translocation. J Biol Chem 2004;279:30195-201. [PMID: 15145929 DOI: 10.1074/jbc.M403539200] [Cited by in Crossref: 86] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
300 Van Erk MJ, Teuling E, Staal YC, Huybers S, Van Bladeren PJ, Aarts JM, Van Ommen B. Time- and dose-dependent effects of curcumin on gene expression in human colon cancer cells. J Carcinog 2004;3:8. [PMID: 15140256 DOI: 10.1186/1477-3163-3-8] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 3.2] [Reference Citation Analysis]
301 Galigniana MD, Harrell JM, O'hagen HM, Ljungman M, Pratt WB. Hsp90-binding Immunophilins Link p53 to Dynein During p53 Transport to the Nucleus. Journal of Biological Chemistry 2004;279:22483-9. [DOI: 10.1074/jbc.m402223200] [Cited by in Crossref: 109] [Cited by in F6Publishing: 41] [Article Influence: 6.1] [Reference Citation Analysis]
302 Wang Y, Helland A, Holm R, Skomedal H, Abeler VM, Danielsen HE, Tropé CG, Børresen-Dale AL, Kristensen GB. TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival. Br J Cancer 2004;90:678-85. [PMID: 14760384 DOI: 10.1038/sj.bjc.6601537] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
303 Oji Y, Yamamoto H, Nomura M, Nakano Y, Ikeba A, Nakatsuka S, Abeno S, Kiyotoh E, Jomgeow T, Sekimoto M, Nezu R, Yoshikawa Y, Inoue Y, Hosen N, Kawakami M, Tsuboi A, Oka Y, Ogawa H, Souda S, Aozasa K, Monden M, Sugiyama H. Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma. Cancer Sci 2003;94:712-7. [PMID: 12901797 DOI: 10.1111/j.1349-7006.2003.tb01507.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 4.3] [Reference Citation Analysis]
304 Mohanty SK, Dey P. Serous effusions: diagnosis of malignancy beyond cytomorphology. An analytic review. Postgrad Med J 2003;79:569-74. [PMID: 14612599 DOI: 10.1136/pmj.79.936.569] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
305 Ionov Y, Matsui S, Cowell JK. A role for p300/CREB binding protein genes in promoting cancer progression in colon cancer cell lines with microsatellite instability. Proc Natl Acad Sci USA. 2004;101:1273-1278. [PMID: 14732695 DOI: 10.10173/pnas.0307276101] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
306 Ionov Y, Matsui S, Cowell JK. A role for p300/CREB binding protein genes in promoting cancer progression in colon cancer cell lines with microsatellite instability. Proc Natl Acad Sci USA. 2004;101:1273-1278. [PMID: 14732695 DOI: 10.1073/pnas.0307276101] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 4.2] [Reference Citation Analysis]
307 Hussein MR. The <i>TP53</i> Tumor Suppressor Gene and Melanoma Tumorigenesis: Is There a Relationship? Tumor Biol 2004;25:200-7. [DOI: 10.1159/000081103] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
308 Uchida H, Shinoura N, Kitayama J, Watanabe T, Nagawa H, Hamada H. 5-Fluorouracil efficiently enhanced apoptosis induced by adenovirus-mediated transfer of caspase-8 in DLD-1 colon cancer cells. J Gene Med. 2003;5:287-299. [PMID: 12692863 DOI: 10.1002/jgm.339] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
309 Smartt HJ, Elder DJ, Hicks DJ, Williams NA, Paraskeva C. Increased NF-kappaB DNA binding but not transcriptional activity during apoptosis induced by the COX-2-selective inhibitor NS-398 in colorectal carcinoma cells. Br J Cancer. 2003;89:1358-1365. [PMID: 14520472 DOI: 10.1038/sj.bjc.6601266] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
310 Lane DP, Hupp TR. Drug discovery and p53. Drug Discov Today 2003;8:347-55. [PMID: 12681938 DOI: 10.1016/s1359-6446(03)02669-2] [Cited by in Crossref: 67] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
311 Wenzel U, Kuntz S, De Sousa UJ, Daniel H. Nitric oxide suppresses apoptosis in human colon cancer cells by scavenging mitochondrial superoxide anions. Int J Cancer 2003;106:666-75. [PMID: 12866025 DOI: 10.1002/ijc.11294] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 2.5] [Reference Citation Analysis]
312 Hussein MR, Haemel AK, Wood GS. p53-related pathways and the molecular pathogenesis of melanoma. Eur J Cancer Prev 2003;12:93-100. [PMID: 12671532 DOI: 10.1097/00008469-200304000-00002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 2.7] [Reference Citation Analysis]
313 Bischof M, Huber P, Stoffregen C, Wannenmacher M, Weber K. Radiosensitization by pemetrexed of human colon carcinoma cells in different cell cycle phases. International Journal of Radiation Oncology*Biology*Physics 2003;57:289-92. [DOI: 10.1016/s0360-3016(03)00595-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
314 Sarkar C, Chattopadhyay P, Ralte AM, Mahapatra AK, Sinha S. Loss of heterozygosity of a locus in the chromosomal region 17p13.3 is associated with increased cell proliferation in astrocytic tumors. Cancer Genet Cytogenet 2003;144:156-64. [PMID: 12850379 DOI: 10.1016/s0165-4608(02)00937-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
315 Chun AC, Jin DY. Transcriptional regulation of mitotic checkpoint gene MAD1 by p53. J Biol Chem. 2003;278:37439-37450. [PMID: 12876282 DOI: 10.1074/jbc.M307185200] [Cited by in Crossref: 39] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
316 Hajri A, Wack S, Meyer C, Smith MK, Leberquier C, Kedinger M, Aprahamian M. In vitro and in vivo efficacy of photofrin and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells. Photochem Photobiol 2002;75:140-8. [PMID: 11883602 DOI: 10.1562/0031-8655(2002)075<0140:ivaive>2.0.co;2] [Cited by in Crossref: 96] [Cited by in F6Publishing: 17] [Article Influence: 5.1] [Reference Citation Analysis]
317 Kinjo T, Kamiyama K, Chinen K, Iwamasa T, Kurihara K, Hamada T. Squamous metaplasia induced by transfection of human papillomavirus DNA into cultured adenocarcinoma cells. Mol Pathol. 2003;56:97-108. [PMID: 12665627 DOI: 10.1136/mp.56.2.97] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
318 Colomer A, Erill N, Verdú M, Roman R, Vidal A, Cordon-cardo C, Puig X. Lack of p53 Nuclear Immunostaining Is Not Indicative of Absence of TP53 Gene Mutations in Colorectal Adenocarcinomas: . Applied Immunohistochemistry & Molecular Morphology 2003;11:130-7. [DOI: 10.1097/00129039-200306000-00007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
319 Perrone F, Oggionni M, Birindelli S, Suardi S, Tabano S, Romano R, Moiraghi ML, Bimbi G, Quattrone P, Cantu G, Pierotti MA, Licitra L, Pilotti S. TP53, p14ARF, p16INK4a and H-ras gene molecular analysis in intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Int J Cancer 2003;105:196-203. [PMID: 12673679 DOI: 10.1002/ijc.11062] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 3.7] [Reference Citation Analysis]
320 Rödel C, Haas J, Groth A, Grabenbauer GG, Sauer R, Rödel F. Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor. Int J Radiat Oncol Biol Phys. 2003;55:1341-1347. [PMID: 12654446 DOI: 10.1016/s0360-3016(02)04618-7] [Cited by in Crossref: 108] [Cited by in F6Publishing: 44] [Article Influence: 5.7] [Reference Citation Analysis]
321 Irwin MS, Kondo K, Marin MC, Cheng LS, Hahn WC, Kaelin WG. Chemosensitivity linked to p73 function. Cancer Cell 2003;3:403-10. [DOI: 10.1016/s1535-6108(03)00078-3] [Cited by in Crossref: 304] [Cited by in F6Publishing: 154] [Article Influence: 16.0] [Reference Citation Analysis]
322 Michalopoulos NV, Saetta A, Lazaris ACh, Voutsinas G, Davaris PS. Detection of genetic abnormalities in neoplasms from Greek patients with FAP. Eur J Surg Oncol 2003;29:38-43. [PMID: 12559075 DOI: 10.1053/ejso.2002.1344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
323 Iacopetta B. TP53 mutation in colorectal cancer. Hum Mutat 2003;21:271-6. [DOI: 10.1002/humu.10175] [Cited by in Crossref: 192] [Cited by in F6Publishing: 169] [Article Influence: 10.1] [Reference Citation Analysis]
324 Fearnhead NS, Wilding JL, Bodmer WF. Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis. Br Med Bull 2002;64:27-43. [PMID: 12421723 DOI: 10.1093/bmb/64.1.27] [Cited by in Crossref: 107] [Cited by in F6Publishing: 88] [Article Influence: 5.6] [Reference Citation Analysis]
325 Mild G, Bachmann F, Boulay JL, Glatz K, Laffer U, Lowy A, Metzger U, Reuter J, Terracciano L, Herrmann R. DCR3 locus is a predictive marker for 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer. Int J Cancer. 2002;102:254-257. [PMID: 12397645 DOI: 10.1002/ijc.10711] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
326 Moucadel V, Totaro MS, Dell CD, Soubeyran P, Dagorn JC, Freund JN, Iovanna JL. The homeobox gene Cdx1 belongs to the p53-p21(WAF)-Bcl-2 network in intestinal epithelial cells. Biochem Biophys Res Commun. 2002;297:607-615. [PMID: 12270138 DOI: 10.1016/s0006-291x(02)02250-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
327 Arnould S, Guichard S, Hennebelle I, Cassar G, Bugat R, Canal P. Contribution of apoptosis in the cytotoxicity of the oxaliplatin-irinotecan combination in the HT29 human colon adenocarcinoma cell line. Biochem Pharmacol 2002;64:1215-26. [PMID: 12234602 DOI: 10.1016/s0006-2952(02)01291-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
328 Ookawa K, Kudo T, Aizawa S, Saito H, Tsuchida S. Transcriptional activation of the MUC2 gene by p53. J Biol Chem. 2002;277:48270-48275. [PMID: 12374798 DOI: 10.1074/jbc.m207986200] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
329 Adachi Y, Lee C, Coffee K, Yamagata N, Ohm JE, Park K, Dikov MM, Nadaf SR, Arteaga CL, Carbone DP. Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines. Gastroenterology 2002;123:1191-204. [DOI: 10.1053/gast.2002.36023] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 2.8] [Reference Citation Analysis]
330 Kuo PL, Lin TC, Lin CC. The antiproliferative activity of aloe-emodin is through p53-dependent and p21-dependent apoptotic pathway in human hepatoma cell lines. Life Sci. 2002;71:1879-1892. [PMID: 12175703 DOI: 10.1016/S0024-3205(02)01900-8] [Cited by in Crossref: 111] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
331 Playle LC, Hicks DJ, Qualtrough D, Paraskeva C. Abrogation of the radiation-induced G2 checkpoint by the staurosporine derivative UCN-01 is associated with radiosensitisation in a subset of colorectal tumour cell lines. Br J Cancer 2002;87:352-8. [PMID: 12177808 DOI: 10.1038/sj.bjc.6600492] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
332 Leslie A, Carey FA, Pratt NR, Steele RJ. The colorectal adenoma-carcinoma sequence. Br J Surg. 2002;89:845-860. [PMID: 12081733 DOI: 10.1046/j.1365-2168.2002.02120.x] [Cited by in Crossref: 376] [Cited by in F6Publishing: 345] [Article Influence: 18.8] [Reference Citation Analysis]
333 Shawler DL, Bartholomew RM, Garrett MA, Trauger RJ, Dorigo O, Van Beveren C, Marchese A, Ferre F, Duffy C, Carlo DJ. Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine. Clin Exp Immunol. 2002;129:99-106. [PMID: 12100028 DOI: 10.1046/j.1365-2249.2002.01863.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
334 Behrensdorf HA, Pignot M, Windhab N, Kappel A. Rapid parallel mutation scanning of gene fragments using a microelectronic protein-DNA chip format. Nucleic Acids Res 2002;30:e64. [PMID: 12136112 DOI: 10.1093/nar/gnf063] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
335 Warren RS, Kirn DH. Liver-directed viral therapy for cancer. Surgical Oncology Clinics of North America 2002;11:571-88. [DOI: 10.1016/s1055-3207(02)00043-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
336 Kim SG, Ravi G, Hoffmann C, Jung YJ, Kim M, Chen A, Jacobson KA. p53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA. Biochem Pharmacol 2002;63:871-80. [PMID: 11911839 DOI: 10.1016/s0006-2952(02)00839-0] [Cited by in Crossref: 49] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
337 Ohbu M, Kobayashi N, Okayasu I. Expression of cell cycle regulatory proteins in the multistep process of oesophageal carcinogenesis: stepwise over-expression of cyclin E and p53, reduction of p21(WAF1/CIP1) and dysregulation of cyclin D1 and p27(KIP1). Histopathology. 2001;39:589-596. [PMID: 11903577 DOI: 10.1046/j.1365-2559.2001.01279.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
338 Walker J, Quirke P. Biology and genetics of colorectal cancer. Eur J Cancer. 2001;37 Suppl 7:S163-S172. [PMID: 11887987 DOI: 10.1016/s0959-8049(01)80018-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
339 Butler LM, Hewett PJ, Fitridge RA, Cowled PA. DEREGULATION OF APOPTOSIS IN COLORECTAL CARCINOMA: THEORETICAL AND THERAPEUTIC IMPLICATIONS. Aust N Z J Surg 2002;69:88-94. [DOI: 10.1046/j.1440-1622.1999.01498.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.6] [Reference Citation Analysis]
340 Fodde R, Smits R, Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer. 2001;1:55-67. [PMID: 11900252 DOI: 10.1038/35094067] [Cited by in Crossref: 603] [Cited by in F6Publishing: 577] [Article Influence: 30.2] [Reference Citation Analysis]
341 Kawaguchi K, Oda Y, Nakanishi K, Saito T, Tamiya S, Nakahara K, Matsuoka H, Tsuneyoshi M. Malignant Transformation of Renal Angiomyolipoma: A Case Report. The American Journal of Surgical Pathology 2002;26:523-9. [DOI: 10.1097/00000478-200204000-00017] [Cited by in Crossref: 65] [Cited by in F6Publishing: 49] [Article Influence: 3.3] [Reference Citation Analysis]
342 Moore BE, Banner BF, Gokden M, Woda B, Liu Y, Ayala A, Jiang Z. p53: a good diagnostic marker for intratubular germ cell neoplasia, unclassified. Appl Immunohistochem Mol Morphol 2001;9:203-6. [PMID: 11556746 DOI: 10.1097/00129039-200109000-00002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
343 Hosaka S, Aoki Y, Akamatsu T, Nakamura N, Hosaka N, Kiyosawa K. Detection of genetic alterations in the p53 suppressor gene and the K-ras oncogene among different grades of dysplasia in patients with colorectal adenomas. Cancer. 2002;94:219-227. [PMID: 11815980 DOI: 10.1002/cncr.10198] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
344 Tong Z, Singh G, Rainbow AJ. Extreme dark cytotoxicity of Nile Blue A in normal human fibroblasts. Photochem Photobiol 2001;74:707-11. [PMID: 11723799 DOI: 10.1562/0031-8655(2001)074<0707:edconb>2.0.co;2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
345 Tang R, Ko MC, Wang JY, Changchien CR, Chen HH, Chen JS, Hsu KC, Chiang JM, Hsieh LL. Humoral response to p53 in human colorectal tumors: a prospective study of 1,209 patients. Int J Cancer. 2001;94:859-863. [PMID: 11745489 DOI: 10.1002/ijc.1541] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 2.4] [Reference Citation Analysis]
346 Bojarski C, Gitter AH, Bendfeldt K, Mankertz J, Schmitz H, Wagner S, Fromm M, Schulzke JD. Permeability of human HT-29/B6 colonic epithelium as a function of apoptosis. J Physiol 2001;535:541-52. [PMID: 11533143 DOI: 10.1111/j.1469-7793.2001.00541.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 81] [Article Influence: 3.6] [Reference Citation Analysis]
347 Albano SA, Santana-sahagun E, Weisman MH. Cigarette smoking and rheumatoid arthritis. Seminars in Arthritis and Rheumatism 2001;31:146-59. [DOI: 10.1053/sarh.2001.27719] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 3.6] [Reference Citation Analysis]
348 Christian AT, Pattee MS, Attix CM, Reed BE, Sorensen KJ, Tucker JD. Detection of DNA point mutations and mRNA expression levels by rolling circle amplification in individual cells. Proc Natl Acad Sci U S A 2001;98:14238-43. [PMID: 11724932 DOI: 10.1073/pnas.251383598] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 4.0] [Reference Citation Analysis]
349 Damalas A, Kahan S, Shtutman M, Ben-Ze'ev A, Oren M. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. EMBO J 2001;20:4912-22. [PMID: 11532955 DOI: 10.1093/emboj/20.17.4912] [Cited by in Crossref: 149] [Cited by in F6Publishing: 141] [Article Influence: 7.1] [Reference Citation Analysis]
350 Sasaki Y, Morimoto I, Ishida S, Yamashita T, Imai K, Tokino T. Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: potential application to gene therapy of colorectal cancer. Gene Ther. 2001;8:1401-1408. [PMID: 11571580 DOI: 10.1038/sj.gt.3301538] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
351 Porcelli B, Frosi B, Terzuoli L, Arezzini L, Marinello E, Vernillo R, De Martino A, Vatti R, Minacci C. Expression of p185 and p53 in benign and malignant colorectal lesions. Histochem J 2001;33:51-7. [PMID: 11352401 DOI: 10.1023/a:1017543930661] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
352 Clarke B, Chetty R. Cell cycle aberrations in the pathogenesis of squamous cell carcinoma of the uterine cervix. Gynecol Oncol 2001;82:238-46. [PMID: 11531273 DOI: 10.1006/gyno.2001.6306] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
353 O'connor DP, Kay EW, Leader M, Murphy GM, Atkins GJ, Mabruk MJEMF. Altered p53 Expression in Benign and Malignant Skin Lesions From Renal Transplant Recipients and Immunocompetent Patients With Skin Cancer: Correlation With Human Papillomaviruses?: . Diagnostic Molecular Pathology 2001;10:190-9. [DOI: 10.1097/00019606-200109000-00007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
354 Li A, Yonezawa S, Matsukita S, Hasui K, Goto M, Tanaka S, Imai K, Sato E. Comparative study for histology, proliferative activity, glycoproteins, and p53 protein between old and recent colorectal adenomas in Japan. Cancer Lett 2001;170:45-52. [PMID: 11448534 DOI: 10.1016/s0304-3835(01)00610-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
355 Wolf JK, Ramirez PT. The molecular biology of cervical cancer. Cancer Invest 2001;19:621-9. [PMID: 11486705 DOI: 10.1081/cnv-100104290] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
356 Bai L, Merchant JL. ZBP-89 promotes growth arrest through stabilization of p53. Mol Cell Biol 2001;21:4670-83. [PMID: 11416144 DOI: 10.1128/MCB.21.14.4670-4683.2001] [Cited by in Crossref: 72] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
357 Schumacher U, Adam E, Feldhaus S, Katoh M, Lane DP. Cell differentiation and chemotherapy influence p53 and Mdm2 immunoreactivity in human HT29 colon cancer cells grown in scid mice. Cancer Lett. 2001;166:215-221. [PMID: 11311495 DOI: 10.1016/S0304-3835(01)00395-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
358 Bartke T, Siegmund D, Peters N, Reichwein M, Henkler F, Scheurich P, Wajant H. p53 upregulates cFLIP, inhibits transcription of NF-kappaB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells. Oncogene. 2001;20:571-580. [PMID: 11313989 DOI: 10.1038/sj.onc.1204124] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 3.2] [Reference Citation Analysis]
359 Shao RG, Cao CX, Nieves-Neira W, Dimanche-Boitrel MT, Solary E, Pommier Y. Activation of the Fas pathway independently of Fas ligand during apoptosis induced by camptothecin in p53 mutant human colon carcinoma cells. Oncogene. 2001;20:1852-1859. [PMID: 11313933 DOI: 10.1038/sj.onc.1204264] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 2.9] [Reference Citation Analysis]
360 Kubens BS, Niggemann B, Zänker KS. Prevention of entrance into G2 cell cycle phase by mimosine decreases locomotion of cells from the tumor cell line SW480. Cancer Lett 2001;162 Suppl:S39-47. [PMID: 11164189 DOI: 10.1016/s0304-3835(00)00651-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
361 Grigorian M, Andresen S, Tulchinsky E, Kriajevska M, Carlberg C, Kruse C, Cohn M, Ambartsumian N, Christensen A, Selivanova G. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem. 2001;276:22699-22708. [PMID: 11278647 DOI: 10.1074/jbc.m010231200] [Cited by in Crossref: 217] [Cited by in F6Publishing: 90] [Article Influence: 10.3] [Reference Citation Analysis]
362 Abdel-Rahman WM, Katsura K, Rens W, Gorman PA, Sheer D, Bicknell D, Bodmer WF, Arends MJ, Wyllie AH, Edwards PA. Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement. Proc Natl Acad Sci USA. 2001;98:2538-2543. [PMID: 11226274 DOI: 10.1073/pnas.041603298] [Cited by in Crossref: 115] [Cited by in F6Publishing: 113] [Article Influence: 5.5] [Reference Citation Analysis]
363 Kobayashi N, Takada Y, Hachiya M, Ando K, Nakajima N, Akashi M. TNF-alpha induced p21(WAF1) but not Bax in colon cancer cells WiDr with mutated p53: important role of protein stabilization. Cytokine 2000;12:1745-54. [PMID: 11097743 DOI: 10.1006/cyto.2000.0782] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
364 Hupp TR, Lane DP, Ball KL. Strategies for manipulating the p53 pathway in the treatment of human cancer. Biochem J. 2000;352 Pt 1:1-17. [PMID: 11062053 DOI: 10.1042/0264-6021:3520001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
365 Tokunaga E, Oda S, Fukushima M, Maehara Y, Sugimachi K. Differential growth inhibition by 5-fluorouracil in human colorectal carcinoma cell lines. Eur J Cancer. 2000;36:1998-2006. [PMID: 11000583 DOI: 10.1016/s0959-8049(00)00200-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
366 Friedlander PL. Genomic instability in head and neck cancer patients. Head Neck 2001;23:683-91. [DOI: 10.1002/hed.1096] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
367 Kancherla RR, Nair JS, Ahmed T, Durrani H, Seiter K, Mannancheril A, Tse-dinh Y. Evaluation of topotecan and etoposide for non-hodgkin lymphoma: Correlation of topoisomerase-DNA complex formation with clinical response. Cancer 2001;91:463-71. [DOI: 10.1002/1097-0142(20010201)91:3<463::aid-cncr1023>3.0.co;2-r] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
368 Warenius HM, Jones M, Gorman T, McLeish R, Seabra L, Barraclough R, Rudland P. Combined RAF1 protein expression and p53 mutational status provides a strong predictor of cellular radiosensitivity. Br J Cancer 2000;83:1084-95. [PMID: 10993658 DOI: 10.1054/bjoc.2000.1409] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
369 Ebisui C, Okazaki M, Kanai T, Hirai T, Ichikawa Y, Fukunishi T, Nagano S, Kouro T, Fujimoto T. Clinicopathological study of colorectal cancers after renal transplantation. Transplantation Proceedings 2000;32:1984-5. [DOI: 10.1016/s0041-1345(00)01522-0] [Cited by in Crossref: 10] [Article Influence: 0.5] [Reference Citation Analysis]
370 Sánchez-fayos Calabuig P, Juzgado Lucas D, Bosch Esteva O, González Guirado A, Porres Cubero J. Cáncer colorrectal: circunstancias inductoras (etiología) y caminos de realización (patogenia). Revista Clínica Española 2000;200:605-16. [DOI: 10.1016/s0014-2565(00)70019-1] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
371 Thompson-Hehir J, Davies MP, Green JA, Halliwell N, Joyce KA, Salisbury J, Sibson DR, Vergote I, Walker C. Novel polymerase chain reaction approach for full-coding p53 mutation detection in microdissected archival tumors. Diagn Mol Pathol 2000;9:110-9. [PMID: 10850547 DOI: 10.1097/00019606-200006000-00007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
372 Sarkar C, Rathore A, Chattopadhyaya P, Mahapatra AK, Sinha S. Role of 17p13.3 chromosomal region in determining p53 protein immunopositivity in human astrocytic tumors. Pathology 2000;32:84-8. [PMID: 10840825 DOI: 10.1080/003130200104286] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
373 Halaschek-wiener J, Wacheck V, Schlagbauer-wadl H, Wolff K, Kloog Y, Jansen B. A Novel Ras Antagonist Regulates Both Oncogenic Ras and the Tumor Suppressor p53 in Colon Cancer Cells. Mol Med 2000;6:693-704. [DOI: 10.1007/bf03402049] [Cited by in Crossref: 37] [Article Influence: 1.7] [Reference Citation Analysis]
374 Lindforss U, Fredholm H, Papadogiannakis N, Gad A, Zetterquist H, Olivecrona H. Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma. Cancer 2000;88:2661-7. [DOI: 10.1002/1097-0142(20000615)88:12<2661::aid-cncr3>3.0.co;2-q] [Cited by in Crossref: 22] [Article Influence: 1.0] [Reference Citation Analysis]
375 Kaserer K, Schmaus J, Bethge U, Migschitz B, Fasching S, Walch A, Herbst F, Teleky B, Wrba F. Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer. J Pathol 2000;190:450-6. [PMID: 10699994 DOI: 10.1002/(SICI)1096-9896(200003)190:4<450::AID-PATH545>3.0.CO;2-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
376 Popanda O, Zheng C, Magdeburg JR, Büttner J, Flohr T, Hagmüller E, Thielmann HW. Mutation analysis of replicative genes encoding the large subunits of DNA polymerase alpha and replication factors A and C in human sporadic colorectal cancers. Int J Cancer 2000;86:318-24. [PMID: 10760817 DOI: 10.1002/(sici)1097-0215(20000501)86:3<318::aid-ijc3>3.0.co;2-b] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
377 Lindström MS, Klangby U, Inoue R, Pisa P, Wiman KG, Asker CE. Immunolocalization of Human p14ARF to the Granular Component of the Interphase Nucleolus. Experimental Cell Research 2000;256:400-10. [DOI: 10.1006/excr.2000.4854] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 2.5] [Reference Citation Analysis]
378 Wolf JK, Mills GB, Bazzet L, Bast RC Jr, Roth JA, Gershenson DM. Adenovirus-mediated p53 growth inhibition of ovarian cancer cells is independent of endogenous p53 status. Gynecol Oncol 1999;75:261-6. [PMID: 10525383 DOI: 10.1006/gyno.1999.5565] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 2.0] [Reference Citation Analysis]
379 Tan DT, Tang WY, Liu YP, Goh HS, Smith DR. Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br J Ophthalmol 2000;84:212-6. [PMID: 10655200 DOI: 10.1136/bjo.84.2.212] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 3.3] [Reference Citation Analysis]
380 Taupin DR, Kinoshita K, Podolsky DK. Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. Proc Natl Acad Sci USA. 2000;97:799-804. [PMID: 10639160 DOI: 10.1073/pnas.97.2.799] [Cited by in Crossref: 186] [Cited by in F6Publishing: 183] [Article Influence: 8.5] [Reference Citation Analysis]
381 Akiyama T, Sugiyama K, Shimizu M, Tamaoki T, Akinaga S. G1-checkpoint function including a cyclin-dependent kinase 2 regulatory pathway as potential determinant of 7-hydroxystaurosporine (UCN-01)-induced apoptosis and G1-phase accumulation. Jpn J Cancer Res 1999;90:1364-72. [PMID: 10665655 DOI: 10.1111/j.1349-7006.1999.tb00721.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
382 Cohen PA, Hupp TR, Lane DP, Daniels DA. Biochemical characterization of different conformational states of the Sf9 cell-purified p53His175 mutant protein. FEBS Lett 1999;463:179-84. [PMID: 10601663 DOI: 10.1016/s0014-5793(99)01603-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
383 Mattar R, Alexandrino AM, Laudanna AA. Infrequent p53 gene alterations in ulcerative colitis. Braz J Med Biol Res 1999;32:1083-8. [PMID: 10464383 DOI: 10.1590/s0100-879x1999000900005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
384 Lam V, McPherson JP, Salmena L, Lees J, Chu W, Sexsmith E, Hedley DW, Freedman MH, Reed JC, Malkin D. p53 gene status and chemosensitivity of childhood acute lymphoblastic leukemia cells to adriamycin. Leuk Res. 1999;23:871-880. [PMID: 10573131 DOI: 10.1016/s0145-2126(99)00102-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
385 Halling KC, French AJ, McDonnell SK, Burgart LJ, Schaid DJ, Peterson BJ, Moon-Tasson L, Mahoney MR, Sargent DJ, O'Connell MJ. Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst. 1999;91:1295-1303. [PMID: 10433618 DOI: 10.1093/jnci/91.15.1295] [Cited by in Crossref: 279] [Cited by in F6Publishing: 266] [Article Influence: 12.1] [Reference Citation Analysis]
386 Ho Y, Liu H, Duh J, Chen R, Ho W, Jeng J, Wang Y, Lin J. Induction of apoptosis by S-Nitrosoglutathione and Cu2+ or Ni2+ ion through modulation of bax, bad, and bcl-2 proteins in human colon adenocarcinoma cells. Mol Carcinog 1999;26:201-11. [DOI: 10.1002/(sici)1098-2744(199911)26:3<201::aid-mc9>3.0.co;2-k] [Cited by in Crossref: 18] [Article Influence: 0.8] [Reference Citation Analysis]
387 Gobert C, Skladanowski A, Larsen AK. The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53. Proc Natl Acad Sci U S A 1999;96:10355-60. [PMID: 10468612 DOI: 10.1073/pnas.96.18.10355] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 2.6] [Reference Citation Analysis]
388 Zhu GH, Wong BC, Ching CK, Lai KC, Lam SK. Differential apoptosis by indomethacin in gastric epithelial cells through the constitutive expression of wild-type p53 and/or up-regulation of c-myc. Biochem Pharmacol. 1999;58:193-200. [PMID: 10403534 DOI: 10.1016/s0006-2952(99)00058-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
389 Zhao B, Kimura W, Futakawa N, Muto T, Kubota K, Harihara Y, Takayama T, Makuuchi M. P53 and P21/Waf1 Protein Expression and K- Ras Codon 12 Mutation in Carcinoma of The Papilla of Vater. American Journal of Gastroenterology 1999;94:2128-34. [DOI: 10.1111/j.1572-0241.1999.01309.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
390 Offner S, Schmaus W, Witter K, Baretton GB, Schlimok G, Passlick B, Riethmüller G, Pantel K. p53 gene mutations are not required for early dissemination of cancer cells. Proc Natl Acad Sci U S A 1999;96:6942-6. [PMID: 10359818 DOI: 10.1073/pnas.96.12.6942] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 1.6] [Reference Citation Analysis]
391 Zhang WG, Li XW, Ma LP, Wang SW, Yang HY, Zhang ZY. Wild-type p53 protein potentiates phototoxicity of 2-BA-2-DMHA in HT29 cells expressing endogenous mutant p53. Cancer Lett. 1999;138:189-195. [PMID: 10378792 DOI: 10.1016/S0304-3835(99)00013-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
392 Yoshikawa H, Nagashima M, Khan MA, McMenamin MG, Hagiwara K, Harris CC. Mutational analysis of p73 and p53 in human cancer cell lines. Oncogene. 1999;18:3415-3421. [PMID: 10362363 DOI: 10.1038/sj.onc.1202677] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 1.7] [Reference Citation Analysis]
393 Shomori K, Sakatani T, Goto A, Matsuura T, Kiyonari H, Ito H. Thymidine phosphorylase expression in human colorectal mucosa, adenoma and carcinoma: Role of p53 expression. Pathol Int 1999;49:491-9. [DOI: 10.1046/j.1440-1827.1999.00897.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
394 Kubba AK, Poole NA, Watson A. Role of p53 assessment in management of Barrett's esophagus. Dig Dis Sci 1999;44:659-67. [PMID: 10219819 DOI: 10.1023/a:1026608319881] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
395 Turnell AS, Grand RJA, Gallimore PH. The Replicative Capacities of Large E1B-Null Group A and Group C Adenoviruses Are Independent of Host Cell p53 Status. J Virol 1999;73:2074-83. [DOI: 10.1128/jvi.73.3.2074-2083.1999] [Cited by in Crossref: 90] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
396 Tomizawa Y, Kohno T, Fujita T, Kiyama M, Saito R, Noguchi M, Matsuno Y, Hirohashi S, Yamaguchi N, Nakajima T. Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma. Oncogene. 1999;18:1007-1014. [PMID: 10023676 DOI: 10.1038/sj.onc.1202384] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 2.3] [Reference Citation Analysis]
397 Suzuki H, Tomida A, Tsuruo T. A novel mutant from apoptosis-resistant colon cancer HT-29 cells showing hyper-apoptotic response to hypoxia, low glucose and cisplatin. Jpn J Cancer Res 1998;89:1169-78. [PMID: 9914786 DOI: 10.1111/j.1349-7006.1998.tb00512.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
398 Alexander RJ, Raicht RF. Purification of total RNA from human stool samples. Dig Dis Sci 1998;43:2652-8. [PMID: 9881497 DOI: 10.1023/a:1026699126899] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
399 Iniesta P, de Juan C, Caldés T, Vega FJ, Massa MJ, Cerdán FJ, López JA, Fernández C, Sánchez A, Torres AJ. Genetic abnormalities and microsatellite instability in colorectal cancer. Cancer Detect Prev. 1998;22:383-395. [PMID: 9727619 DOI: 10.1046/j.1525-1500.1998.00049.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
400 Nita ME, Nagawa H, Tominaga O, Tsuno N, Fujii S, Sasaki S, Fu CG, Takenoue T, Tsuruo T, Muto T. 5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins. Br J Cancer. 1998;78:986-992. [PMID: 9792140 DOI: 10.1038/bjc.1998.617] [Cited by in Crossref: 103] [Cited by in F6Publishing: 105] [Article Influence: 4.3] [Reference Citation Analysis]
401 Nishi K, Schnier JB, Bradbury EM. The accumulation of cyclin-dependent kinase inhibitor p27kip1 is a primary response to staurosporine and independent of G1 cell cycle arrest. Exp Cell Res 1998;243:222-31. [PMID: 9743582 DOI: 10.1006/excr.1998.4166] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
402 Pratsinis H, Saetta A, Gagos S, Davaris P. Isolation and characterization of a novel bladder cancer cell line: Inhibition by epidermal growth factor. In Vitro Cell Dev Biol -Animal 1998;34:722-8. [DOI: 10.1007/s11626-998-0068-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
403 Ren J, Ulvik A, Refsum H, Ueland PM. Chemical mismatch cleavage combined with capillary electrophoresis: detection of mutations in exon 8 of the cystathionine β-synthase gene. Clinical Chemistry 1998;44:2108-14. [DOI: 10.1093/clinchem/44.10.2108] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
404 Lee WJ, Shun CT, Hong RL, Wu MS, Chang KJ, Chen KM. Overexpression of p53 predicts shorter survival in diffuse type gastric cancer. Br J Surg. 1998;85:1138-1142. [PMID: 9718015 DOI: 10.1046/j.1365-2168.1998.00712.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
405 Aktas D, Ayhan A, Tunçbilek E, Özdemir A, Uzunalimoğlu B. No Evidence for Overexpression of the p53 Protein and Mutations in Exons 4–9 of the p53 Gene in a Large Family With Adenomatous Polyposis. American Journal of Gastroenterology 1998;93:1524-6. [DOI: 10.1111/j.1572-0241.1998.00414.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
406 Yokoi T, Tsuzuki T, Yatabe Y, Suzuki M, Kurumaya H, Koshikawa T, Kuhara H, Kuroda M, Nakamura N, Nakatani Y. Solitary fibrous tumour: significance of p53 and CD34 immunoreactivity in its malignant transformation. Histopathology. 1998;32:423-432. [PMID: 9639117 DOI: 10.1046/j.1365-2559.1998.00412.x] [Cited by in Crossref: 158] [Cited by in F6Publishing: 119] [Article Influence: 6.6] [Reference Citation Analysis]
407 Kong L, Ogawa N, Mcguff H, Nakabayashi T, Sakata K, Masago R, Vela-roch N, Talal N, Dang H. Bcl-2 Family Expression in Salivary Glands from Patients with Primary Sjögren's Syndrome: Involvement of Bax in Salivary Gland Destruction. Clinical Immunology and Immunopathology 1998;88:133-41. [DOI: 10.1006/clin.1998.4556] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 2.0] [Reference Citation Analysis]
408 Stenbäck F, Mäkinen M, Jussila T. p53 expression in skin carcinogenesis and its relationship to cell proliferation and tumour growth. European Journal of Cancer 1998;34:1415-24. [DOI: 10.1016/s0959-8049(98)00062-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
409 Abdel-Fattah R, Challen C, Griffiths TR, Robinson MC, Neal DE, Lunec J. Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: high frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosis. Br J Cancer 1998;77:2230-8. [PMID: 9649138 DOI: 10.1038/bjc.1998.371] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 1.8] [Reference Citation Analysis]
410 Ellis TP, Humphrey KE, Smith MJ, Cotton RG. Chemical cleavage of mismatch: a new look at an established method. Hum Mutat 1998;11:345-53. [PMID: 9600452 DOI: 10.1002/(SICI)1098-1004(1998)11:5<345::AID-HUMU1>3.0.CO;2-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
411 el Sebaı̈ H, Ged C, Bonichon F, de Verneuil H, Longy M. Genetic Alterations in Colorectal Cancer, Comparative Analysis of Deletion Events, and Point Mutations. Cancer Genetics and Cytogenetics 1998;104:32-8. [DOI: 10.1016/s0165-4608(97)00415-9] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
412 Naida JD, Davis MA, Lawrence TS. The effect of activation of wild-type p53 function on fluoropyrimidine-mediated radiosensitization. International Journal of Radiation Oncology*Biology*Physics 1998;41:675-80. [DOI: 10.1016/s0360-3016(98)00134-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
413 Nitti D, Belluco C, Montesco M, Bertorelle R, Da Pian P, Fassina A, Ninfo V, Chieco-bianchi L, Lise M. Nuclear p53 protein expression in resected hepatic metastases from colorectal cancer: an independent prognostic factor of survival. European Journal of Cancer 1998;34:851-5. [DOI: 10.1016/s0959-8049(97)10165-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
414 Han EK, Arber N, Yamamoto H, Lim JT, Delohery T, Pamukcu R, Piazza GA, Xing WQ, Weinstein IB. Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines. Breast Cancer Res Treat 1998;48:195-203. [DOI: 10.1023/a:1005924730450] [Cited by in Crossref: 55] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
415 Akashi M, Koeffler HP. Li-Fraumeni syndrome and the role of the p53 tumor suppressor gene in cancer susceptibility. Clin Obstet Gynecol 1998;41:172-99. [PMID: 9504235 DOI: 10.1097/00003081-199803000-00024] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
416 Stokke T, Smedshammer L, Jonassen TS, Blomhoff HK, Skarstad K, Steen HB. Uncoupling of the order of the S and M phases: effects of staurosporine on human cell cycle kinases. Cell Prolif. 1997;30:197-218. [PMID: 9420612 DOI: 10.1111/j.1365-2184.1997.tb00935.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
417 Wolkowicz R, Peled A, Barry Elkind, Rotter V. DNA-Binding Activity of Wild-Type p53 Protein is Mediated by the Central Part of the Molecule and Controlled by Its C Terminus. Cancer Detect Prev 1998;22:1-13. [DOI: 10.1046/j.1525-1500.1998.00003.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
418 Heidenreich A, Schenkman NS, Sesterhenn IA, Mostofi KF, Moul JW, Srivastava S, Engelmann UH. Immunohistochemical and mutational analysis of the p53 tumour suppressor gene and the bcl-2 oncogene in primary testicular germ cell tumours. APMIS 1998;106:90-100. [DOI: 10.1111/j.1699-0463.1998.tb01324.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
419 Lelièvre V, Muller J, Falcón J. Adenosine modulates cell proliferation in human colonic adenocarcinoma. I. Possible involvement of adenosine A1 receptor subtypes in HT29 cells. European Journal of Pharmacology 1998;341:289-97. [DOI: 10.1016/s0014-2999(97)01462-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
420 Lee C, Chou S. p53 protein immunoreactivity in fibrohistiocytic tumors of the skin. Pathology 1998;30:272-5. [DOI: 10.1080/00313029800169436] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
421 Peller S, Yona R, Kopilova Y, Prokocimer M, Goldfinger N, Uysal A, Karabulut HG, Tukun A, Bokesoy I, Tuncman G, Rotter V. Molecular alterations in theTP53 gene of peripheral blood cells of patients with chronic myeloid leukemia. Genes Chromosom Cancer 1998;21:2-7. [DOI: 10.1002/(sici)1098-2264(199801)21:1<2::aid-gcc2>3.0.co;2-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
422 Tominaga O, Nita ME, Nagawa H, Fujii S, Tsuruo T, Muto T. Expressions of cell cycle regulators in human colorectal cancer cell lines. Jpn J Cancer Res. 1997;88:855-860. [PMID: 9369933 DOI: 10.1111/j.1349-7006.1997.tb00461.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
423 Plummer SJ, Paris MJ, Myles J, Tubbs R, Crowe J, Casey G. Four regions of allelic imbalance on 17q12-qter associated with high-grade breast tumors. Genes Chromosom Cancer 1997;20:354-62. [DOI: 10.1002/(sici)1098-2264(199712)20:4<354::aid-gcc6>3.0.co;2-0] [Cited by in Crossref: 34] [Article Influence: 1.4] [Reference Citation Analysis]
424 Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci U S A 1997;94:10895-900. [PMID: 9380731 DOI: 10.1073/pnas.94.20.10895] [Cited by in Crossref: 234] [Cited by in F6Publishing: 232] [Article Influence: 9.4] [Reference Citation Analysis]
425 Jia LQ, Osada M, Ishioka C, Gamo M, Ikawa S, Suzuki T, Shimodaira H, Niitani T, Kudo T, Akiyama M, Kimura N, Matsuo M, Mizusawa H, Tanaka N, Koyama H, Namba M, Kanamaru R, Kuroki T. Screening the p53 status of human cell lines using a yeast functional assay. Mol Carcinog 1997;19:243-53. [PMID: 9290701 DOI: 10.1002/(sici)1098-2744(199708)19:4<243::aid-mc5>3.0.co;2-d] [Cited by in Crossref: 118] [Cited by in F6Publishing: 51] [Article Influence: 4.7] [Reference Citation Analysis]
426 Salem CE, Tomasic NA, Elmajian DA, Esrig D, Nichols PW, Taylor CR, Skinner DG, Roy-burman P, Lieskovsky G, Cote RJ. p53 Protein and Gene Alterations in Pathological Stage C Prostate Carcinoma. Journal of Urology 1997;158:510-4. [DOI: 10.1016/s0022-5347(01)64520-8] [Cited by in Crossref: 15] [Article Influence: 0.6] [Reference Citation Analysis]
427 Shao R, Shimizu T, Pommier Y. 7-Hydroxystaurosporine (UCN-01) Induces Apoptosis in Human Colon Carcinoma and Leukemia Cells Independently of p53. Experimental Cell Research 1997;234:388-97. [DOI: 10.1006/excr.1997.3650] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 2.1] [Reference Citation Analysis]
428 Heise C, Sampson-Johannes A, Williams A, McCormick F, Von Hoff DD, Kirn DH. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat Med. 1997;3:639-645. [PMID: 9176490 DOI: 10.1038/nm0697-639] [Cited by in Crossref: 625] [Cited by in F6Publishing: 545] [Article Influence: 25.0] [Reference Citation Analysis]
429 Yagi K, Kunitomo K, Ii K, Tashiro S. Relationship of P-glycoprotein and p53 protein to chemosensitivity in colorectal cancer. Int J Clin Oncol 1997;2:81-91. [DOI: 10.1007/bf02488878] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
430 Rey A, Lara PC, Redondo E, Apolinario EVR. Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter: Relation to tumor proliferation and survival. Cancer 1997;79:2178-85. [DOI: 10.1002/(sici)1097-0142(19970601)79:11<2178::aid-cncr16>3.0.co;2-t] [Cited by in Crossref: 43] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
431 Djelloul S, Forgue-Lafitte ME, Hermelin B, Mareel M, Bruyneel E, Baldi A, Giordano A, Chastre E, Gespach C. Enterocyte differentiation is compatible with SV40 large T expression and loss of p53 function in human colonic Caco-2 cells. Status of the pRb1 and pRb2 tumor suppressor gene products. FEBS Lett 1997;406:234-42. [PMID: 9136893 DOI: 10.1016/s0014-5793(97)00208-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
432 Kang M, Mitomi H, Sada M, Tokumitsu Y, Takahashi Y, Igarashi M, Katsumata T, Okayasu I. Ki-67, p53, and Bcl-2 expression of serrated adenomas of the colon. Am J Surg Pathol. 1997;21:417-423. [PMID: 9130988 DOI: 10.1097/00000478-199704000-00007] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 1.9] [Reference Citation Analysis]
433 Yao T, Utsunomiya T, Nagai E, Oya M, Tsuneyoshi M. p53 expression patterns in colorectal adenomas and early carcinomas: a special reference to depressed adenoma and non-polypoid carcinoma. Pathol Int. 1996;46:962-967. [PMID: 9110348 DOI: 10.1111/j.1440-1827.1996.tb03575.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
434 Chaves P, Pereira AD, Pinto A, Oliveira AG, Queimado L, Glória L, Cardoso P, Mira FC, Soares J. p53 protein immunoexpression in esophageal squamous cell carcinoma and adjacent epithelium. J Surg Oncol 1997;65:3-9. [DOI: 10.1002/(sici)1096-9098(199705)65:1<3::aid-jso2>3.0.co;2-c] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
435 Caruana SM, Zwiebel N, Cocker R, Mccormick SA, Eberle RC, Lazarus P. p53 alteration and human papilloma virus infection in paranasal sinus cancer. Cancer 1997;79:1320-8. [DOI: 10.1002/(sici)1097-0142(19970401)79:7<1320::aid-cncr8>3.0.co;2-k] [Cited by in Crossref: 45] [Article Influence: 1.8] [Reference Citation Analysis]
436 Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature 1997;386:623-7. [DOI: 10.1038/386623a0] [Cited by in Crossref: 1277] [Cited by in F6Publishing: 1198] [Article Influence: 51.1] [Reference Citation Analysis]
437 Arita D, Kambe M, Ishioka C, Kanamaru R. Induction of p53-independent apoptosis associated with G2M arrest following DNA damage in human colon cancer cell lines. Jpn J Cancer Res 1997;88:39-43. [PMID: 9045894 DOI: 10.1111/j.1349-7006.1997.tb00299.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
438 Ronca F, Chan SL, Yu VC. 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine induces apoptosis in human neuroblastoma cells, SH-SY5Y, through a p53-dependent pathway. J Biol Chem 1997;272:4252-60. [PMID: 9020141 DOI: 10.1074/jbc.272.7.4252] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 1.9] [Reference Citation Analysis]
439 Yeudall WA, Jakus J, Ensley JF, Robbins KC. Functional characterization of p53 molecules expressed in human squamous cell carcinomas of the head and neck. Mol Carcinog 1997;18:89-96. [PMID: 9049184 DOI: 10.1002/(sici)1098-2744(199702)18:2<89::aid-mc4>3.0.co;2-l] [Cited by in Crossref: 30] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
440 Wang A, Yoshimi N, Ino N, Tanaka T, Mori H. WAF1 expression andp53 mutations in human colorectal cancers. J Cancer Res Clin Oncol 1997;123:118-23. [DOI: 10.1007/bf01269890] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
441 Zhu Q, White F, Tipoe G. p53 Oncoprotein accumulation in adenoid cystic carcinoma of parotid and palatine salivary glands. Pathology 1997;29:154-8. [DOI: 10.1080/00313029700169784] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
442 Tomita T. p53 And proliferating cell nuclear antigen in endocrine tumors of pancreas and intestinal carcinoids. Pathology 1997;29:147-53. [DOI: 10.1080/00313029700169774] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
443 Tomida A, Yun J, Tsuruo T. Glucose-regulated stresses induce resistance to camptothecin in human cancer cells. Int J Cancer 1996;68:391-6. [PMID: 8903483 DOI: 10.1002/(SICI)1097-0215(19961104)68:3<391::AID-IJC19>3.0.CO;2-B] [Cited by in Crossref: 34] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
444 Carethers JM. THE CELLULAR AND MOLECULAR PATHOGENESIS OF COLORECTAL CANCER. Gastroenterology Clinics of North America 1996;25:737-54. [DOI: 10.1016/s0889-8553(05)70272-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
445 Chakravarty G, Redkar A, Mittra I. A comparative study of detection of p53 mutations in human breast cancer by flow cytometry, single-strand conformation polymorphism and genomic sequencing. Br J Cancer 1996;74:1181-7. [PMID: 8883402 DOI: 10.1038/bjc.1996.514] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
446 Matsuda K, Watanabe H, Ajioka Y, Kobayashi M, Satto H, Sasaki M, Yasuda K, Kuwabara A, Nishikura K, Muto T. Ulcerative colitis with overexpression of p53 preceding overt histological abnormalities of the epithelium. J Gastroenterol 1996;31:860-7. [DOI: 10.1007/bf02358616] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
447 Takei K, Watanabe H, Itol T, Saito T. p53 and Ki-67 immunoreactivity and nuclear morphometry of ‘carcinoma-in-adenoma’ and adenoma of the gall-bladder. Pathology International 1996;46:908-17. [DOI: 10.1111/j.1440-1827.1996.tb03569.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 0.9] [Reference Citation Analysis]
448 Morin PJ, Vogelstein B, Kinzler KW. Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci. 1996;93:7950-7954. [PMID: 8755583 DOI: 10.1073/pnas.93.15.7950] [Cited by in Crossref: 308] [Cited by in F6Publishing: 312] [Article Influence: 11.8] [Reference Citation Analysis]
449 Crist KA, Fuller RD, Chaudhuri B, Chaudhuri P, You M. Brief communication, P53 accumulation in N-methyl-N-nitrosourea-induced rat mammary tumors. Toxicol Pathol 1996;24:370-5. [PMID: 8736394 DOI: 10.1177/019262339602400314] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
450 Fujioka M, Shimada K, Kitazawa S, Maeda S. Molecular characterization of a novel cancer cell line established from human carcinoma in pleomorphic adenoma (CaPA-4). Int J Cancer 1996;67:204-10. [PMID: 8760589 DOI: 10.1002/(SICI)1097-0215(19960717)67:2<204::AID-IJC10>3.0.CO;2-B] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
451 Hirota Y, Horiuchi T, Akahane K. p53 antisense oligonucleotide inhibits growth of human colon tumor and normal cell lines. Jpn J Cancer Res 1996;87:735-42. [PMID: 8698624 DOI: 10.1111/j.1349-7006.1996.tb00286.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
452 Aizawa S, Sasaki M, Wada R, Koyama M, Yagihashi S. P53 protein expression in pancreatic tumors and its relationship to clinicopathological factors and prognosis. J Surg Oncol 1996;62:279-83. [PMID: 8691842 DOI: 10.1002/(SICI)1096-9098(199608)62:4<279::AID-JSO11>3.0.CO;2-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
453 Slebos RJ, Baas IO, Clement M, Polak M, Mulder JW, van den Berg FM, Hamilton SR, Offerhaus GJ. Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma. Br J Cancer 1996;74:165-71. [PMID: 8688317 DOI: 10.1038/bjc.1996.333] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 1.6] [Reference Citation Analysis]
454 Smith DR, Ji CY, Goh HS. Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas. Br J Cancer 1996;74:216-23. [PMID: 8688324 DOI: 10.1038/bjc.1996.340] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 2.2] [Reference Citation Analysis]
455 De Luca A, Santra M, Baldi A, Giordano A, Iozzo RV. Decorin-induced Growth Suppression Is Associated with Up-regulation of p21, an Inhibitor of Cyclin-dependent Kinases. Journal of Biological Chemistry 1996;271:18961-5. [DOI: 10.1074/jbc.271.31.18961] [Cited by in Crossref: 171] [Cited by in F6Publishing: 172] [Article Influence: 6.6] [Reference Citation Analysis]
456 Fredrikson M, Axelson O, Sun XF, Arbman G, Nilsson E, Nordenskjöld B, Sjödahl R, Söderkvist P. A pilot study on risk factors and p53 gene expression in colorectal cancer. Br J Cancer 1996;73:1428-30. [PMID: 8645592 DOI: 10.1038/bjc.1996.271] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
457 Maruyama K, Tanaka T, Baba S, Nakamura S, Endo Y, Sugimura H. p53 accumulation in colorectal cancer with hepatic metastasis. Jpn J Cancer Res 1996;87:368-76. [PMID: 8641968 DOI: 10.1111/j.1349-7006.1996.tb00232.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
458 Klemi PJ, Pylkkänen L, Kiilholma P, Kurvinen K, Joensuu H. p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma. Cancer 1995;76:1201-8. [PMID: 8630898 DOI: 10.1002/1097-0142(19951001)76:7<1201::aid-cncr2820760716>3.0.co;2-l] [Cited by in Crossref: 82] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
459 Theobald M, Biggs J, Dittmer D, Levine AJ, Sherman LA. Targeting p53 as a general tumor antigen. Proc Natl Acad Sci U S A 1995;92:11993-7. [PMID: 8618830 DOI: 10.1073/pnas.92.26.11993] [Cited by in Crossref: 196] [Cited by in F6Publishing: 175] [Article Influence: 7.5] [Reference Citation Analysis]
460 Takei K, Watanabe H, Itoi T, Saito T. p53 and Ki-67 immunoreactivity and nuclear morphometry of ‘carcinoma-in-adenoma’ and adenoma of the gall-bladder. Pathology International 1996;46:426-35. [DOI: 10.1111/j.1440-1827.1996.tb03633.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
461 Park DJ, Chumakov AM, Miller CW, Pham EY, Koeffler HP. p53 transactivation through various p53-responsive elements. Mol Carcinog 1996;16:101-8. [DOI: 10.1002/(sici)1098-2744(199606)16:2<101::aid-mc6>3.0.co;2-l] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
462 Kato M, Ito Y, Kobayashi S, Isono K. Detection of DCC and Ki-ras gene alterations in colorectal carcinoma tissue as prognostic markers for liver metastatic recurrence. Cancer 1996;77:1729-35. [PMID: 8608570 DOI: 10.1002/(SICI)1097-0142(19960415)77:8<1729::AID-CNCR47>3.0.CO;2-Z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
463 Roth JA. Modification of Tumor Suppressor Gene Expression and Induction of Apoptosis in Non-Small Cell Lung Cancer (NSCLC) with an Adenovirus Vector Expressing Wildtype p53 and Cisplatin. University of Texas M.D. Anderson Cancer Center, Houston, Texas. Human Gene Therapy 1996;7:1013-30. [DOI: 10.1089/hum.1996.7.8-1013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
464 Sameshima S, Kubota Y, Sawada T, Watanabe T, Kuroda T, Tsuno N, Higuchi Y, Shinozaki M, Sunouchi K, Masaki T, Saito Y, Muto T. Overexpression of p53 protein and histologic grades of dysplasia in colorectal adenomas. Diseases of the Colon & Rectum 1996;39:562-7. [DOI: 10.1007/bf02058712] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
465 Roth JA. Modification of Tumor Suppressor Gene Expression in Non-Small Cell Lung Cancer (NSCLC) with a Retroviral Vector Expressing Wildtype (normal) p53. University of Texas M.D. Anderson Cancer Center, Houston, Texas. Human Gene Therapy 1996;7:861-74. [DOI: 10.1089/hum.1996.7.7-861] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
466 Sandberg AA, Meloni AM, Suijkerbuijk RF. Reviews of Chromosome Studies in Urological Tumors. III. Cytogenetics and Genes in Testicular Tumors. Journal of Urology 1996;155:1531-56. [DOI: 10.1016/s0022-5347(01)66124-x] [Cited by in Crossref: 91] [Article Influence: 3.5] [Reference Citation Analysis]
467 Kusama K, Okutsu S, Takeda A, Himiya T, Kojima A, Kidokoro Y, Chu L, Iwanari S, Kudo I, Moro I. p53 GENE ALTERATIONS AND p53 PROTEIN IN ORAL EPITHELIAL DYSPLASIA AND SQUAMOUS CELL CARCINOMA. J Pathol 1996;178:415-21. [DOI: 10.1002/(sici)1096-9896(199604)178:4<415::aid-path548>3.0.co;2-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
468 Ieda S, Watatani M, Yoshida T, Kuroda K, Inui H, Yasutomi M. Immunohistochemical analysis of p53 and ras p21 expression in colorectal adenomas and early carcinomas. Surg Today 1996;26:230-5. [DOI: 10.1007/bf00311580] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
469 Payne CM, Bernstein C, Bernstein H. Apoptosis overview emphasizing the role of oxidative stress, DNA damage and signal-transduction pathways. Leuk Lymphoma 1995;19:43-93. [PMID: 8574171 DOI: 10.3109/10428199509059662] [Cited by in Crossref: 109] [Cited by in F6Publishing: 103] [Article Influence: 4.2] [Reference Citation Analysis]
470 Kawamura T, Goseki N, Koike M, Takizawa T, Endo M. Acceleration of proliferative activity of esophageal squamous cell carcinoma with invasion beyond the mucosa: Immunohistochemical analysis of Ki-67 and p53 antigen in relation to histopathologic findings. Cancer 1996;77:843-9. [DOI: 10.1002/(sici)1097-0142(19960301)77:5<843::aid-cncr6>3.0.co;2-f] [Cited by in Crossref: 22] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
471 Tang HY, Weber KL, Lawrence TS, Merchant AK, Maybaum J. Dependence of fluorodeoxyuridine-induced cytotoxicity and megabase DNA fragment formation on S phase progression in HT29 cells. Cancer Chemother Pharmacol 1996;37:486-90. [DOI: 10.1007/s002800050416] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
472 Peller S, Kopilova Y, Slutzki S, Halevy A, Kvitko K, Rotter V. A novel polymorphism in intron 6 of the human p53 gene: a possible association with cancer predisposition and susceptibility. DNA Cell Biol 1995;14:983-90. [PMID: 8534372 DOI: 10.1089/dna.1995.14.983] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.2] [Reference Citation Analysis]
473 Kashiwagi H, Spigelman AD, Talbot IC, Phillip RKS. Overexpression of p53 in duodenal tumours in patients with familial adenomatous polyposis. Br J Surg 1996;83:225-8. [DOI: 10.1002/bjs.1800830223] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
474 Chen YH, Li CD, Yap EP, McGee JO. Detection of loss of heterozygosity of p53 gene in paraffin-embedded breast cancers by non-isotopic PCR-SSCP. J Pathol 1995;177:129-34. [PMID: 7490678 DOI: 10.1002/path.1711770205] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
475 El-habashil A, Freeman S, El-morsi B, Morris GF, Marroqi A. p53 and PCNA Coexpression of 81 Pleural and Peritoneal Effusion Specimens: An Immunohistochemical Study. Pathology - Research and Practice 1996;192:834-9. [DOI: 10.1016/s0344-0338(96)80057-4] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
476 Polkowski W, van Lanschot JJ, Ten Kate FJ, Baak JP, Tytgat GN, Obertop H, Voorn WJ, Offerhaus GJ. The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence. Surg Oncol. 1995;4:163-171. [PMID: 7582189 DOI: 10.1016/S0960-7404(10)80021-0] [Cited by in Crossref: 55] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
477 Iwai K, Hachisuga T, Iwasaka T, Sugimori H. Immunohistochemical detection of p53 overexpression in formalin-fixed, paraffin-embedded sections of endometrial carcinoma. J Obstet Gynaecol (Tokyo 1995) 1995;21:593-600. [PMID: 8640471 DOI: 10.1111/j.1447-0756.1995.tb00918.x] [Reference Citation Analysis]
478 Ng IO, Lai EC, Chan AS, So MK. Overexpression of p53 in hepatocellular carcinomas: a clinicopathological and prognostic correlation. J Gastroenterol Hepatol. 1995;10:250-255. [PMID: 7548799 DOI: 10.1111/j.1440-1746.1995.tb01089.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
479 Grewal H, Guillem JG, Klimstra DS, Cohen AM. p53 Nuclear overexpression may not be an independent prognostic marker in early colorectal cancer. Diseases of the Colon & Rectum 1995;38:1176-81. [DOI: 10.1007/bf02048333] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
480 Lee CS, Pirdas A, Lee MW. p53 in cutaneous melanoma: Immunoreactivity and correlation with prognosis. Australas J Dermatol 1995;36:192-5. [DOI: 10.1111/j.1440-0960.1995.tb00971.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
481 Lee CS, Pirdas A. p53 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater. Pathology. 1995;27:117-120. [PMID: 7567135 DOI: 10.1080/00313029500169692] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
482 Hasegawa H, Ueda M, Furukawa K, Watanabe M, Teramoto T, Mukai M, Kitajima M. p53 gene mutations in early colorectal carcinoma. De novo vs. adenoma-carcinoma sequence. Int J Cancer 1995;64:47-51. [PMID: 7665248 DOI: 10.1002/ijc.2910640110] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
483 Subramaniam P, Sinha SN, Wilkinson S. Immunohistochemical detection of p53 and the recurrence of rectal adenocarcinoma. Aust N Z J Surg 1995;65:740-2. [PMID: 7487716 DOI: 10.1111/j.1445-2197.1995.tb00549.x] [Reference Citation Analysis]
484 Poremba C, W. Yandell D, Mellin W, W. Schmid K, Reers B, Böcker W, Dockhorn-dworniczak B. Adenocarcinoma of the Cardia in a Young Man: Detection of Somatic p53 Mutation by Immunohistochemistry and Automated Direct Sequencing. Pathology - Research and Practice 1995;191:1004-9. [DOI: 10.1016/s0344-0338(11)80599-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
485 Younes M, Riley S, Genta RM, Mosharaf M, Mody DR. p53 protein accumulation in tumors of the ampulla of Vater. Cancer 1995;76:1150-4. [DOI: 10.1002/1097-0142(19951001)76:7<1150::aid-cncr2820760709>3.0.co;2-e] [Cited by in Crossref: 26] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
486 Shiff SJ, Qiao L, Tsai LL, Rigas B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest. 1995;96:491503. [PMID: 7615821 DOI: 10.1172/jci118060] [Cited by in Crossref: 267] [Cited by in F6Publishing: 59] [Article Influence: 9.9] [Reference Citation Analysis]
487 Akashi M, Hachiya M, Osawa Y, Spirin K, Suzuki G, Koeffler HP. Irradiation Induces WAF1 Expression through a p53-independent Pathway in KG-1 Cells. Journal of Biological Chemistry 1995;270:19181-7. [DOI: 10.1074/jbc.270.32.19181] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 1.4] [Reference Citation Analysis]
488 Fléjou JF, Muzeau F, Potet F, Lepelletier F, Fékété F, Hénin D. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas. Pathol Res Pract. 1994;190:1141-1148. [PMID: 7540752 DOI: 10.1016/s0344-0338(11)80440-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
489 Bland KI, Konstadoulakis MM, Vezeridis MP, Wanebo HJ. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg. 1995;221:706-18; discussion 718-20. [PMID: 7794075 DOI: 10.1097/00000658-199506000-00010] [Cited by in Crossref: 88] [Cited by in F6Publishing: 79] [Article Influence: 3.3] [Reference Citation Analysis]
490 Mulder JW, Baas IO, Polak MM, Goodman SN, Offerhaus GJ. Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma. Br J Cancer 1995;71:1257-62. [PMID: 7779721 DOI: 10.1038/bjc.1995.243] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 1.6] [Reference Citation Analysis]
491 Liu F, Ho ES, Chen J, Shih RT, Yang C, Shih A. Overexpression or mutation of the p53 tumor suppressor gene does not occur in malignant ovarian germ cell tumors. Cancer 1995;76:291-5. [DOI: 10.1002/1097-0142(19950715)76:2<291::aid-cncr2820760220>3.0.co;2-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
492 Piris MA, Villuendas R, Martinez JC, Sanchez-Beato M, Orradre JL, Mateo MS, Martinez P. p53 expression in non-Hodgkin's lymphomas: a marker of p53 inactivation? Leuk Lymphoma 1995;17:35-42. [PMID: 7773162 DOI: 10.3109/10428199509051701] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
493 Peller S, Halevy A, Slutzki S, Kopilova Y, Rotter V. p53 mutations in matched primary and metastatic human tumors. Mol Carcinog 1995;13:166-72. [DOI: 10.1002/mc.2940130306] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 0.8] [Reference Citation Analysis]
494 Ojanguren I, Ariza A, Castellà EM, Fernández-Vasalo A, Mate JL, Navas-Palacios JJ. p53 immunoreactivity in hepatocellular adenoma, focal nodular hyperplasia, cirrhosis and hepatocellular carcinoma. Histopathology. 1995;26:63-68. [PMID: 7713485 DOI: 10.1111/j.1365-2559.1995.tb00622.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
495 Zhang ZF, Zeng ZS, Sarkis AS, Klimstra DS, Charytonowicz E, Pollack D, Vena J, Guillem J, Marshall JR, Cordon-Cardo C. Family history of cancer, body weight, and p53 nuclear overexpression in Duke's C colorectal cancer. Br J Cancer. 1995;71:888-893. [PMID: 7710960 DOI: 10.1038/bjc.1995.171] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
496 Oohashi Y, Watanabe H, Ajioka Y, Hatakeyama K. p53 immunostaining distinguishes malignant from benign lesions of the gall-bladder. Pathol Int. 1995;45:58-65. [PMID: 7704245 DOI: 10.1111/j.1440-1827.1995.tb03380.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 1.4] [Reference Citation Analysis]
497 Hayashi N, Ito I, Nakamura Y, Yanagisawa A, Kato Y, Nakamori S, Imaoka S, Watanabe H, Hayashi N, Ogawa M, Nakamura Y. Genetic diagnosis of lymph-node metastasis in colorectal cancer. The Lancet 1995;345:1257-9. [DOI: 10.1016/s0140-6736(95)90922-2] [Cited by in Crossref: 203] [Cited by in F6Publishing: 42] [Article Influence: 7.5] [Reference Citation Analysis]
498 Costa A, Marasca R, Valentinis B, Savarino M, Faranda A, Silvestrini R, Torelli G. p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers. J Pathol 1995;176:45-53. [DOI: 10.1002/path.1711760108] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 1.6] [Reference Citation Analysis]
499 Li X, Tsuji T, Wen S, Sobhan F, Wang Z, Shinozaki F. Cytoplasmic expression of p53 protein and its morphological features in salivary gland lesions. J Oral Pathol Med 1995;24:201-5. [DOI: 10.1111/j.1600-0714.1995.tb01167.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
500 Nakanishi Y, Noguchi M, Mukai K, Matsuno Y, Hirohashi S, Saikawa M, Shimosato Y. p53 expression in multicentric squamous cell carcinoma and surrounding squamous epithelium of the upper aerodigestive tract. Immunohistochemical analysis of 95 lesions. Cancer 1995;75:1657-62. [DOI: 10.1002/1097-0142(19950401)75:7<1657::aid-cncr2820750716>3.0.co;2-g] [Cited by in Crossref: 30] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
501 Prendergast NJ, Walther PJ. Genetic Alterations in Prostate Adenocarcinoma. Surgical Oncology Clinics of North America 1995;4:241-55. [DOI: 10.1016/s1055-3207(18)30451-4] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
502 Oiwa H, Maehara Y, Ohno S, Sakaguchi Y, Ichiyoshi Y, Sugimachi K. Growth pattern and p53 overexpression in patients with early gastric cancer. Cancer 1995;75:1454-9. [DOI: 10.1002/1097-0142(19950315)75:6+<1454::aid-cncr2820751511>3.0.co;2-g] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
503 Li C, Suardet L, Little JB. Potential Role of WAF1/Cip1/p21 as a Mediator of TGF-β Cytoinhibitory Effect. Journal of Biological Chemistry 1995;270:4971-4. [DOI: 10.1074/jbc.270.10.4971] [Cited by in Crossref: 177] [Cited by in F6Publishing: 172] [Article Influence: 6.6] [Reference Citation Analysis]
504 Hamana T, Kawai K, Serizawa A, Tsutsumi Y, Watanabe K. Immunohistochemical demonstration of p53 protein in colorectal adenomas and adenocarcinomas. Reliable application of the heat-induced antigen retrieval method to formalin-fixed, paraffin-embedded material. Pathol Int 1994;44:765-70. [PMID: 7834078 DOI: 10.1111/j.1440-1827.1994.tb02924.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
505 Soini Y, Niemelä A, Kamel D, Herva R, Bloigu R, Pääkkö P, Vähäkangas K. p53 immunohistochemical positivity as a prognostic marker in intracranial tumours. APMIS 1994;102:786-92. [PMID: 7826609 DOI: 10.1111/j.1699-0463.1994.tb05235.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.6] [Reference Citation Analysis]
506 Yaginuma Y, Yamashita T, Takuma N, Katayama H, Ishikawa M. Analysis of the p53 gene in human choriocarcinoma cell lines. Br J Cancer 1995;71:9-12. [PMID: 7819056 DOI: 10.1038/bjc.1995.3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.6] [Reference Citation Analysis]
507 Nadal A, Campo E, Pinto J, Mallofré C, Palacín A, Arias C, Traserra J, Cardesa A. p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium. Absence of a correlation with prognostic factors. J Pathol 1995;175:181-8. [DOI: 10.1002/path.1711750205] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 1.5] [Reference Citation Analysis]
508 Niwa K, Itoh M, Murase T, Morishita S, Itoh N, Mori H, Tamaya T. Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significance. Br J Cancer 1994;70:1191-7. [PMID: 7981076 DOI: 10.1038/bjc.1994.472] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 1.6] [Reference Citation Analysis]
509 Smith-Ravin J, England J, Talbot IC, Bodmer W. Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients. Gut 1995;36:81-6. [PMID: 7890240 DOI: 10.1136/gut.36.1.81] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 2.5] [Reference Citation Analysis]
510 Froggatt NJ, Leveson SH, Garner RC. Low frequency and late occurrence ofp53 anddcc aberrations in colorectal tumours. J Cancer Res Clin Oncol 1995;121:7-15. [DOI: 10.1007/bf01202723] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
511 Dix B, Robbins P, Carrello S, House A, Iacopetta B. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br J Cancer. 1994;70:585-590. [PMID: 7917901 DOI: 10.1038/bjc.1994.355] [Cited by in Crossref: 87] [Cited by in F6Publishing: 88] [Article Influence: 3.1] [Reference Citation Analysis]
512 Browne SJ, Williams AC, Hague A, Butt AJ, Paraskeva C. Loss of APC protein expressed by human colonic epithelial cells and the appearance of a specific low-molecular-weight form is associated with apoptosis in vitro. Int J Cancer 1994;59:56-64. [PMID: 7927905 DOI: 10.1002/ijc.2910590113] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 1.3] [Reference Citation Analysis]
513 Chen Y, Chen PL, Lee WH. Hot-spot p53 mutants interact specifically with two cellular proteins during progression of the cell cycle. Mol Cell Biol 1994;14:6764-72. [PMID: 7935394 DOI: 10.1128/mcb.14.10.6764-6772.1994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.0] [Reference Citation Analysis]
514 Chen Y, Chen PL, Lee WH. Hot-spot p53 mutants interact specifically with two cellular proteins during progression of the cell cycle. Mol Cell Biol 1994;14:6764-72. [PMID: 7935394 DOI: 10.1128/mcb.14.10.6764-6772.1994] [Cited by in Crossref: 18] [Article Influence: 0.6] [Reference Citation Analysis]
515 Pezzella F, Micklem K, Turley H, Pulford K, Jones M, Kocialkowski S, Delia D, Aiello A, Bicknell R, Smith K. Antibody for detecting p53 protein by immunohistochemistry in normal tissues. J Clin Pathol 1994;47:592-6. [PMID: 8089212 DOI: 10.1136/jcp.47.7.592] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 0.9] [Reference Citation Analysis]
516 Auvinen A, Isola J, Visakorpi T, Koivula T, Virtanen S, Hakama M. Overexpression of p53 and long-term survival in colon carcinoma. Br J Cancer. 1994;70:293-296. [PMID: 8054278 DOI: 10.1038/bjc.1994.295] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 1.6] [Reference Citation Analysis]
517 Walker C, Robertson LJ, Myskow MW, Pendleton N, Dixon GR. p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas. Br J Cancer 1994;70:297-303. [PMID: 7914423 DOI: 10.1038/bjc.1994.296] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 1.5] [Reference Citation Analysis]
518 Yukawa M, Fujimori T, Maeda S, Tabuchi M, Nagasako K. Comparative clinicopathological and immunohistochemical study of ras and p53 in flat and polypoid type colorectal tumours. Gut 1994;35:1258-61. [PMID: 7959233 DOI: 10.1136/gut.35.9.1258] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 1.6] [Reference Citation Analysis]
519 Tanaka M, Omura K, Watanabe Y, Oda Y, Nakanishi I. Prognostic factors of colorectal cancer: K-ras mutation, overexpression of the p53 protein, and cell proliferative activity. J Surg Oncol 1994;57:57-64. [DOI: 10.1002/jso.2930570115] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 1.7] [Reference Citation Analysis]
520 Lewis DJ, Sesterhenn IA, McCarthy WF, Moul JW. Immunohistochemical expression of P53 tumor suppressor gene protein in adult germ cell testis tumors: clinical correlation in stage I disease. J Urol 1994;152:418-23. [PMID: 8015085 DOI: 10.1016/s0022-5347(17)32753-2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
521 Inoue M, Okayama A, Fujita M, Enomoto T, Sakata M, Tanizawa O, Ueshima H. Clinicopathological characteristics of p53 overexpression in endometrial cancers. Int J Cancer 1994;58:14-9. [PMID: 8014010 DOI: 10.1002/ijc.2910580104] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 1.7] [Reference Citation Analysis]
522 Patterson H, Gill S, Fisher C, Law MG, Jayatilake H, Fletcher CD, Thomas M, Grimer R, Gusterson BA, Cooper CS. Abnormalities of the p53 MDM2 and DCC genes in human leiomyosarcomas. Br J Cancer 1994;69:1052-8. [PMID: 8198970 DOI: 10.1038/bjc.1994.207] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 1.5] [Reference Citation Analysis]
523 Faille A, De Cremoux P, Extra JM, Linares G, Espie M, Bourstyn E, De Rocquancourt A, Giacchetti S, Marty M, Calvo F. p53 mutations and overexpression in locally advanced breast cancers. Br J Cancer 1994;69:1145-50. [PMID: 8198984 DOI: 10.1038/bjc.1994.225] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 1.7] [Reference Citation Analysis]
524 Duan L, Ozaki I, Oakes JW, Taylor JP, Khalili K, Pomerantz RJ. The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication. J Virol 1994;68:4302-13. [DOI: 10.1128/jvi.68.7.4302-4313.1994] [Cited by in Crossref: 67] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
525 Meyer JS, He W. High proliferative rates demonstrated by bromodeoxyuridine labeling index in breast carcinomas with p53 overexpression. J Surg Oncol 1994;56:146-52. [DOI: 10.1002/jso.2930560304] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
526 Lane DP. The regulation of p53 function: Steiner Award Lecture. Int J Cancer. 1994;57:623-627. [PMID: 8194867 DOI: 10.1002/ijc.2910570502] [Cited by in Crossref: 103] [Cited by in F6Publishing: 102] [Article Influence: 3.7] [Reference Citation Analysis]
527 Joypaul BV, Hopwood D, Newman EL, Qureshi S, Grant A, Ogston SA, Lane DP, Cuschieri A. The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma. Br J Cancer 1994;69:943-6. [PMID: 8180028 DOI: 10.1038/bjc.1994.182] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 2.3] [Reference Citation Analysis]
528 Lübbe J, Reichel M, Burg G, Kleihues P. Absence of p53 gene mutations in cutaneous melanoma. J Invest Dermatol 1994;102:819-21. [PMID: 8176269 DOI: 10.1111/1523-1747.ep12381544] [Cited by in Crossref: 87] [Cited by in F6Publishing: 74] [Article Influence: 3.1] [Reference Citation Analysis]
529 Hardwick RH, Shepherd NA, Moorghen M, Newcomb PV, Alderson D. Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence. Gut 1994;35:764-8. [PMID: 8020801 DOI: 10.1136/gut.35.6.764] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 1.4] [Reference Citation Analysis]
530 Ng HK, Lo SY, Huang DP, Poon WS. Paraffin section p53 protein immunohistochemistry in neuroectodermal tumors. Pathology 1994;26:1-5. [PMID: 8165016 DOI: 10.1080/00313029400169001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
531 Kawai A, Noguchi M, Beppu Y, Yokoyama R, Mukai K, Hirohashi S, Inoue H, Fukuma H. Nuclear immunoreaction of p53 protein in soft tissue sarcomas. A possible prognostic factor. Cancer 1994;73:2499-505. [DOI: 10.1002/1097-0142(19940515)73:10<2499::aid-cncr2820731008>3.0.co;2-g] [Cited by in Crossref: 95] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
532 Asamoto M, Mann AM, Macatee TL, Cohen SM. Mutations and expression of the p53 gene in rat bladder carcinomas and cell lines. Mol Carcinog 1994;9:236-44. [PMID: 8148056 DOI: 10.1002/mc.2940090408] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
533 Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B. Multifactorial analysis ofp53 alteration in human cancer: A review. Int J Cancer 1994;57:1-9. [DOI: 10.1002/ijc.2910570102] [Cited by in Crossref: 230] [Cited by in F6Publishing: 214] [Article Influence: 8.2] [Reference Citation Analysis]
534 Joypaul BV, Newman EL, Hopwood D, Grant A, Qureshi S, Lane DP, Cuschieri A. Expression of p53 protein in normal, dysplastic, and malignant gastric mucosa: an immunohistochemical study. J Pathol. 1993;170:279-283. [PMID: 8133401 DOI: 10.1002/path.1711700310] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 2.1] [Reference Citation Analysis]
535 Korkolopoulou P, Oates J, Kittas C, Crocker J. p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas. J Clin Pathol. 1994;47:9-14. [PMID: 7907610 DOI: 10.1136/jcp.47.1.9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 0.9] [Reference Citation Analysis]
536 Verpy E, Biasotto M, Meo T, Tosi M. Efficient detection of point mutations on color-coded strands of target DNA. Proc Natl Acad Sci U S A 1994;91:1873-7. [PMID: 8127898 DOI: 10.1073/pnas.91.5.1873] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 1.9] [Reference Citation Analysis]
537 Losi L, Di Gregorio C, Brausi M, Fante R, Hurlimann J. Expression of p53 Protein in Prostate Cancers of Different Histologic Types. Pathology - Research and Practice 1994;190:384-8. [DOI: 10.1016/s0344-0338(11)80411-5] [Cited by in Crossref: 8] [Article Influence: 0.3] [Reference Citation Analysis]
538 Inagaki T, Matsuwari S, Takahashi R, Shimada K, Fujie K, Maeda S. Establishment of human oral-cancer cell lines (KOSC-2 and -3) carrying p53 and c-myc abnormalities by geneticin treatment. Int J Cancer 1994;56:301-8. [PMID: 8314315 DOI: 10.1002/ijc.2910560226] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
539 Cesarman E, Liu YF, Knowles DM. The MDM2 oncogene is rarely amplified in human lymphoid tumors and does not correlate with p53 gene expression. Int J Cancer 1994;56:457-8. [PMID: 8314334 DOI: 10.1002/ijc.2910560329] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
540 Lohmann DR, Funk A, Niedermeyer HP, Häupel S, Höfler H. Identification of p53 gene mutations in gastrointestinal and pancreatic carcinoids by nonradioisotopic SSCA. Virchows Arch B Cell Pathol Incl Mol Pathol 1993;64:293-6. [PMID: 8287125 DOI: 10.1007/BF02915125] [Cited by in Crossref: 47] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
541 Aka K, Bruner JM, Bondy ML, Ligon K, Nishi T, del Giglio A, Moser RP, Levin VA, Saya H. Detection of p53 alterations in human astrocytomas using frozen tissue sections for the polymerase chain reaction. J Neurooncol 1993;16:125-33. [PMID: 7904621 DOI: 10.1007/BF01324699] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
542 Frank JL, Bur ME, Garb JL, Kay S, Ware JL, Sismanis A, Neifeld JP. p53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx. Cancer 1994;73:181-6. [PMID: 8275422 DOI: 10.1002/1097-0142(19940101)73:1<181::aid-cncr2820730131>3.0.co;2-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
543 Morrison BW. The Genetics of Breast Cancer. Hematology/Oncology Clinics of North America 1994;8:15-27. [DOI: 10.1016/s0889-8588(18)30185-0] [Cited by in Crossref: 4] [Article Influence: 0.1] [Reference Citation Analysis]
544 Wadayama B, Toguchida J, Yamaguchi T, Sasaki MS, Yamamuro T. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br J Cancer. 1993;68:1134-1139. [PMID: 8260365 DOI: 10.1038/bjc.1993.493] [Cited by in Crossref: 99] [Cited by in F6Publishing: 92] [Article Influence: 3.5] [Reference Citation Analysis]
545 Collier JD, Carpenter M, Burt AD, Bassendine MF. Expression of mutant p53 protein in hepatocellular carcinoma. Gut 1994;35:98-100. [PMID: 8307460 DOI: 10.1136/gut.35.1.98] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
546 Lee CS, Rush M, Charalambous D, Rode J. Immunohistochemical demonstration of the p53 tumour suppressor gene product in cancer of the pancreas and chronic pancreatitis. J Gastroenterol Hepatol 1993;8:465-9. [PMID: 8218996 DOI: 10.1111/j.1440-1746.1993.tb01550.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
547 Cooper K, Herrington CS, Evans MF, Gatter KC, McGee JO. p53 antigen in cervical condylomata, intraepithelial neoplasia, and carcinoma: relationship to HPV infection and integration. J Pathol. 1993;171:27-34. [PMID: 8229452 DOI: 10.1002/path.1711710107] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 0.8] [Reference Citation Analysis]
548 Suzuki T, Takano Y. Comparative immunohistochemical studies of p53 and proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions in pancreatic duct cell carcinomas. Jpn J Cancer Res 1993;84:1072-7. [PMID: 7901190 DOI: 10.1111/j.1349-7006.1993.tb02803.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.4] [Reference Citation Analysis]
549 Soini Y, Turpeenniemi-Hujanen T, Kamel D, Autio-Harmainen H, Risteli J, Risteli L, Nuorva K, Pääkkö P, Vähäkangas K. p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression. Br J Cancer 1993;68:1029-35. [PMID: 8217593 DOI: 10.1038/bjc.1993.475] [Cited by in Crossref: 60] [Cited by in F6Publishing: 43] [Article Influence: 2.1] [Reference Citation Analysis]
550 Koshiyama M, Konishi I, Wang DP, Mandai M, Komatsu T, Yamamoto S, Nanbu K, Naito MF, Mori T. Immunohistochemical analysis of p53 protein over-expression in endometrial carcinomas: inverse correlation with sex steroid receptor status. Virchows Arch A Pathol Anat Histopathol 1993;423:265-71. [PMID: 8236823 DOI: 10.1007/BF01606889] [Cited by in Crossref: 42] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
551 Chadburn A, Cesarman E, Jagirdar J, Subar M, Mir RN, Knowles DM. CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer 1993;72:3078-90. [DOI: 10.1002/1097-0142(19931115)72:10<3078::aid-cncr2820721033>3.0.co;2-f] [Cited by in Crossref: 89] [Cited by in F6Publishing: 4] [Article Influence: 3.1] [Reference Citation Analysis]
552 Roa I, Araya JC, Shiraishi T, Yatani R, Wistuba I, Villaseca M, Aretxabala XD. DNA content in gallbladder carcinoma: a flow cytometric study of 96 cases. Histopathology 1993;23:459-64. [DOI: 10.1111/j.1365-2559.1993.tb00495.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
553 Lee JC, Pillai S. Complete nucleotide sequence of MHC class I alleles in the HT29 colon cancer cell line. Tissue Antigens 1993;42:530-2. [PMID: 8146863 DOI: 10.1111/j.1399-0039.1993.tb02199.x] [Reference Citation Analysis]
554 Thomas DJ, Robinson M, King P, Hasan T, Charlton R, Martin J, Carr TW, Neal D. p53 Expression and Clinical Outcome in Prostate Cancer. British Journal of Urology 1993;72:778-81. [DOI: 10.1111/j.1464-410x.1993.tb16267.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
555 Joypaul BV, Vojtesek B, Newman EL, Hopwood D, Grant A, Lane DP, Cuschieri A. Enzyme-linked immunosorbent assay for p53 in gastrointestinal malignancy: comparison with immunohistochemistry. Histopathology 1993;23:465-70. [DOI: 10.1111/j.1365-2559.1993.tb00496.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
556 Brown R, Clugston C, Edlin A, Vasey P, Kaye SB, Burns P, Vojtěšek B. Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines. Int J Cancer 1993;55:678-84. [DOI: 10.1002/ijc.2910550428] [Cited by in Crossref: 143] [Cited by in F6Publishing: 136] [Article Influence: 4.9] [Reference Citation Analysis]
557 Rizzo MG, Soddu S, Tibursi G, Calabretta B, Sacchi A. Wild-type p53 differentially affects tumorigenic and metastatic potential of murine metastatic cell variants. Clin Exp Metastasis 1993;11:368-76. [PMID: 8375112 DOI: 10.1007/BF00132980] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
558 Smith DR, Myint T, Goh HS. Over-expression of the c-myc proto-oncogene in colorectal carcinoma. Br J Cancer 1993;68:407-13. [PMID: 8347498 DOI: 10.1038/bjc.1993.350] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 1.9] [Reference Citation Analysis]
559 Lipponen P, Ji H, Aaltomaa S, Syrjänen S, Syrjänen K. p53 protein expression in breast cancer as related to histopathological characteristics and prognosis. Int J Cancer 1993;55:51-6. [PMID: 8344753 DOI: 10.1002/ijc.2910550110] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 2.1] [Reference Citation Analysis]
560 Ogunbiyi OA, Scholefield JH, Smith JH, Polacarz SV, Rogers K, Sharp F. Immunohistochemical analysis of p53 expression in anal squamous neoplasia. J Clin Pathol 1993;46:507-12. [PMID: 8392521 DOI: 10.1136/jcp.46.6.507] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
561 Ullrich SJ, Sakaguchi K, Lees-Miller SP, Fiscella M, Mercer WE, Anderson CW, Appella E. Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53. Proc Natl Acad Sci U S A 1993;90:5954-8. [PMID: 8327466 DOI: 10.1073/pnas.90.13.5954] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 2.4] [Reference Citation Analysis]
562 Burns JE, Baird MC, Clark LJ, Burns PA, Edington K, Chapman C, Mitchell R, Robertson G, Soutar D, Parkinson EK. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. Br J Cancer 1993;67:1274-84. [PMID: 8390283 DOI: 10.1038/bjc.1993.238] [Cited by in Crossref: 90] [Cited by in F6Publishing: 90] [Article Influence: 3.1] [Reference Citation Analysis]
563 Vojtĕsek B, Fisher CJ, Barnes DM, Lane DP. Comparison between p53 staining in tissue sections and p53 proteins levels measured by an ELISA technique. Br J Cancer 1993;67:1254-8. [PMID: 7685617 DOI: 10.1038/bjc.1993.234] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 1.2] [Reference Citation Analysis]
564 Oka K, Nakano T, Arai T. p53CM1 expression is not associated with prognosis in uterine cervical carcinoma. Cancer 1993;72:160-4. [DOI: 10.1002/1097-0142(19930701)72:1<160::aid-cncr2820720130>3.0.co;2-c] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
565 Vojtesek B, Lane D. Regulation of p53 protein expression in human breast cancer cell lines. Journal of Cell Science 1993;105:607-12. [DOI: 10.1242/jcs.105.3.607] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 1.3] [Reference Citation Analysis]
566 Shimaya K, Shiozaki H, Inoue M, Tahara H, Monden T, Shimano T, Mori T. Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma. Vichows Archiv A Pathol Anat 1993;422:271-6. [DOI: 10.1007/bf01608335] [Cited by in Crossref: 61] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
567 Lauritzen AF, Hou-jensen K, Ralfkiaer E. P53 protein expression in Hodgkin's disease. APMIS 1993;101:689-94. [DOI: 10.1111/j.1699-0463.1993.tb00166.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
568 Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature. 1993;363:458-460. [PMID: 8099202 DOI: 10.1038/363458a0] [Cited by in Crossref: 1249] [Cited by in F6Publishing: 1029] [Article Influence: 43.1] [Reference Citation Analysis]
569 Fléjou JF, Potet F, Muzeau F, Le Pelletier F, Fékété F, Hénin D. Overexpression of p53 protein in Barrett's syndrome with malignant transformation. J Clin Pathol 1993;46:330-3. [PMID: 8496390 DOI: 10.1136/jcp.46.4.330] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 1.7] [Reference Citation Analysis]
570 Weiss J, Schwechheimer K, Cavenee WK, Herlyn M, Arden KC. Mutation and expression of the p53 gene in malignant melanoma cell lines. Int J Cancer 1993;54:693-9. [DOI: 10.1002/ijc.2910540427] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 2.3] [Reference Citation Analysis]
571 Furihata M, Ohtsuki Y, Ogoshi S, Takahashi A, Tamiya T, Ogata T. Prognostic significance of human papillomavirus genomes (type-16, -18) and aberrant expression of p53 protein in human esophageal cancer. Int J Cancer. 1993;54:226-230. [PMID: 8387463 DOI: 10.1002/ijc.2910540211] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 2.1] [Reference Citation Analysis]
572 Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, Halperin AJ, Baden HP, Shapiro PE, Bale AE. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A 1993;90:4216-20. [PMID: 8483937 DOI: 10.1073/pnas.90.9.4216] [Cited by in Crossref: 519] [Cited by in F6Publishing: 443] [Article Influence: 17.9] [Reference Citation Analysis]
573 Kramer R, Arceci R, Weber TK, Morse B, Simpson H, Steele GD, Summerhayes IC. Modulation of MDR-1 expression by a H-ras oncogene in a human colon carcinoma cell line. Int J Cancer 1993;54:275-81. [DOI: 10.1002/ijc.2910540219] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
574 Yin X, Smith ML, Whiteside TL, Locker J, Johnson JT, Herberman RB. Abnormalities in the p53 gene in tumors and cell lines of human squamous-cell carcinomas of the head and neck. Int J Cancer 1993;54:322-7. [DOI: 10.1002/ijc.2910540226] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
575 Scott N, Bell SM, Sagar P, Blair GE, Dixon MF, Quirke P. p53 expression and K-ras mutation in colorectal adenomas. Gut 1993;34:621-4. [PMID: 8504962 DOI: 10.1136/gut.34.5.621] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 1.2] [Reference Citation Analysis]
576 Singh S, Simon M, Meybohm I, Jantke I, Jonat W, Maass H, Goedde HW. Human breast cancer: frequent p53 allele loss and protein overexpression. Hum Genet 1993;90:635-40. [PMID: 8444469 DOI: 10.1007/BF00202481] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
577 Foord O, Navot N, Rotter V. Isolation and characterization of DNA sequences that are specifically bound by wild-type p53 protein. Mol Cell Biol 1993;13:1378-84. [PMID: 8441383 DOI: 10.1128/mcb.13.3.1378-1384.1993] [Cited by in Crossref: 21] [Article Influence: 0.7] [Reference Citation Analysis]
578 Kakeji Y, Korenaga D, Tsujitani S, Baba H, Anai H, Maehara Y, Sugimachi K. Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. Br J Cancer. 1993;67:589-593. [PMID: 8439509 DOI: 10.1038/bjc.1993.108] [Cited by in Crossref: 94] [Cited by in F6Publishing: 96] [Article Influence: 3.2] [Reference Citation Analysis]
579 Foord O, Navot N, Rotter V. Isolation and characterization of DNA sequences that are specifically bound by wild-type p53 protein. Mol Cell Biol 1993;13:1378-84. [PMID: 8441383 DOI: 10.1128/mcb.13.3.1378-1384.1993] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
580 Bosari S, Roncalli M, Viale G, Bossi P, Coggi G. p53 Immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix. J Pathol 1993;169:425-30. [DOI: 10.1002/path.1711690407] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 1.5] [Reference Citation Analysis]
581 Dei Tos AP, Doglioni C, Laurino L, Barbareschi M, Fletcher CD. p53 protein expression in non-neoplastic lesions and benign and malignant neoplasms of soft tissue. Histopathology 1993;22:45-50. [PMID: 8436341 DOI: 10.1111/j.1365-2559.1993.tb00068.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 2.1] [Reference Citation Analysis]
582 Evans HJ, Prosser J. Tumor-suppressor genes: cardinal factors in inherited predisposition to human cancers. Environ Health Perspect 1992;98:25-37. [PMID: 1336726 DOI: 10.1289/ehp.929825] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
583 Tsuda H, Hirohashi S. Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes. Jpn J Cancer Res 1992;83:1184-91. [PMID: 1336492 DOI: 10.1111/j.1349-7006.1992.tb02743.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 1.2] [Reference Citation Analysis]
584 Ueda Y, Dockhorn-Dworniczak B, Blasius S, Mellin W, Wuisman P, Böcker W, Roessner A. Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone. J Cancer Res Clin Oncol 1993;119:172-8. [PMID: 8418091 DOI: 10.1007/BF01229533] [Cited by in Crossref: 52] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
585 Lipponen PK. Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value. Int J Cancer 1993;53:365-70. [DOI: 10.1002/ijc.2910530304] [Cited by in Crossref: 182] [Cited by in F6Publishing: 156] [Article Influence: 6.3] [Reference Citation Analysis]
586 Yasui W, Ayhan A, Kitadai Y, Nishimura K, Yokozaki H, Ito H, Tahara E. Increased expression of p34cdc2 and its kinase activity in human gastric and colonic carcinomas. Int J Cancer. 1993;53:36-41. [PMID: 8416202 DOI: 10.1002/ijc.2910530108] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 2.5] [Reference Citation Analysis]
587 Bártek J, Bártková J, Lukáš J, Stašková Z, Vojtěšek B, Lane DP. Immunohtstochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies. J Pathol 1993;169:27-34. [DOI: 10.1002/path.1711690106] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 2.2] [Reference Citation Analysis]
588 Holm R, Skomedal H, Helland Å, Kristensen G, Bøsrresen A, Nesland JM. Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri. J Pathol 1993;169:21-6. [DOI: 10.1002/path.1711690105] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 1.6] [Reference Citation Analysis]
589 Ding-wei Y, Jia-fu Z, Song-xi Q, Young-jiang M. Expression of p53 product in Chinese human bladder carcinoma. Urol Res 1993;21:223-6. [DOI: 10.1007/bf00590040] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
590 Takahashi K, Sumimoto H, Suzuki K, Ono T. Protein synthesis—dependent cytoplasmic translocation of p53 protein after serum stimulation of growth-arrested MCF-7 cells. Mol Carcinog 1993;8:58-66. [DOI: 10.1002/mc.2940080112] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 0.7] [Reference Citation Analysis]
591 Pezzella F, Morrison H, Jones M, Gatter K, Lane D, Harris A, Mason D. Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphoma. Histopathology 1993;22:39-44. [DOI: 10.1111/j.1365-2559.1993.tb00067.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 72] [Article Influence: 2.6] [Reference Citation Analysis]
592 Smith ML, Yeleswarapu L, Lombardi B, Shinozuka H. Lack of mutations of thep53 tumor suppressor gene in hepatocellular carcinomas induced in rats by a peroxisome proliferator. Mol Carcinog 1993;7:89-93. [DOI: 10.1002/mc.2940070206] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
593 van Veldhuizen PJ, Sadasivan R, Garcia F, Austenfeld MS, Stephens RL. Mutant p53 expression in prostate carcinoma. Prostate 1993;22:23-30. [DOI: 10.1002/pros.2990220104] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 1.9] [Reference Citation Analysis]
594 Bowcock AM. Molecular cloning of BRCA1: a gene for early onset familial breast and ovarian cancer. Breast Cancer Res Tr 1993;28:121-35. [DOI: 10.1007/bf00666425] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
595 Boag G, Lee CS, Charalambous D, Rode J. p53 Expression in laryngeal carcinoma. Pathology 1993;25:394-7. [DOI: 10.3109/00313029309090866] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
596 Naito M, Satake M, Sakai E, Hirano Y, Tsuchida N, Kanzaki H, Ito Y, Mori T. Detection of p53 gene mutations in human ovarian and endometrial cancers by polymerase chain reaction-single strand conformation polymorphism analysis. Jpn J Cancer Res 1992;83:1030-6. [PMID: 1333465 DOI: 10.1111/j.1349-7006.1992.tb02717.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 0.9] [Reference Citation Analysis]
597 Hanski C, Bornhoeft G, Shimoda T, Hanski M, Lane DP, Stein H, Riecken E. Expression of p53 protein in invasive colorectal carcinomas of different histologic types. Cancer 1992;70:2772-7. [DOI: 10.1002/1097-0142(19921215)70:12<2772::aid-cncr2820701208>3.0.co;2-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
598 Tobal K, Warren W, Cooper CS, McCartney A, Hungerford J, Lightman S. Increased expression and mutation of p53 in choroidal melanoma. Br J Cancer 1992;66:900-4. [PMID: 1419633 DOI: 10.1038/bjc.1992.382] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.0] [Reference Citation Analysis]
599 Remvikos Y, Tominaga O, Hammel P, Laurent-Puig P, Salmon RJ, Dutrillaux B, Thomas G. Increased p53 protein content of colorectal tumours correlates with poor survival. Br J Cancer. 1992;66:758-764. [PMID: 1419618 DOI: 10.1038/bjc.1992.352] [Cited by in Crossref: 90] [Cited by in F6Publishing: 94] [Article Influence: 3.0] [Reference Citation Analysis]
600 Challen C, Lunec J, Warren W, Collier J, Bassendine MF. Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain. Hepatology 1992;16:1362-6. [PMID: 1332921 DOI: 10.1002/hep.1840160610] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 2.2] [Reference Citation Analysis]
601 Gupta RK, Norton AJ, Thompson IW, Lister TA, Bodmer JG. p53 expression in Reed-Sternberg cells of Hodgkin's disease. Br J Cancer 1992;66:649-52. [PMID: 1419601 DOI: 10.1038/bjc.1992.331] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 0.9] [Reference Citation Analysis]
602 Laurent-Puig P, Flejou JF, Fabre M, Bedossa P, Belghiti J, Gayral F, Franco D. Overexpression of p53: a rare event in a large series of white patients with hepatocellular carcinoma. Hepatology. 1992;16:1171-1175. [PMID: 1330867 DOI: 10.1002/hep.1840160511] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 1.2] [Reference Citation Analysis]
603 Kaklamanis L, Gatter KC, Mortensen N, Harris AL. Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer. Br J Cancer 1992;66:712-6. [PMID: 1419612 DOI: 10.1038/bjc.1992.343] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 0.7] [Reference Citation Analysis]
604 Watling DL, Gown AM, Coltrera MD. Overexpression of P53 in head and neck cancer. Head Neck 1992;14:437-44. [DOI: 10.1002/hed.2880140603] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 1.9] [Reference Citation Analysis]
605 Starzynska T, Bromley M, Ghosh A, Stern PL. Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer. 1992;66:558-562. [PMID: 1520594 DOI: 10.1038/bjc.1992.314] [Cited by in Crossref: 146] [Cited by in F6Publishing: 158] [Article Influence: 4.9] [Reference Citation Analysis]
606 Weber TK, Steele G, Summerhayes IC. Differential pp60c-src activity in well and poorly differentiated human colon carcinomas and cell lines. J Clin Invest 1992;90:815-21. [PMID: 1381724 DOI: 10.1172/JCI115956] [Cited by in Crossref: 38] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
607 Friedmann T. Gene therapy of cancer through restoration of tumor-suppressor functions? Cancer 1992;70:1810-7. [PMID: 1516033 DOI: 10.1002/1097-0142(19920915)70:4+<1810::aid-cncr2820701624>3.0.co;2-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
608 Wynford-Thomas D. P53 in tumour pathology: can we trust immunocytochemistry? J Pathol. 1992;166:329-330. [PMID: 1517889 DOI: 10.1002/path.1711660402] [Cited by in Crossref: 299] [Cited by in F6Publishing: 322] [Article Influence: 10.0] [Reference Citation Analysis]
609 Barbareschi M, Iuzzolino P, Pennella A, Allegranza A, Arrigoni G, Dalla Palma P, Doglioni C. p53 protein expression in central nervous system neoplasms. J Clin Pathol 1992;45:583-6. [PMID: 1355494 DOI: 10.1136/jcp.45.7.583] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 1.2] [Reference Citation Analysis]
610 Kafiri G, Thomas D, Shepherd N, Krausz T, Lane D, Hall P. p53 expression is common in malignant mesothelioma. Histopathology 1992;21:331-4. [DOI: 10.1111/j.1365-2559.1992.tb00403.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 1.7] [Reference Citation Analysis]
611 Warnakulasuriya KAAS, Johnson NW. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions. J Oral Pathol Med 1992;21:404-8. [DOI: 10.1111/j.1600-0714.1992.tb01028.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 2.6] [Reference Citation Analysis]
612 Lemoine NR, Hughes CM, Cowell JK. Aberrant expression of the tumour suppressor gene p53 is very frequent in Wilms' tumours. J Pathol 1992;168:237-42. [DOI: 10.1002/path.1711680213] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 0.7] [Reference Citation Analysis]
613 Jaros E, Perry RH, Adam L, Kelly PJ, Crawford PJ, Kalbag RM, Mendelow AD, Sengupta RP, Pearson AD. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer 1992;66:373-85. [PMID: 1503912 DOI: 10.1038/bjc.1992.273] [Cited by in Crossref: 183] [Cited by in F6Publishing: 184] [Article Influence: 6.1] [Reference Citation Analysis]
614 Takahashi K, Suzuki K, Uehara Y, Ono T. Growth inhibition by anchorage-deficiency is associated with increased level but reduced phosphorylation of mutant p53. Jpn J Cancer Res 1992;83:358-65. [PMID: 1506270 DOI: 10.1111/j.1349-7006.1992.tb00115.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
615 Dolcetti R, Doglioni C, Maestro R, Gasparotto D, Barzan L, Pastore A, Romanelli M, Boiocchi M. p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: Genetic and prognostic implications. Int J Cancer 1992;52:178-82. [DOI: 10.1002/ijc.2910520204] [Cited by in Crossref: 94] [Cited by in F6Publishing: 92] [Article Influence: 3.1] [Reference Citation Analysis]
616 Thompson SJ, Mellon K, Charlton RG, Marsh C, Robinson M, Neal DE. P53 and Ki-67 immunoreactivity in human prostate cancer and benign hyperplasia. Br J Urol 1992;69:609-13. [PMID: 1379102 DOI: 10.1111/j.1464-410x.1992.tb15632.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
617 Ronen D, Teitz Y, Goldfinger N, Rotter V. Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses. Nucleic Acids Res 1992;20:3435-41. [PMID: 1630914 DOI: 10.1093/nar/20.13.3435] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
618 Berchuck A, Kohler MF, Bast RC. Oncogenes in Ovarian Cancer. Hematology/Oncology Clinics of North America 1992;6:813-27. [DOI: 10.1016/s0889-8588(18)30311-3] [Cited by in Crossref: 18] [Article Influence: 0.6] [Reference Citation Analysis]
619 Jankowski J, Coghill G, Hopwood D, Wormsley KG. Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus. Gut 1992;33:1033-8. [PMID: 1398227 DOI: 10.1136/gut.33.8.1033] [Cited by in Crossref: 101] [Cited by in F6Publishing: 105] [Article Influence: 3.4] [Reference Citation Analysis]
620 Leonardi E, Girlando S, Serio G, Mauri FA, Perrone G, Scampini S, Dalla Palma P, Barbareschi M. PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables. J Clin Pathol 1992;45:416-9. [PMID: 1350788 DOI: 10.1136/jcp.45.5.416] [Cited by in Crossref: 189] [Cited by in F6Publishing: 173] [Article Influence: 6.3] [Reference Citation Analysis]
621 Seruca R, David L, Holm R, Nesland JM, Fangan BM, Castedo S, Sobrinho-Simões M, Børresen AL. p53 mutations in gastric carcinomas. Br J Cancer. 1992;65:708-710. [PMID: 1586599 DOI: 10.1038/bjc.1992.149] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 1.1] [Reference Citation Analysis]
622 Schärer E, Iggo R. Mammalian p53 can function as a transcription factor in yeast. Nucleic Acids Res 1992;20:1539-45. [PMID: 1579447 DOI: 10.1093/nar/20.7.1539] [Cited by in Crossref: 103] [Cited by in F6Publishing: 122] [Article Influence: 3.4] [Reference Citation Analysis]
623 Davidoff AM, Iglehart JD, Marks JR. Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc Natl Acad Sci U S A 1992;89:3439-42. [PMID: 1373500 DOI: 10.1073/pnas.89.8.3439] [Cited by in Crossref: 168] [Cited by in F6Publishing: 168] [Article Influence: 5.6] [Reference Citation Analysis]
624 Pignatelli M, Stamp GW, Kafiri G, Lane D, Bodmer WF. Over-expression of p53 nuclear oncoprotein in colorectal adenomas. Int J Cancer 1992;50:683-8. [PMID: 1347513 DOI: 10.1002/ijc.2910500503] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 1.8] [Reference Citation Analysis]
625 Hiyoshi H, Matsuno Y, Kato H, Shimosato Y, Hirohashi S. Clinicopathological significance of nuclear accumulation of tumor suppressor gene p53 product in primary lung cancer. Jpn J Cancer Res 1992;83:101-6. [PMID: 1544866 DOI: 10.1111/j.1349-7006.1992.tb02358.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 1.4] [Reference Citation Analysis]
626 Pierceall WE, Mukhopadhyay T, Goldberg LH, Ananthaswamy HN. Mutations in the p53 tumor suppressor gene in human cutaneous squamous cell carcinomas. Mol Carcinog 1991;4:445-9. [PMID: 1793482 DOI: 10.1002/mc.2940040606] [Cited by in Crossref: 87] [Cited by in F6Publishing: 80] [Article Influence: 2.9] [Reference Citation Analysis]
627 Barbareschi M, Girlando S, Mauri FA, Arrigoni G, Laurino L, Palma PD, Doglioni C. Tumour suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasms. J Pathol 1992;166:343-50. [DOI: 10.1002/path.1711660405] [Cited by in Crossref: 76] [Cited by in F6Publishing: 67] [Article Influence: 2.5] [Reference Citation Analysis]
628 Thompson AM, Anderson TJ, Condie A, Prosser J, Chetty U, Carter DC, Evans HJ, Steel CM. p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters. Int J Cancer 1992;50:528-32. [DOI: 10.1002/ijc.2910500405] [Cited by in Crossref: 101] [Cited by in F6Publishing: 106] [Article Influence: 3.4] [Reference Citation Analysis]
629 Barton CM, Staddon SL, Hughes CM, Hall PA, O’Sullivan C, Klöppel G, Theis B, Russell RC, Neoptolemos J, Williamson RC. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer. 1991;64:1076-1082. [PMID: 1764370 DOI: 10.1038/bjc.1991.467] [Cited by in Crossref: 257] [Cited by in F6Publishing: 253] [Article Influence: 8.6] [Reference Citation Analysis]
630 Walker RA, Dearing SJ, Lane DP, Varley JM. Expression of p53 protein in infiltrating and in-situ breast carcinomas. J Pathol 1991;165:203-11. [PMID: 1684809 DOI: 10.1002/path.1711650303] [Cited by in Crossref: 95] [Cited by in F6Publishing: 97] [Article Influence: 3.2] [Reference Citation Analysis]
631 Gjerset RA, Arya J, Volkman S, Haas M. Association of induction of a fully tumorigenic phenotype in murine radiation-induced T-lymphoma cells with loss of differentiation antigens, gain of CD44, and alterations in p53 protein levels. Mol Carcinog 1992;5:190-8. [DOI: 10.1002/mc.2940050305] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.2] [Reference Citation Analysis]
632 Fromentel CCD, Soussi T. TP53 tumor suppressor gene: A model for investigating human mutagenesis. Genes Chromosom Cancer 1992;4:1-15. [DOI: 10.1002/gcc.2870040102] [Cited by in Crossref: 334] [Cited by in F6Publishing: 333] [Article Influence: 11.1] [Reference Citation Analysis]
633 Risinger JI, Dent GA, Ignar-trowbridge D, Mclachlan JA, Tsao M, Senterman M, Boyd J. p53 gene mutations in human endometrial carcinoma. Mol Carcinog 1992;5:250-3. [DOI: 10.1002/mc.2940050403] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 1.9] [Reference Citation Analysis]
634 Saleeba JA, Ramus SJ, Cotton RGH. Complete mutation detection using unlabeled chemical cleavage. Hum Mutat 1992;1:63-9. [DOI: 10.1002/humu.1380010110] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
635 Mørkve O, Laerum OD. Flow cytometric measurement of p53 protein expression and DNA content in paraffin-embedded tissue from bronchial carcinomas. Cytometry 1991;12:438-44. [PMID: 1935458 DOI: 10.1002/cyto.990120509] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 0.8] [Reference Citation Analysis]
636 Davidoff AM, Kerns BM, Pence JC, Marks JR, Iglehart JD. p53 alterations in all stages of breast cancer. J Surg Oncol 1991;48:260-7. [DOI: 10.1002/jso.2930480409] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 0.7] [Reference Citation Analysis]
637 Foord OS, Bhattacharya P, Reich Z, Rotter V. A DNA binding domain is contained in the C-terminus of wild type p53 protein. Nucleic Acids Res 1991;19:5191-8. [PMID: 1923804 DOI: 10.1093/nar/19.19.5191] [Cited by in Crossref: 52] [Cited by in F6Publishing: 63] [Article Influence: 1.7] [Reference Citation Analysis]
638 Ciardiello F, Kim N, Saeki T, Dono R, Persico MG, Plowman GD, Garrigues J, Radke S, Todaro GJ, Salomon DS. Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc Natl Acad Sci USA. 1991;88:7792-7796. [PMID: 1715580 DOI: 10.1073/pnas.88.17.7792] [Cited by in Crossref: 164] [Cited by in F6Publishing: 151] [Article Influence: 5.3] [Reference Citation Analysis]
639 Iwaya K, Tsuda H, Hiraide H, Tamaki K, Tamakuma S, Fukutomi T, Mukai K, Hirohashi S. Nuclear p53 immunoreaction associated with poor prognosis of breast cancer. Jpn J Cancer Res 1991;82:835-40. [PMID: 1679056 DOI: 10.1111/j.1349-7006.1991.tb02710.x] [Cited by in Crossref: 127] [Cited by in F6Publishing: 126] [Article Influence: 4.1] [Reference Citation Analysis]
640 Bártkov´ J, Bártek J, Lukáŝ J, Vojtêŝek B, Staŝková Z, Rejthar A, Kova??ík J, Midgley CA, Lane DP. p53 Protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia. Int J Cancer 1991;49:196-202. [DOI: 10.1002/ijc.2910490209] [Cited by in Crossref: 97] [Cited by in F6Publishing: 90] [Article Influence: 3.1] [Reference Citation Analysis]
641 Wright C, Mellon K, Johnston P, Lane DP, Harris AL, Horne CH, Neal DE. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br J Cancer 1991;63:967-70. [PMID: 1712624 DOI: 10.1038/bjc.1991.211] [Cited by in Crossref: 135] [Cited by in F6Publishing: 121] [Article Influence: 4.4] [Reference Citation Analysis]
642 Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature. 1991;351:453-456. [PMID: 2046748 DOI: 10.1038/351453a0] [Cited by in Crossref: 2434] [Cited by in F6Publishing: 2457] [Article Influence: 78.5] [Reference Citation Analysis]
643 Gannon JV, Lane DP. Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport. Nature 1991;349:802-6. [PMID: 2000149 DOI: 10.1038/349802a0] [Cited by in Crossref: 121] [Cited by in F6Publishing: 133] [Article Influence: 3.9] [Reference Citation Analysis]
644 Wrede D, Tidy JA, Crook T, Lane D, Vousden KH. Expression of RB and p53 proteins in HPV-positive and HPV-negative cervical carcinoma cell lines. Mol Carcinog 1991;4:171-5. [DOI: 10.1002/mc.2940040302] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 1.5] [Reference Citation Analysis]
645 [DOI: 10.1101/293712] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]